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Abstract 
 
THE PHARMACIST SUPPLY IN THE UNITED STATES, 1994-2009:  
A POPULATION ECOLOGY PERSPECTIVE  
 
By Kevin Shawn Joseph Lett 
 
A dissertation submitted in partial fulfillment of the requirements  
for the degree of Doctor of Philosophy at Virginia Commonwealth University 
 
Major Director: Director: Dr. Michael A. Pyles 
 
The U.S. healthcare system is a complex segment of our society that is constantly 
evolving with changes to various areas such as education, financing, safety, and health.  There 
continues to be a critical examination of how healthcare professionals are trained and utilized as 
healthcare demands increase. One category of healthcare professionals that has evolved over 
time to address societal needs is pharmacists.  Pharmacists have kept their traditional function of 
dispensing medications while expanding into multiple areas of expertise and training from 
patient counseling and drug therapy, to being part of multidisciplinary teams treating acute care 
patients.   
According to the National Association of Boards of Pharmacy (NABP) in 2009 there 
were approximately 265,000 licensed pharmacists in the U.S. (NABP, 2010).  The Health 
Resources and Services Administration (HRSA) reported the settings with the largest number of 
positions are chain pharmacies (77,300), hospitals (49,200), and independent pharmacies 
(36,200) (DHHS, 2008).   
  
The ratio of pharmacists per 100,000 population is expected to increase from 68.9 
pharmacists per 100,000 population to 76.7 per 100,000 between 1995 and 2020 (Gershon, 
Cultice, & Knapp, 2000).  This increase in the pharmacist to population ratio is consistent with a 
growth rate of 13% during this time period of time.   
Until 1998, the supply of pharmacists in the U.S. appeared to be in reasonable balance 
with demand.  Market forces gradually upset the delicate balance between the supply of 
pharmacists and the demand for their services between 1998 and 2009.  In particular, a 
precipitous increase in the volume of prescription written and filled during this time period 
contributed to upsetting this delicate balance between the supply of pharmacists and demand 
(Cooksey, Walton, Stankewicz, & Knapp, 2003). 
Researchers have noted a number of environmental factors affecting the pharmacist 
supply in the U. S. This inquiry explores these factors within the context of the population 
ecology theoretical framework.  In addition to the volume of prescriptions, additional 
environmental factors believed to have a discernible impact on the pharmacist supply include, 
the number of physicians, size of the business industry and insurance coverage. Previous studies 
on pharmacists supply have pointed to income, physician population, and population among 
other variables that predict the demand for pharmacists (Walton, Cooksey, Knapp, Quist, & 
Miller, 2004; Cherry, D.K., Woodwell, D.A., & Rechtsteiner 2007; Walton, Knapp, Miller, & 
Schumock 2007).  U. S. physicians wrote over 4 billion prescriptions in 2007 (Medical 
Expenditure Panel Survey, 2008). Physicians are the primary healthcare providers that generate 
prescriptions to be filled.  Consequently, the number of physicians is believed to be a significant 
environmental factor affecting the supply of pharmacists.   
 There were approximately 940,000 physicians in the U. S. in 2008.  Projections call for 
continuous growth of the number of physicians well into the future (Smart, 2010).    Another 
important environmental factor potentially impacting the demand for pharmacists is the size of 
the business industry. In 2006, the health plan offer rate for large or medium organizations (50 or 
more employees) was 96.7% compared to 61.2% for small organizations (50 or less employees) 
(Sommers & Crimmel, 2008; Crimmel & Sommers, 2008).   
Insurance coverage has the potential to have a positive impact on the demand for 
pharmacists because it provides the opportunity to obtain required prescriptions (Ranji, Wyn, 
Salganicoff, & Yu, 2007; Weinick, Byron, & Bierman, 2005).  The population ecology 
theoretical framework has been used in the study of restaurants, newspapers, and physicians and 
their interactions with their surrounding environments.  The theoretical framework proved to be 
beneficial in the exploration of the pharmacist supply vis-á-vis the environment.   The primary 
constructs in the population ecology theory are carrying capacity and density.  Carrying capacity 
consists of two sub-constructs: munificence and concentration.  Density points to the current 
pharmacists supply and its impact on the future pharmacist supply.   
Numerous variables have been used in previous empirical studies of the pharmacist 
supply.  Among the indicators of munificence in previous studies in the extant literature on 
pharmacist supply are total population, elderly population, hospitals, and median household 
income.  In the present inquiry, total population was found to be a statistically significant 
environmental factor affecting the pharmacist supply.  This was hypothesized that there is a 
positive linear relationship between total population and the pharmacist supply.   
The number of hospitals with pharmacies was also found to be a statistically significant 
environmental factor affecting the pharmacist supply.  Hospital pharmacies are important venues 
 wherein pharmacists can demonstrate their unique expertise and make discernible contributions 
to desirable health care outcomes when pharmaceutical interventions are required.  In light of 
this empirical finding, it seems reasonable that a growth in hospital pharmacies corresponds with 
an increased demand for pharmacists (Kaboli, Hoth, McClimon, & Schnipper, 2006).  
Measures of the concentration dimension included the number of hospital beds per 
100,000 population, employer volume and size and the number of insured.  The only putative 
indicator of concentration that was found to be statistically significant in this inquiry was the 
number of employers with 20 or more employees.  Previous pharmacist supply was found to be a 
significant environmental factor affecting the pharmacist supply in the future.  Thus, density is a 
significant environmental factor affecting the pharmacist supply.  Five of the 13 hypotheses 
tested in this inquiry were accepted. These findings are consistent with related findings in the 
extant literature on the pharmacist supply.   
Empirical findings from this inquiry are believed to make significant contributions to the 
literature on the pharmacist supply.  The population ecology theoretical framework appears to be 
a suitable tool for exploring environmental factors affecting the pharmacist supply.  
Recommendations for future research are presented in the final chapter.   
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Chapter 1: Introduction 
 
Background on Pharmacist Supply  
The pharmacist supply continues to be one of great interest in a dynamic healthcare 
environment faced with increasing demand to fill a high volume of prescriptions for 
pharmaceuticals in addition to the infusion of multiple roles and responsibilities.  Pharmacist 
supply represents the third largest health professional group in the U.S. with approximately 
265,000 active pharmacists in 2009 (NABP, 2010).  The pharmacist supply has received 
significant attention over the past two decades.  In December 1999, the United States Congress 
directed the Secretary of Health and Human Services to conduct a study on the potential shortage 
of licensed pharmacists (Department of Health and Human Services [DHHS], 2000).  The Health 
Resources and Services Administration (HRSA) reported the settings with the largest number of 
positions are chain pharmacies (77,300), hospitals (49,200), and independent pharmacies 
(36,200) (DHHS, 2008).   
Synopsis of Pharmacist Demand 
While the pharmacist supply is increasing, there are multiple factors that can affect 
pharmacist supply levels.  One factor is the increased use of prescription medications.  
From 1997 to 2004, the number of prescriptions purchased increased by approximately 
one billion (Stagnitti, 2007).  There is no projection for the number of drugs being prescribed or 
dispensed subsiding in the near future.  
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Physicians are the primary healthcare professionals who write prescriptions filled by 
pharmacists.  An increase in prescription volume will lead to an increase in work volume and a 
potential need for pharmacists.  The number of physicians in the U.S. was approximately 
940,000 in 2008 with projections for continuous growth well into the future (Smart, 2010).  In 
2005 there were approximately 963 million physician office visits in the U.S. and over 679 
million of those visits resulted in medication being provided or prescribed by a physician 
(Cherry, Woodwell, & Rechtsteiner, 2007). Undoubtedly, for an increase in office visits and 
medications prescribed to patients to occur, there more than likely has been a gateway developed 
to attain care.  The increased access to healthcare through insurance coverage has created 
this gateway.    In 1995 the over 65 population accounted for 24% of all physician office visits; 
this percentage increased to 26% by 2005 (Cherry, Woodwell, & Rechtsteiner, 2007).  The 
implementation of Medicare Part D in 2006 allowed additional older Americans to receive 
medication benefits. The Centers for Medicare & Medicaid Services (CMS) estimated in 2004 
that 15 million of the 40 million Americans eligible for Medicare had no prescription drug 
coverage (Reissman, 2004).   
Implementation of Part D of Medicare could potentially help make 14 to 30 million 
prescriptions available to persons who may not have been able to afford their prescription drugs 
previously (Reissman, 2004).  The ability for one to afford prescriptions is an important driving 
force in the needed supply of pharmacists.  As noted by Reed (2005), approximately 51% of 
uninsured working adults surveyed did not purchase a prescription compared to 14% and 31.5% 
of working adults who have private and public insurance, respectively.   
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In addition to Medicare Part D, the Patient Protection and Affordable Care Act is 
estimated to give 32 million previously uninsured Americans insurance coverage (Stefanacci & 
Spivack, 2010).  This influx is projected to significantly increase prescription drug use (Matzke 
& Ross, 2010). Thus, the demand for traditional pharmacist services will rise as these new 
provisions take effect.  The volume of prescriptions has the ability to increase substantially in 
communities that can afford their medications.  Communities have a strong desire to retain their 
pharmacists because these individuals provide expert health advice, provide prescriptions, while 
serving either formally or informally as health educators, thereby improving the community’s 
public health (Manasse & Speedie, 2007).   
In addition to an analysis of the insured and prescribers, there are the facilities in which 
pharmacists provide their services.  The increase in the number of pharmacy facilities may also 
be an important predictor in reviewing the pharmacists supply.  The number of pharmacy chain 
drug stores has increased from approximately 51,000 in 1997 to approximately 56,000 in 2007 
(NACDS, 2007).  In conjunction with community pharmacies is the infrastructure for dispensing 
and distributing prescription medications.  These infrastructures consist of nearly 6,000 U.S, 
hospitals, mail order pharmacies and foreign sources for obtaining prescription medications 
(Manasse & Speedie, 2007).   
Studies on Pharmacist Supply and Limitations 
A number of studies have pointed to the importance of examining the pharmacist supply 
and have done so utilizing varying timeframes and variables.   Walton, Cooksey, Knapp, Quist, 
and Miller (2004) have examined the impact of supply and demand factors on filled pharmacist 
positions.  They reported that after controlling for population, the number of filled pharmacy 
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positions was significantly correlated with prescriptions, hospital days, pharmacies, and residents 
older than 65 years.  Although not addressed in the Walton et al. (2004) study, Cherry et al. 
(2007) reported that demand can be affected by the supply of physicians in a state.   
A second study by Walton and his colleagues 2007 examined the relationship between 
demographic and economic variables in their attempt to understand variations in the pharmacist 
supply in America.  Walton and his colleagues found that surrounding population size, 
community income levels, and the number of healthcare facilities all play a role in the future size 
of the pharmacist workforce. These results concurred with some of the evidence found in his 
previous study in 2004. 
Findings from extant studies on pharmacy supply in the literature, provides some insight 
into the relationship among environmental factors that may impact the pharmacist supply in 
America (Knapp, 1999; Manasse & Speedie, 2007; Burt 2002; Meissner et al., 2006; & 
Sommers, 2004, Mott et al., 2006; & Knapp et al, 2005).   An examination of pharmacist practice 
environment allows researchers, policy makers and healthcare administrators an opportunity 
ability to assess the demand for pharmacy services and address current local needs (American 
Society of Health System Pharmacists [ASHP], 2007).     
Conceptual Framework.  
The theoretical framework for this inquiry is that of the population ecology.  This 
theoretical framework is conducive to an exploration of the pharmacist supply and considers the 
environment.  The population ecology theoretical framework has been utilized to study 
restaurants, newspapers, and physicians and their interactions with their surrounding 
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environment (Freeman & Hannan, 1983; Carroll, 1984; Jiang & Begun, 2002), and is based on 
Darwin’s Theory of Evolution.   
Darwin’s Theory of Evolution looked at growth and decline among species while 
accounting for environmental factors (Darwin, 1859).  Darwin dismissed any premise that a 
population’s evolution could be attributed to a predetermined developmental trend (Bowler, 
2009).  Many theorists have concurred with Darwin’s assessment that environmental forces 
produce and shape populations that occupy and flourish in a particular geographical setting.  
 The selection of the population ecology theory was based upon its emphasis on 
organization-environment relationships (Hannan & Freeman, 1977).  Population ecologists view 
the environment as a resource, which aids in the continued viability of populations and 
communities.  This perspective recognizes much of the ongoing change within health services as 
a function of necessity to better fit the environment (Hurley & Kaluzny, 1987).  Using the 
population ecology theoretical framework allows focus on two major mechanisms to evaluate the 
growth and decline of the pharmacist supply: the environment’s carrying capacity and population 
density.   
The environment’s carrying capacity for the pharmacist population consists of 
munificence, which refers to quantity of resources such as the physician population, pharmacy 
facilities, and prescription volume; and concentration, which refers to the geographical 
concentration of resources in specified vicinity such as hospital beds per 100,000 population, 
pharmacies per 100,000 population, and number of insured.  The second major mechanism for 
evaluating the growth and decline of the pharmacist supply is population density.  Population 
density refers to the current pharmacists’ supply impact on the future growth of the pharmacist 
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supply.  As the pharmacist supply increases it affects the carrying capacity for pharmacist 
services of an area, which in turn may lead to a decrease in the growth rate of the future 
pharmacists supply due the inability to support too many pharmacists.  In this inquiry there will 
be an investigation of the pharmacist supply and its interaction with the environment within the 
context of the population ecology theoretical framework.  This theoretical framework lends itself 
to a longitudinal research design such as the one developed in this inquiry.  Gaining an 
understanding of the demographic changes that influence the pharmacist supply may help 
identify ways to increase staff recruitment and retention, while addressing a host of additional 
healthcare issues in the community.   
Research Questions. 
The conceptual framework for this inquiry will provide the ability to seek empirically 
based answers to two broad research questions.       
1. What are the environmental factors that influence the number of pharmacists in  
                   the United States? 
 
2. Does the past number of pharmacists impact the current and future number of  
                   pharmacists?  
Significance of the Study 
This study will provide beneficial information about environmental dimensions of the 
United States and its impact on the pharmacist supply change over time.  Variables such as the 
pharmacies, hospitals, physicians, prescriptions filled, insurance coverage, wealth, and 
businesses all bring a different dynamic to this inquiry.    
Physicians are primarily responsible for the volume of prescriptions written; therefore, it 
is important to gauge their supply vis-à-vis the pharmacist supply.  While having the medical 
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personnel available is important to prescribe medications, the ability to pay for the prescriptions 
is equally as important.  The ability to pay for ones medication through either personal wealth or 
health insurance that is primarily provided by an employer/business aide in determining the 
volume of prescriptions a pharmacy and pharmacists are tasked with filling.    
Pharmacists fill prescriptions in numerous types of pharmacy work settings.  Some 
pharmacists may choose to work in a chain pharmacy or hospital based upon the ability to make 
more money.  In one survey hospital CEO’s describe their frustration and stress induced by their 
continuing difficulty in filling pharmacist’s positions within their hospitals (AMN, 2009).   
This inquiry provides the effects of environmental factors on the pharmacist supply and 
will be useful for hospital administrators and pharmacy employers as they develop their strategic 
plans for recruitment and retention of pharmacists. There have been numerous studies on the 
pharmacist supply in relation to segments of the environment; however, there are limited studies 
that reviewed the pharmacist supply on a yearly basis and none utilizing this length of time.  This 
study measured the change in the pharmacist supply over time, while accounting for a myriad of 
environmental factors.   
Summary of Findings 
 The pharmacist supply was measured overtime to attain an understanding of the 
environments impact on its level of growth.  There were 13 hypotheses tested with five of the 
hypotheses results being statistically significant.  The population and hospitals were the only two 
variables found to be statistically significant while measuring munificence.  Employers with 20 
or more employees and the number of insured were also found to be statistically significant when 
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measuring concentration.  The last hypothesis on pharmacist supply displayed the ability to 
consistently grow when accounting for the previous year growth in pharmacist supply.   
The empirical evidence found in these hypotheses was corroborated by multiple studies and will 
be discussed in more detail in the following chapters. 
Implications 
The population ecology theoretical framework proved to be useful in the study of the 
pharmacist supply. There are several implications from this inquiry one would be on the insured 
population which was proven to have a significant positive linear relationship with the 
pharmacist supply.   Couple this result with an increase in utilization and workload with the 
introduction of the Healthcare Reform Act and you have a state of affairs that can considerably 
impact the pharmacist supply.  The inclusion of 32 million previously uninsured people receiving 
insurance coverage could significantly change the pharmacist workforce landscape.    
It is of the essence that healthcare players determine what the local market forces are that 
impact their ability to determine their pharmacist manpower needs.  Some of the questions that 
can help determine and form their strategic goals/plans are: how many pharmacists are needed at 
my hospital and will it improve the quality of care in the community? Is the number of 
pharmacists in my community sufficient to address the number of insured and physicians in the 
geographical area?  Evaluating one’s environmental needs will help to ensure that a practical 
plan is developed.  This should help to guarantee that an appropriate number of pharmacists are 
available to meet the current and changing demands of their surrounding environment.  
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Outline of the Remaining Chapters 
Chapter 2 will provide an overview of the literature on the number of pharmacists in the 
United States.  Chapter 3 provides an overview of the theoretical framework for this inquiry as 
well as the hypotheses to be tested.  Chapter 4 presents the research design, variables and 
statistical methods used to test the hypotheses presented in Chapter 3.  Chapter 5 provides the 
results of the analysis which include the descriptive statistics, and the repeated measures 
regression analysis.  Chapter 6 presents interpretations of each hypothesis, in addition to 
implications for various entities.  The chapter concludes with the limitations of the study and 
suggestions for future research.    
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Chapter 2: Literature Review 
 
In this chapter, a review of the literature regarding the role of pharmacists in the 
healthcare system and factors affecting the supply and demand of pharmacists in the United 
States are delineated.  Factors that have changed in the healthcare arena that impact the dynamics 
associated with the pharmacist supply and demand are discussed and a general statement of the 
problem to be addressed in this study is presented. 
Importance of Pharmacists for the United States Healthcare System  
Pharmacists serve in varying roles in the US healthcare system. They distribute drugs 
prescribed by physicians and other health practitioners and provide information to patients about 
medications and their use.  They interact with physicians, patients and the staff of healthcare 
facilities.  Pharmacists in the US dispense over 3.6 billion prescriptions per year (DHHS, 2008).  
Pharmacists who practice in clinical settings such as hospitals, clinics, and nursing homes 
are called clinical pharmacists.  Other settings in which pharmacists practice include the 
managed care industry and the pharmaceutical research industry.  The American College of 
Clinical Pharmacy (ACCP) defines clinical pharmacists as pharmacists that care for patients in 
all healthcare settings (American College of Clinical Pharmacy [ACCP], 2008).  The proportion 
of U.S. pharmacists working in traditional community pharmacy practice settings (independent, 
chain, mass merchandiser, and supermarket pharmacies) remained relatively stable between 2000 
(55.4%) and 2004 (56.4%)  (Beardy et al., 2004).   
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Some other areas in which pharmacists’ skills are being used to improve the medication 
use process include medication therapy management, pharmaceutical care, drug-use review, 
drug-use management, disease management, and pharmacy benefit management (Schommer, 
Sogol, and Brown, 2007).  Outside of being directly involved with the discovery and testing of 
new pharmaceutical agents, pharmacists may also work as medication sales representatives or 
consultants for managed care organizations. Hospital pharmacists work in hospitals, and hospital 
outpatient settings such as clinics, and nursing homes and they advise medical staff on the 
selection of appropriate drugs and optimal dosing.  Hospital pharmacists may also be involved in 
activities related to monitoring drug levels for patients in the hospital, teaching, supervising 
pharmacy interns and residents and conducting research.  The proportion of pharmacists in 
governmental and nongovernmental hospital settings remained stable between 2000 and 2004, 
24.0% and 24.7%, respectively (Berardi et al., 2004). In 2001,   U.S. hospitals reported nearly 2 
billion drug orders for hospital in-patients (Knapp, 2002).  This statistic is important in light of 
the fact that 75% of the pharmacists surveyed reported entering over 90% of the medication 
orders in hospitals and health systems through utilization of electronic order entry (Ringold, 
Santell, & Schneider, 2000).  
According to the National Association of Boards of Pharmacy (NABP) in 2009 there 
were approximately 265,000 licensed pharmacists in the United States (NABP, 2010).  The 
Health Resources and Services Administration (HRSA) reported the settings with the largest 
number of positions are chain pharmacies (77,300), hospitals (49,200), and independent 
pharmacies (36,200) (DHHS, 2008).  Pharmacists play a vital role in maintaining the quality of 
system by providing their patients with valuable information on the safe and proper handling of 
prescription and over-the-counter medications.   
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Pharmacists are the primary source of scientifically valid information and advice on the 
best use of medications. They are uniquely positioned within the healthcare system to deliver 
objective, evidence-based therapeutic information and recommendations to assist their patients in 
achieving optimal pharmacotherapeutic outcomes.  This expertise entails offering 
recommendations that include both traditional and nontraditional therapies and medications 
(ACCP, 2008).  Another vital function performed by pharmacists involves monitoring for 
potential interactions of the medications being taken by a patient. 
A study by Bond, Raehl, and Franke (1999) pointed to the importance of clinical 
pharmacists in maintaining the quality of patient care in hospitals.  This study utilized Medicare 
Hospital Mortality Information Data and the National Clinical Pharmacy Services (NCPS) 
database provided by the Centers for Medicare and Medicaid Services (CMS) (formerly the 
Healthcare Financing Administration; (HCFA).  In the aforementioned study the authors reported 
that overall there were 44.15 fewer deaths per year, per hospital in hospitals that had pharmacist-
provided drug information services compared to those that did not.  Put another way, these 
authors found that there were 10,463 fewer deaths per year in the 237 hospitals in which 
pharmacists provided drug information services.  This study clearly illustrates the vital role of 
pharmacists in the U.S. healthcare system; especially in hospital settings.  The consistent and 
effective use of pharmacists in hospitals can reduce mortality in hospitals and contribute to 
eliminating or reducing unnecessary medication incidents.  Medication dispensing and 
distribution practices affect safe medication administration (Pederson, Schneider, & 
Scheckelhoff, 2009).  Thus, pharmacists play a key role in safe medication use.  MacLaren and 
Bond (2009) found that mortality rates in patients with thromboembolic or infarction-related 
events only and thromboembolic or infarction-related events with bleeding complications were 
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higher by 37% and 31%, respectively, in ICUs without clinical pharmacy services when 
compared to ICUs with clinical pharmacy services.  The lengths of ICU stay were also longer in 
ICUs without clinical pharmacy services. 
MacLaren and Bond also reported a significant economic impact of not providing clinical 
pharmacy services in ICUs.  Based on their analysis, excess charges to Medicare ranged from 
$63,175,725 to $215,397,354; depending on the presence of complications.  These figures do not 
include the additional realized drug charges, which also increase without pharmacist services 
being present.  Although their study was limited to a specific in-hospital setting, it was 
concluded that care provided by intensive care pharmacists enhance clinical and economic 
outcomes of critically ill patients.  This was reaffirmed by additional studies measuring 
effectiveness of pharmacists in intensive care settings.  It may be plausible to speculate that the 
addition of pharmacists to varying settings may help with the clinical and economic outcomes of 
patients.    
In a study of pharmacist review of medication orders in the Emergency Room (ER), 
Brown et al. (2008) utilized retrospective chart review to investigate the frequency of medication 
errors in an emergency department (ED) before and after an ED pharmacist was assigned to 
check medication orders.  They reported that the rate of errors was 66.6% higher when no 
pharmacist was present to check medication orders in the ER.  Following an in-depth review of 
topics and study designs that involved pharmacists, Ellitt (2009) recommended that pharmacists 
continue their successful interventions and multidisciplinary collaborations to ensure continuity 
of care and optimal pharmacotherapeutic outcomes.  Given the importance of pharmacists to the 
healthcare system and to maintaining the health of the U.S. population, the availability of 
pharmacists in adequate numbers is a crucial issue.  Healthcare providers and professional 
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organizations report signs of a moderate current shortage of pharmacists, as indicated by 
persistent vacancy rates, difficulty recruiting and retaining pharmacists, growing dissatisfaction 
among pharmacists due to working long hours, and rising costs to employ pharmacists (DHHS, 
2008).  Whether or not there is indeed a shortage of pharmacists is beyond the scope of this 
inquiry.  However, it is conceivable that environmental factors may play some role in the 
distribution of pharmacists that could result in either a shortage or surplus.  From the perspective 
of the pharmacist supply, perceptions of key players may warrant some exploration within the 
context of the population ecology framework. 
Eighty six percent of hospital CEOs surveyed by AMN Healthcare, the nation’s largest 
provider of clinical staffing, believe there is a shortage of pharmacists (AMN, 2009).  Forty six 
percent of the CEOs surveyed see this perceived pharmacist shortage as serious, while another 
46% see the perceived shortage as moderate (AMN, 2009).  To put these percentages in 
perspective, only 30% of these hospital CEOs thought they had enough pharmacists at their 
facility. 
In light of perceptions that there is a shortage of pharmacists, it appears there is indeed a 
need to understand the environmental factors that influence the pharmacist supply in the U.S.  In 
the next section, a summary of the Bureau of Health Professions model to evaluate the supply of 
pharmacists in the US will be presented and its utility in understanding the factors that influence 
the supply of pharmacists will be discussed.   
Pharmacist Supply in the United States 
The Bureau of Health Professions Model. 
The Bureau of Health Professions (BHP) developed a model that is based on a year-by-
year progression of cohorts of pharmacists (Gershon, Cultice, & Knapp, 2000).  The pharmacist 
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supply in any given year is the sum of the male and female pharmacists from 1-year age group 
cohorts starting at age 24 and extending to age 75.  The data for each of the base cohorts were 
drawn from the 1989-1991 Pharmacist Manpower Project (PMP) (Gershon et al., 2000).  The 
final calculation of pharmacists for each year is based upon varying scenarios using the latest 
available data on enrollment and graduate trends and assumptions about losses from the supply 
pool.  This calculation is a projection of the number of new entrants into the pharmacy industry 
while subtracting both the number of base year pharmacists and new entrants who will die or 
retire (Gershon et al., 2000).  International Pharmacy Graduates (IPGs) were also accounted for 
in BHP’s pharmacist supply model. A table depicting the Pharmacist Supply Model is presented 
in Appendix A.   
The growth rate of pharmacists during the 1980s and 1990s outpaced that of other 
healthcare professions, such as nurses and physicians (Shih, 1999).  The ratio of pharmacists per 
100,000 population from 1995 to 2020 is expected to increase from 68.9 pharmacists per 
100,000 population to 76.7 per 100,000 (Gershon et al., 2000).  There is a predicted growth rate 
of pharmacists of 13% between 1995 and 2020.  Many observers have predicted that the 
pharmacist supply will outpace the growth rate of the United States population during the same 
period of time (Gershon et al., 2000). 
Despite this appearance of growth in the pharmacist supply, there continues to be 
concerns about a shortage of pharmacists needed in the United States.  Until 1998 the supply of 
pharmacists in the U.S. appeared to be in reasonable balance with demand.  However, this 
delicate balance vanished gradually due to market forces, particularly related to the increased use 
of prescriptions dispensed (Cooksey, Walton, Stankewicz, & Knapp, 2003). In the pharmacy 
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setting it is important to have the appropriate manpower to meet the needs of the population.  
The proportion of pharmacists working with three or more technicians increased from 33% to 
46% between 2000 and 2004 (Mott, 2005). Mott’s finding seems to point to a societal need for  
increased pharmacy manpower.  One might infer that the need for more pharmacy technicians is  
closely tied to an increased volume of prescriptions that need to be filled.  There may also be a  
perception for a need for more pharmacists to provide administrative support for the delivery of  
pharmaceutical care and general oversight for all aspects of pharmacy operations as an  
increasing number of pharmacists find themselves supervising more pharmacy technicians on  
their shifts. 
The imbalance involving the demand for and supply of pharmacists is so severe in some 
instances that pharmacies must close on certain days or shutdown all together due to lack of 
pharmacists to staff their facilities (Buscher, 2005).  Over the years, various observers have 
attempted to identify and describe the factors that affect the pharmacist supply.  Among such 
attempts was the Aggregate Demand Index (ADI).  In 2007, the National Association of Chain 
Drug Stores (NACDS) reported over 3900 pharmacist vacancies (NACDS, 2007).  A summary 
of the NACDS surveys can be found in Appendices A, B & C.  The development of the ADI 
represents one-step toward understanding societal needs and pharmacist workforce dynamics.  
The ADI was developed by the Pharmacy Manpower Project (PMP), whose purpose is to collect, 
analyze and disseminate data on the supply of and demand for licensed pharmacists and 
pharmacy services in the U.S. The PMP is an independent not-for-profit organization created in 
the late 1980s when the demand for pharmacists exceeded the national supply.  The PMP is 
comprised of numerous organizations such as the Academy of Managed Care Pharmacy, 
American Association of Colleges of Pharmacy, American Pharmaceutical Association, 
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American Society of Consultant Pharmacists, American Society of Health-System Pharmacists, 
and the Bureau of Health Professions (Knapp, 1999).  The ADI is an ongoing, monthly survey by 
members of the PMP who are directly responsible for hiring pharmacists.  The members of the 
PMP who are responsible for completing the questionnaire that generates the ADI do not receive 
compensation and serve by invitation based on their organization’s direct role in hiring 
pharmacists (Knapp & Livesey, 2002).   
The monthly survey is delineated by state and average demand index scores and is 
important to this study because the ADI addresses two broad areas of the pharmacy workforce.  
First, the ADI questionnaire contains questions that can be used to determine if there is a 
pharmacist shortage in a state.  If there indeed is a shortage, the ADI allows observers to 
determine the degree to which the shortage affects the citizens of the state.  The ADI also permits 
observers to determine if there is a national shortage of pharmacists and the degree to which a 
national shortage affects the citizens of the United States as a whole.  The second area of the 
pharmacy workforce that the ADI addresses is pharmacy workforce shortage severity.  The ADI 
allows observers to describe the effect of a shortage by looking at pharmacy practice settings 
(Knapp, Quist, Surrey, & Miller, 2005).  There is a projected need for over 400,000 pharmacists 
by the year 2020 according to estimates presented during a PMP conference in the early 2000s 
(Knapp & Livesey, 2002).   
It is imperative to understand not just fluctuations in the number of pharmacists, but the 
antecedents to the supply so that it is determined how to appropriately adjust health manpower 
resources to bring about a balance in demand and supply.  The lack of pharmacists is not 
relegated to one region.  It seems there are issues across the entire country from the east coast to 
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the west coast (Vandervoet, 2007).  Some of the factors considered are demographics of the 
population, health organization direction, and drug use trends.   
No setting is immune to a deficiency in pharmacist manpower; even hospitals are also 
having difficulty meeting adequate pharmacist staffing levels (Wisconsin Hospital Association, 
2006).  Lack of pharmacists can lead to individuals not being able to fill their medications in 
their geographic vicinity, which can lead to patients having to travel to distant locations in order 
to have their prescriptions filled.  The lack of pharmacists also leads to increasing salaries and 
sign-on bonuses to recruit pharmacists.  In addition, geography can significantly affect the nature 
of a pharmacist’s work.  A pharmacist’s applicable skill may be dependent, to a certain degree, 
on the availability of other health providers in or near that community (Manasse & Speedie, 
2007). Communities have a strong desire to retain their pharmacists, because these individuals 
provide expert health advice and fill prescriptions, while serving, either formally or informally, 
as health educators, thereby improving the community’s public health (Manasse & Speedie, 
2007).   
An adequate supply of pharmacists is important for the efficiency and effectiveness of the 
healthcare system.  A shortage of pharmacists can affect other healthcare providers and the care 
patients receive (Ricuitti, 2001). A shortage in pharmacists is believed to stem from a rapid 
increase in demand and a limited ability to increase supply (Talley, 2001).  An overworked labor 
force due to potential shortages creates the possibility for increased incidences of medication-
related errors, adding more stress to the pharmacist's already busy day.  This correlates strongly 
with the Institute of Medicine (IOM) report on medication errors.  
 The IOM pointed out that maintaining reasonable working hours, workloads and staffing 
ratios, and avoiding distractions, are needed in order to keep errors to a minimum (IOM, 2000).  
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Mott et al. (2002) considered work variables (e.g., work status, part-time work, secondary 
employment, and full-time equivalents) in their examination of characteristics of actively 
practicing pharmacists in the United States between 1990 and 2000.  The findings of their study 
have some significance in the present context because the trends they identified are among the 
environmental factors that affect the pharmacist supply.  Unlike previous studies, Mott examined 
time series data instead of questionnaires involving opinions and perceptions. Mott’s approach is 
consistent with this inquiry because it begins to fill in gaps in the literature where the pharmacist 
supply is concerned.  This inquiry is more explanatory in nature therefore much of the research 
on the pharmacist supply has been descriptive in nature.  Such research documents the balance or 
imbalance between the pharmacist supply and demand but does not provide much insight 
regarding the interaction of the factors that contribute to the situation.  Explanatory research is 
expected to generate empirical knowledge about factors that impact the pharmacist supply and 
provide insights as to how such factors are interrelated. 
Data for the Mott et al (2002) study were obtained from two national studies of the 
pharmacist workforce conducted in 1990 and 2000.  The study contained the final report of the 
1990-1991 National Pharmacists' Compensation Survey by Schondelmeyer, Mason, Miller, and 
Kibbe (1992).  The survey focused on personal profile, current employment profile, 
compensation profile, and fringe benefits in addition to other compensation of pharmacists and 
attempted to explain how these all contributed to the size of the pharmacist workforce.   The 
second survey was the National Pharmacist Workforce Survey conducted by Pedersen, Doucette, 
Gaither, Mott, and Schommer (2000).  Insofar as the demand for pharmacists is concerned, 
results from these studies suggest that the current pharmacist workforce has responded to an 
increased demand for pharmacists by increasing the amount of work supplied to the pharmacist 
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labor market, while limiting the number of pharmacists working outside the profession.  The net 
effect of such trends appears to be fewer pharmacists performing more tasks.   
Factors Affecting the Supply of Pharmacists 
Pharmacist Education and Training.  
One factor affecting the supply of pharmacists is the extent of the training process. There 
has been a lengthening of the training period for United States pharmacy students. In the past, 
pharmacists were only required to obtain a Bachelor of Science degree in order to be eligible to 
take the National Pharmacist Licensing Examination (NAPLEX).  In 2003 the American Council 
on Pharmaceutical Education (ACPE), which is responsible for the accreditation of professional 
degree programs in pharmacy and providers of continuing pharmacy education, changed the 
minimum requirement to practice pharmacy to persons who received the Pharm.D. as the entry 
level degree from an ACPE accredited school of pharmacy.  The new requirements also 
restricted eligibility for accreditation to those schools offering the Pharm.D. as the entry level 
degree (DHHS, 2000).  
This change compelled schools with B.S. programs to develop curricula to meet the new 
ACPE program standards.  As a result of the new curriculum requirements, the scope of 
pharmacy practice has been significantly broadened and has set the stage for inquiries such as 
this one to explore factors affecting the pharmacist supply.  A study conducted by Baran, Shaw, 
and Crumlich (1998) found that Pharm.D. students were attracted to hospital pharmacy settings, 
whereas more students in the B.S. program saw their future practice setting in a community 
pharmacy.  If this is true, there is the potential for a shortage of pharmacists in the community 
setting, assuming that there are enough hospital positions to accommodate holders of the 
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Pharm.D. degree seeking such positions.  This has very important implications for the pharmacist 
supply, at least insofar as site and scope of practice may be concerned.  
Approximately 20% of pharmacy graduates seek additional postgraduate education in a 
variety of fields (e.g., residencies and fellowships, master of business administration, doctor of 
law, master of public health, doctor of philosophy) (Manasse & Speedie, 2007).  A majority of 
pharmacy school graduates seek one-year residency training positions in an attempt to increase 
their opportunity for a position involving direct patient care.   
While a residency is not required to practice pharmacy, some healthcare institutions make 
this a requirement for employment; especially when it relates to certain clinical specialties 
(American Society of Health-System Pharmacist, [ASHP], 2007; Kostick, 2006).  Those desiring 
academic or research roles in academia or the pharmaceutical industry often complete two to 
three years of fellowship training in addition to a one- or two-year residency. 
To compensate for the increased length of time to add pharmacists to the workforce, 
some schools have increased their class size.  Another measure taken by the profession is to open 
new pharmacy schools.  The increase in pharmacy schools that began in the 1990s and continue 
currently accounts for a 35% increase in the pharmacist supply (Knapp & Cultice, 2007).  
Between 2001 and 2009 alone 31 new pharmacy schools were established (American 
Association of Colleges of Pharmacy, 2010).  The rate of new schools may be an important 
environmental factor affecting the pharmacist supply and should be accounted for in research on 
the pharmacist supply in the U.S. 
Age and Retirement. 
It is also noteworthy that the median age of the pharmacy workforce is increasing.  Mott 
et al. (2005) reported that 44% of the practicing pharmacists surveyed in 2000 were 40 years of 
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age or younger compared to 33% in 2004.While the percentage of younger pharmacists 
decreased during this period, the percentage of practicing pharmacists over the age of 55 
increased from 17% to 25% (Mott et al., 2005). This indicates that the supply of pharmacists 
may decrease as the older pharmacists take retirement and there may not be enough younger, 
trained pharmacists to take their place.  If there is not a shortage, per se, age trends among 
licensed pharmacists could portend a misdistribution of pharmacists.  Both of these situations 
may significantly affect the supply of pharmacists.   
Patient Interaction.  
Pharmacists are crucial in medication reconciliation and consultation with physicians and 
patients.  Pharmacists are vital to ensuring that quality pharmacy services are provided, while 
transforming the practice of pharmacy to increase patient education on the proper use of 
pharmaceuticals (Kong, 1995). In some instances a community pharmacy may be utilized as a 
healthcare facility and may provide more services than what may be typically expected of or 
available in a traditional community pharmacy.  This is most likely to be the case in areas where 
medical offices and clinics are in short supply.   According to Knapp, Paavola, Maine, Sorofman, 
and Politzer (1999),  pharmacies may be a place where patients receive medical consultation and 
education by pharmacists and other health professionals.  
Pharmacist Practice Setting and Salary Forecasting. 
As prescription volumes continue to increase so does the level of salaries being offered to 
pharmacists by employers.  A Drug Topics' 2010 salary survey drew 1,619 responses from 
across the country, with respondents earning an average salary of $115,455 (Rajecki, 2010).  A 
previous survey by Drug Topics found that pharmacists working in health maintenance 
organizations received the highest annual salary at $114,067; followed by pharmacists who 
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practice at independent pharmacies ($109,618); mass-merchandisers ($109,466); chains 
($107,885); hospitals ($107,168); supermarkets ($106,302); and mail order ($101,500) (Levy, 
2008).  
While pharmacist salaries continue to increase there are signs that increases are slowing.  
One example is the amount of extra income pharmacists took home between 2002 and 2006.  
Only 50% of the respondents received additional pay from sources such as bonuses and profit-
sharing, compared with 88% in the 2000 survey (Ukens, 2007).   
Annual raises are also continuing to trend downwards for pharmacists. Ukens reported an 
average raise of 3.8% in 2006, compared with 4.9% in 2004 and 7% in 2002.  Rising salaries for 
pharmacists have a positive impact on supply, however it has also led to pharmacies scaling back 
on the number of hours they are open and scaling back on staff due to rising labor costs (DHHS, 
2008). 
 Increase in the number of Women in Pharmacy. 
One trend that is occurring quite rapidly is the number of females entering the profession.  
Presently more females are applying to pharmacy school and receiving degrees than males.  In 
2006, 59.5% of applications to schools and colleges of pharmacy were submitted by women; 
they also received 68.2% of the first professional pharmacy degrees conferred in that year and 
60.8% of the post baccalaureate degrees conferred (Deyton et al., 2007).  The percentage of 
licensed female pharmacists increased significantly from 31% in 1990 to 43% and 46% in 2000  
and 2004, respectively (Mott, Doucette, Gaither, Pedersen, & Schommer, 2002).  This 
information is presented in Figure 1.  
According to Mott et al. (2005) approximately 30% of female pharmacists surveyed 
between the ages of 31 and 60 worked part-time.  Approximately 3% of male pharmacists  
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Figure 1. Estimated Number of Pharmacists by Sex, 1995-2020.  
From “How Many Pharmacists Are in Our Future? The Bureau of Health Professions  
Projects Supply to 2020,” by Gershon et al., 2000, Journal of the American Pharmacists  
Association, 40(6), p. 760.  
 
between 23-40 years of age work part time compared to 23% of their female counterparts (Mott 
et al., 2002).  There may be many factors affecting this difference in the percentage of female 
and male pharmacists working part-time.  This difference is noteworthy because of its 
implications for pharmacy manpower.  Women are more likely to work part-time during the 
childbearing years. This can further affect the pharmacist manpower needs of the environment.   
The number of pharmacists may indeed be increasing.  However, due to trends such as 
the one described above there could still be a shortfall in the number of pharmacists available to 
fill prescriptions due to more females working part-time.   
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Summary of Environmental and Demographic Factors Affecting Pharmacist supply in the 
Literature 
There appears to be a consensus in the literature that a myriad of factors and interactions 
among these factors affect the supply of pharmacists in the U.S.   Among the factors that 
previous studies have examined in relation to the number of pharmacists  are rates of pharmacist 
employment turnover, antecedents to pharmacist workforce decisions (e.g., reasons pharmacists 
give for choosing part-time employment over full-time employment), pharmacist-to-population 
ratio, rate of opening of new schools of pharmacy, age, practice venue (e.g.,  hospital or 
institutional versus community), prescription volume and salary.  Many observers believe that 
even with growth in the number of pharmacists, strong factors of demand may confound the 
adequacy of the supply of pharmacists.  The net effects of supply trends may lead to a shortage 
or misdistribution of pharmacists.  Whether there is a shortage or surplus warrants a separate 
inquiry that explores this phenomenon specifically.  The focus of this inquiry is the impact of 
environmental factors on the overall pharmacist supply. 
The rapid growth in prescription volume, the increase in new drugs and its greater 
complexities and the growth in the elderly population are additional factors that may have a 
significant and remarkable impact on the supply of pharmacists (Gershon, Cultice, & Knapp, 
2000).   
Factors Affecting the Demand for Pharmacists 
Physicians are primarily responsible for the volume of prescriptions written, so the 
locations of their practices and the volume of prescriptions written play a crucial role in the 
pharmacist supply.  The number of prescriptions dispensed per year in the United States has 
increased from approximately 1.9 billion to 2.9 billion between 1992 and 2004 (Stagnitti, 2007). 
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The increase in the insured population is significant because it leads to a potential increased 
workload for pharmacists striving to meet the prescription demand.  The continuous 
development of new drugs, many of which have high costs, will stimulate demand for more 
pharmacists now and in the future. It is important to also note that managing drug interactions is 
becoming more complex as a result of numerous drugs being used to treat multiple chronic 
conditions.  This problem is especially worrisome in hospital settings.  Taken together these facts 
certainly suggest that there will be an increased demand for pharmacists.  Their expertise will be 
sought by physicians and patients alike in all healthcare settings. 
Physicians will be providing care to larger numbers of elderly persons in their practices in 
the coming years.  These patients often require multiple medications to manage their health 
problems.  Consequently, physicians write more prescriptions and patients are at greater risk for 
drug interactions and medication misadventures.  Under such circumstances it would appear 
reasonable to expect that there will be a greater demand for pharmacists.  Insofar as the elderly 
and prescription volume are concerned, the passage of Medicare Part D is expected to have a 
very remarkable.  In addition to Medicare Part D is the passage of the 2010 Healthcare Reform 
Act, both of which may have a positive impact on the demand for pharmacists.   
Physicians and the Increased Volume of Prescriptions. 
In light of their role as the primary source of prescriptions being written, any examination 
of factors affecting the pharmacist supply should include some consideration of the physician 
supply; as the forgoing discussion suggests. It is reasonable to assume that the likelihood of a 
patient receiving a prescription as a result of a visit to their physician may increase as new 
medications become available to treat more conditions. 
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Access to prescription drugs is facilitated by an increased number of prescribers, 
primarily physicians.  The number of primary prescribers ((Medical Doctors (MDs) or Doctors 
of Osteopathy (DOs)) per 1,000 population has increased steadily since 1985 (Kaiser Family 
Foundation, 2000).  The percentage of office visits with multiple drug orders increased from 
45.3% in 1985 to 58.1% in 1999 (Burt, 2002).   
In this study it was also shown that once the distribution of visits by patients’ age, 
number of diagnoses, source of payment, and physician specialty are adjusted for, physicians 
were 43% more likely to prescribe multiple drugs in 1999 than in 1985.  The development of 
better treatments involving pharmaceutical interventions will also lead to a greater dependence 
on such drugs for maintaining a high quality of life (Burt, 2002).  According to Mott et al. (2005) 
61% of pharmacists working in chain settings (e.g., CVS, RiteAid, Eckerd) reported dispensing 
over 200 prescriptions per day.  Findings in the literature clearly suggest a direct, positive 
correlation between prescription volume and the demand for pharmacists.  As prescription 
volume increases, so does the demand for pharmacists. 
According to the National Ambulatory Medical Care Survey (NAMCS), in 1996 there 
was an estimated 734.5 million visits made to physician offices in the United States (Woodwell, 
1997).  There were over 210 million more physician office visits in 2005 than in 1996 (Cherry, 
Woodwell, & Rechtsteiner, 2007).  Nearly two-thirds of the visits made to ambulatory 
physicians’ offices in 1996 resulted in at least one medication being provided by or prescribed by 
the physician; or about 469 million prescriptions (Woodwell, 1997).  There were over 120 
million physician visits in 1996 made by patients who had at least three medications provided by 
or prescribed by a physician.  This number has more than doubled by 2005 (Cherry et al., 2007).  
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According to the Agency for Healthcare Research and Quality (AHRQ) Medical 
Expenditure Panel Survey (MEPS), physicians wrote over 4 billion prescriptions in 2007 with 
physicians being primarily responsible for the majority of the prescriptions written                      
(Medical Expenditure Panel Survey, 2008).  Presently there are more than 750,000 physicians 
practicing in the United States, with a physician supply projection of more than 900,000 by the 
year 2020 (DHHS, 2006).  
Prescriptions filled by chain drugstores alone increased by 7% between 2005 and 2007, 
from 3.3 billion in 2005 to 3.52 billion in 2007 (NACDS, 2008).  These figures suggest there 
will be an increasing need for more pharmacists to dispense the rising number of prescriptions 
being prescribed by physicians.  
Employers and Pharmacist Workload. 
The primary source of prescription drug coverage for most Americans (both non- 
Medicare and Medicare) is their employers.  For retirees and the majority of persons age 65 and 
over Medicare Part D is the primary source of coverage for prescription drugs.  In 2008, 157 
million Americans (60% of the nonelderly population) were covered by employer-based health 
insurance (Kaiser Family Foundation, 2009).  Approximately 99% of employees under employer 
health plans have drug coverage (Kreling, Mott, Wiederholt, Lundy, & Levitt, 2000; Kaiser 
Family Foundation, 2007). 
Another important demographic factor potentially impacting the demand for pharmacists 
is the size of the business industry. The more employees there are in an organization or industry 
the greater the demand will be for benefits and services (Sommers, 2004).   Among the 80.1 
million employees who worked for large private sector employers in 2002, 97.8% were offered 
employer-based health insurance and 62.7% of those employees enrolled in plans offered by 
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their employers (Sommers, 2004).  Organizations with large numbers of employees are more 
likely to offer their employees health insurance (Stanton, 2004).   
 These facts are particularly salient in the context of this inquiry because employer 
sponsored insurance enrollees are 4 times less likely to forego filling a prescription drug due to 
cost as compared to the uninsured population, according to findings reported by Cunningham 
(2002) from the community tracking study household survey. As a result, it would be expected 
that the demand for pharmacists to be greater in such communities due to a larger volume of 
prescriptions to be filled.  In 2006 the health plan offer rate for large or medium organizations 
(50 or more employees) was 96.7% compared to 61.2% for small organizations (50 or less 
employees) (Sommers & Crimmel, 2008; Crimmel & Sommers, 2008).  Reed & Hargraves 
(2003) reported that the uninsured population was more than three times as likely as those with 
private health coverage to have gone without at least one prescription in 2001 because of cost 
concerns.  Poisal and Chulis (2000) reported that Medicare beneficiaries with some type of 
prescription drug coverage utilized an average of five more prescriptions per person than 
beneficiaries that were uninsured.   
 It is plausible that if the proportion of persons covered by employer-sponsored plans 
increases substantially in a region, there could be a disproportionately greater need for 
pharmacists as a result of more persons then being covered by such plans.  An analysis of such 
trends might lead one at first glance to conclude that there is a sharp and sudden increase in 
health conditions requiring prescription medications.  However, it is more likely the case that the 
increase may be due to more persons having their previously unmet prescription drug needs met 
as a result of health insurance coverage that includes coverage for prescription drugs.  In any 
event there will presumably be a need for more pharmacists to handle the increase in prescription 
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volume and to provide expert recommendations to manage all aspects of pharmacotherapeutic 
interventions to ensure safety and efficiency.      
Health Insurance and Paying for Prescriptions. 
Americans obtain health insurance to help cover their expenditures related to the receipt 
of healthcare.  One aspect of receiving healthcare is the acquisition of prescription drugs and 
pharmacotherapy services.  In general, Americans purchase health insurance either individually, 
paying out of their own pocket or through their employers as a benefit of employment.   
In the latter instance the employer may provide coverage for their employees by fully 
assuming the financial burden of providing it, or through some degree of cost sharing involving 
employers and employees.   
According to the United States Census Bureau (2006), in 2005 approximately 84% of the 
United States population was insured through the government or private companies.  The 
majority of health plans provide coverage for prescription drugs, to varying degrees.  According 
to findings reported from the Health System Change (HSC) survey, approximately 12-13% of 
American adults had problems filling a prescription between 2001 and 2003 (Reed, 2005). 
Insurance coverage has the potential to have a positive impact on the demand for  
Pharmacist’s because of its positive effect on the ability to obtain required prescriptions (Ranji, 
Wyn, Salganicoff, & Yu, 2007; Weinick, Byron, & Bierman, 2005).  The ability to pay for 
prescriptions plays a vital role in the volume of prescriptions to be filled, which in turn plays a 
role in the need for pharmacists.  In order to employ and retain pharmacists there must be a 
constant flow of patients in need of prescription medicines.  Health insurance is usually the 
primary source for paying for prescriptions. The growth of drug insurance coverage has 
improved access to prescription drugs and the services of pharmacists.  Ultimately, the growth of 
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insurance for prescription medications is very likely to precipitate a greater demand for 
pharmacists and the services that they provide (Knapp, 2002).   Findings in the literature suggest 
that having insurance is associated with a higher volume of prescriptions. 
The implementation of Medicare Part D is one example of the effect of insurance for 
prescription medications on the demand for pharmacists.  It has been estimated that Medicare 
Part D will allow 15 million elderly Americans with no prescription drug coverage to now obtain 
coverage for prescription drugs.  In turn, observers have projected that an additional 14 to 30 
million prescriptions will be written and dispensed each month following the implementation of 
Medicare Part D (Reissman, 2004).   
While it is clear that being insured greatly affects one’s ability to obtain healthcare, 
including prescription drugs, it is also clear that the lack of insurance nearly always leads to a 
corresponding inability to obtain healthcare and prescription drugs.  From a practical point of 
view, it would seem reasonable that the percentage of the population that is uninsured may have 
an impact on the pharmacist supply.  In this case there may be a decreased demand for 
pharmacists as the volume of prescriptions may be lower.   
Reed and Hargraves (2003) reported that in 2001 the uninsured were more than three 
times as likely as those with private health insurance to forgo at least one prescription because of 
cost concerns.  In a study involving data from the HSC Reed (2005) reported that, regardless of 
insurance coverage, low-income adults (incomes 200% below the federal poverty level, or 
$36,800 for a family of four in 2003) faced significant financial barriers to obtaining prescribed 
drugs.  As mentioned above, the percentage of uninsured persons in the population at a given 
point in time is one environmental factor that could significantly reduce the demand for 
pharmacists and, thus, affect the pharmacist supply.   
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On March 23, 2010, President Barack Obama signed into law the Affordable Care Act. 
The law puts into place comprehensive health insurance reforms that will help in lowering 
healthcare costs, while guaranteeing more healthcare choices, and enhanced quality of healthcare 
for all Americans (DHHS, 2010).  The main selling point for the healthcare reform package put 
forth by the Obama administration is that it offered healthcare benefits to some 32 million 
uninsured Americans (Wechsler, 2010).  Another major, positive step put forth by that legislation 
was its promise to address the coverage gap or “donut hole” which affects one in four Medicare 
Part D beneficiaries (Steffancci, 2010).  The coverage gap, which occurs in the majority of 
Medicare Part D prescription drug plans, involves beneficiaries paying the entire cost of their 
prescription drugs, once they reach a certain limit.  This limit is reached once a senior has spent 
$2830 on prescription drugs in 2010. This limit lasts until catastrophic coverage kicks in (when a 
Medicare beneficiary has spent $4550 out-of-pocket on medications) (Steffancci, 2010).  
 The Obama administration’s healthcare reform bill has developed a plan to start 
gradually closing the donut hole with an anticipated full closure by 2020. As of 2011, 
pharmaceutical manufacturers required to provide a 50% discount on brand-name prescriptions 
in the Medicare Part D coverage gap.  In 2013 federal subsidies for generic prescriptions will be 
phased in while the out-of-pocket amount that qualifies an enrollee for catastrophic coverage 
under Medicare Part D will gradually be reduced beginning in 2014 and continuing through 2019 
until the donut hole is completely closed (Wechsler, 2010).  
  These changes to Medicare will augment drug usage by seniors.  From changes in health 
insurance parameters to quality assurance modifications, this legislation will alter the health-care 
environment for providers in the US.  Prescription drug coverage is included on the list of 
essential benefits required to be offered by all insurance plans pursuant to mandates in this 
                      
33 
          
historic legislation.  Decreasing copayments and other expenses associated with prescription 
medication use will expand pharmaceutical benefits to patients in need, and conceivably, lead to 
a greater need for pharmacists.   
The healthcare reform initiated in 2010 has the potential to provide tens of millions of 
Americans with access to healthcare coverage and allow others to retain coverage.  The 
researcher further notes that the laws that constitute healthcare reform seem to have a potential 
two-fold impact on the pharmacist supply.  First, there is a new requirement that premium 
subsidies be provided for individuals to purchase health insurance.  As previously discussed, as 
access to insurance increases the volume of prescriptions written and subsequently dispensed 
also increases, directly increasing the demand for pharmacists and the services they provide.  
Secondly, new laws that have been enacted as a part of healthcare reform require that tax credits 
be given to small employers as an inducement for them to offer health insurance to their 
employees (Matzke, 2010). Matzke further notes that a swell in the number of insured 
individuals are expected to significantly increase prescription drug use and lead to an expanded 
role for pharmacists in the U.S. healthcare system through medication therapy management 
(MTM) programs (Matzke, 2010).  It is difficult to accurately project exactly how the pharmacist 
supply will be impacted by the healthcare reform begun in 2010.  The purpose here is to just give 
insight into future changes in the environment that may affect the pharmacist supply in the 
future.    
Increasing Complexity of Medications and Pharmaceutical Treatment. 
The increase in the number of medications developed to treat varying medical conditions 
has increased the need for pharmacists to help manage drug utilization. Additionally, there has 
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been the introduction of pharmaceuticals to treat diseases for which drug therapy previously was 
not available or had limited efficacy (Mott & Kreling, 1994).   
The increasing acuity of hospitalized patients receiving complex medication regimens, in 
conjunction with the national focus on medication safety, and the increasing number of drug 
safety warnings issued by the Food and Drug Administration that focus on medications, strongly 
support the need to identify and describe factors affecting the pharmacist supply (Shane& 
Gouveia, 2009).  Pharmacists are an integral part of the healthcare team in the hospital and other 
healthcare settings and they are very involved in the management of a variety of illnesses, 
especially those requiring complex drug therapies such as chemotherapy or treatment for life-
threatening infections. 
Pharmacists are best poised to oversee the entire drug distribution system including 
prescribing, dispensing, and administration and safety of drugs.  Such oversight by pharmacists 
clearly describes the important role they play in improving medication safety (Guchelaar, Colen, 
Kalmeijer, Hudson, & Teepe-Twiss, 2005). Geography can significantly affect the nature of a 
pharmacist’s work.  A pharmacists' applicable skill may be dependent, to a certain degree, on the 
availability of other health providers in or near that community (Manasse & Speedie, 2007).  
Communities have a strong desire to retain their pharmacists because they provide expert health 
advice, fill prescriptions and serve as formal or informal health educators (Manasse & Speedie, 
2007).   
Growth in the Older Population and Those with Chronic Diseases. 
The graying of America also seems to be having an impact on the number of 
prescriptions written.  As Americans live longer, and as the population of persons 65 years of age 
and over increases, the volume of prescriptions being filled per year continues to grow.  There is 
                      
35 
          
expected to be an increase in the number of prescriptions written by physicians treating the 
elderly as the baby boom population enters late life.  This is because the over 65 segment of the 
population consumes a disproportionately higher volume of prescription medicines than the rest 
of the population (ASHP, 2001).   
Older patients generally have more chronic illness than younger individuals, which 
usually leads to more complicated medication treatment plans.  Eighty-five percent of Americans 
65 years of age and older have at least one chronic disease that is primarily managed with a 
prescription drug (ASHP, 2001).  This trend suggests that there will be an increase in the volume 
of prescriptions to be filled and dispensed.  Concomitant with any increase in prescription 
volume will be the need for more pharmacists (Deyton et al., 2007). 
To put the volume of prescriptions in perspective, there were approximately 1.9 billion 
patient prescriptions filled in 1997, versus 2.9 billion in 2004 (Stagnitti, 2007).  During the 
period 1997 to 2004 there was a 40% increase in the average number of prescriptions filled per 
person per year for persons over the age of 65.   In 1997 persons over the age of 65 averaged 
21.9 prescriptions per year compared to 30.8 prescriptions per year in 2004 (Stagnitti, 2007).  
These figures are more than twice those for persons under 65 years of age, who averaged 8.8 and 
12.6 prescriptions per year, respectively, during the same period of time.   
It is estimated that 77 % of the over 65 population surveyed regularly use three or more 
prescription medications (ASHP, 2001).  The over 65 population comprises approximately 13% 
of the total U.S. population, or just over 40 million people (U.S. Census Bureau, 2008). This 
segment of the population is projected to grow significantly over the next few decades, 
especially the 85 and over segment of those over 65 years of age.  Current projections estimate 
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that the over 65 population will account for 18% of the U.S. population in 2020 and 22% in 2030 
(U.S. Census Bureau, 2008).   
The Medicare Prescription Drug Improvement and Modernization Act (MMA) were 
signed into law in 2003 and went into effect on January 1, 2006 (Gore & Seeds, 2004).  The 
MMA’s goal was to provide an estimated 7 to 15 million older Americans who had no 
prescription drug coverage with such coverage with the addition of Medicare Part D.  Medicare 
Part D is aimed primarily at helping these individuals by providing them with assistance in 
paying for the prescription drugs they need.  As a result of the MMA, all Medicare beneficiaries 
are able to enroll in a prescription drug plan.  It is estimated that as many as 14 to 30 million 
additional prescriptions may be written and dispensed each month by retail pharmacies as a 
result of MMA (Reissman, 2004).  Increased pharmacist manpower will likely be needed to 
address the increasing elderly population and its large and varying consumption of medications. 
Central Fill Pharmacies. 
The decade following 2008 was marked by an emerging trend within the  
pharmacy profession that could conceivably impact the future of the profession in coming 
decades.  The time period for this inquiry covers the 16 years between 1994 and 2009.   
This emerging trend is believed to have occurred toward the end of this time period and will not 
be examined in this inquiry.  However, the trend warrants being mentioned here because of its 
theoretical importance in examining environmental factors affecting the pharmacist supply. 
At the core of this trend is the increasing use of central fill operations to accommodate 
increased demand for pharmacist services caused by an increasing volume of prescriptions to be 
filled.  Key players in the profession appear to be developing these central-fill pharmacies to act 
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as mass-dispensing centers for retail pharmacies to meet the growing demand for pharmacist 
services at the retail level. 
These centers are allowed to receive non-controlled and controlled substance  
prescriptions from retail pharmacies as long as they subsequently dispense the prepared  
prescription to the same originating retail pharmacy (Anderson & Crawford, 2010).   
Central-fill pharmacies are not allowed to take prescriptions directly from a patient or  
practitioner and they are not allowed to dispense prescriptions directly to a patient or 
practitioner.    
While a closer examination of this emerging trend is beyond the scope of this  
inquiry, it would be remiss to not mention it because it may be a noteworthy environmental  
factor affecting the supply of pharmacists in the future.  One major benefit of central-fill  
pharmacies is that they enable busy retail pharmacies to send their entire volume of prescriptions  
(especially refills) to a central location for processing. In terms of our theoretical framework, 
these central fill pharmacies are likely to have an appreciable effect on two of the constructs in 
the population ecology framework:  density and concentration.  Central fill pharmacies may very  
well alter the distribution of pharmacists and, thereby, significantly impact pharmacist supply.  
Having the option of sending prescriptions to another location to be filled frees staff in  
local retail pharmacies to concentrate on dispensing acute care prescriptions and to perform other  
essential duties such as patient counseling and medication therapy management (MTM) (Chain  
Drug Review, 2010). Future studies of the pharmacist supply using the population ecology  
theoretical framework should include an examination of this trend toward central fill pharmacies 
to shed more empirical light on its impact.   
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Studies on the Pharmacist Supply  
This section summarizes studies that have examined environmental factors impacting the 
pharmacist supply in the United States.  Practice setting can affect the extent to which 
pharmacists can serve as active members of collaborative healthcare teams in the community 
(Schommer, Reshmi, Cline, & Hadsall, 2006).  It seems very likely that the pharmacist supply 
may be significantly affected by the realization of these goals by future pharmacists. 
Walton et al. (2004) examined supply and demand factors across states and analyzed 
differences in relation to pharmacy labor using data from the Bureau of Labor Statistics (BLS).  
BLS estimates of the number of filled pharmacist positions were used to generate state-level data 
regarding the size of the pharmacist labor market.  BLS estimates rely on industry surveys that 
require the selected industry to disclose the number of filled positions they have for each 
occupation on the list.  
Based on their analysis of BLS data, Walton et al. (2004) stated that the pharmacist 
supply can be explained in terms of four variables: 1) wages earned by pharmacists in a state; 2) 
the number of new graduates; 3) the number of existing pharmacists; and 4) work preferences.  
Demand was defined as the number of pharmacist positions available at a given wage in each 
state.  
These investigators also determined that the demand for pharmacists at the market level 
is positively related to the number of community pharmacy prescriptions and population.  They 
reported that after controlling for population, the number of filled pharmacy positions was 
significantly correlated with prescriptions, hospital days, pharmacies, and residents older than 65 
years.  Although not addressed in the Walton et al. (2004) study, Cherry et al. (2007) reported 
that demand can be affected by the supply of physicians in a state.   
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In another study, Walton, Knapp, Miller, and Schumock (2007) examined the 
relationship between demographic and economic variables in their attempt to understand 
variations in the pharmacist supply in America.  Walton and his colleagues found that 
surrounding population size, community income levels, and the number of healthcare facilities 
all play a role in the future size of the pharmacist workforce. 
Summary of Extant Studies on the Number of Pharmacists 
There have been numerous studies on the factors that impact the pharmacist supply in 
America. Some of the key variables that have been common to a majority of the studies on the 
number of pharmacists in the literature are patient population, practice setting, practice location, 
salary, utilization of skills, benefits, pharmacy student enrollment, managed care penetration and 
insurance coverage, work hours, practitioner gender, prescription volume, demand for clinical 
pharmacy services, number of pharmacies in a community, number of physician visits, size of 
population over 65 years of age, per 100,000 population  income, number of pharmacist 
vacancies in a community, number of physicians, size and number of employers, implementation 
of healthcare reform and passage of new laws.  
In broad terms, these factors fall into one of three domains that have emerged from 
previous research on the pharmacist supply:  (1) Demographic, (2) Ecological and (3) 
Institutional/Legal.  A summary of studies in these domains is presented in Table 1 below. 
Findings from extant studies on pharmacist supply in the literature, when taken as a group, 
provides some insight into the interrelationships among factors that may determine the 
pharmacist supply in America (Knapp, 1999; Manasse & Speedie, 2007; Burt 2002; Meissner et 
al., 2006; & Sommers, 2004).  The changing demographics of the pharmacy profession may 
require innovative approaches to recruitment, retention, and training of faculty and clinical 
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specialists to meet current and future needs of a population that includes a growing number of 
persons with chronic illnesses and increasingly more complex pharmacotherapeutic regimens 
(Patry & Eiland, 2007).   
While healthcare facilities try to find a way to meet their demands, retail pharmacies also 
must turn to the same pool of pharmacists to meet their demand as well.  These facts point to the 
dire need for more empirical evidence about the factors that impact the pharmacist supply.   
Managing the balance between the demand for pharmacists and the supply of pharmacists will 
continue to be of paramount concern to the profession over the next several decades.  In light of 
limited, dwindling resources, there must be ways found to maximize our resources to avoid 
critical imbalances between supply and demand for pharmacists.  Several researchers have 
suggested a shortage of pharmacists.   
Assessing the environment is a critical prerequisite for adequate workforce planning to 
address the challenges in maintaining a suitable number of pharmacists.  Among the variables to 
be considered are increasing work-force demands, patient safety, resource constraints, and health 
work-force policy reforms (Wuliji, 2009). Understanding the environmental dynamics that help 
determine pharmacists supply and distribution throughout the United States may help 
communities, hospital administrators, and other pertinent personnel in determining the 
appropriate number of pharmacists to meet population demands.  In this chapter the role and 
importance of pharmacists in the U.S. healthcare system have been reviewed. There was an 
exploration of factors that affect supply and demand and there was a discussion of the dynamic 
nature of the relationship between the two.  Changes in the organization of healthcare services, 
including pharmacy services, changes in the demographics of the population and changes in the
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financing of healthcare will impact supply and demand where pharmacists are concerned. Table 
1 provides a summary of studies that have been conducted on pharmacist supply/manpower.  
Table 1.   Summary of Research Domains on the pharmacist supply found in the Literature. 
 
Key Variables  Point of Interest  Reference  
Salary, utilization of 
skills, and benefits 
Assessing the factors that impact pharmacy 
graduates’ practice location preference 
Besier & Jang, 1992 
Student Program 
Enrollment Status, 
Pharmacy Practice 
Setting 
Practice Location Preferences for B.S. and 
PhamD. Students 
Baran & Cumlich, 1998 
 
Pharmacists Manpower, 
Managed Care 
Penetration 
The impact of managed care on pharmacy 
practices and the ability to retain roles that are 
useful to the system and satisfying to pharmacists 
in a changing healthcare system. Pharmacists 
participation in population-based patient 
management programs, adaptation to new 
relationships with other providers. 
Knapp, 1999 
Pharmacist population 
size, Pharmacy School 
Enrollment 
Investigation of the existence of a pharmacist 
shortage in the United States for the years 1987 
to 1991. Utilization of earnings data for 
pharmacists at a regional and state level to 
determine which areas of the U.S. or which 
individual states are most in need of more 
pharmacists by practice settings to determine 
supply levels. 
Mott & Kreling 1994 
Aging Pharmacist 
Population, Increased 
Hours worked and 
Increased female 
pharmacist population 
The U.S. Department of Health and Human 
Services, Health Resources and Services 
Administration's (HRSA's) 2008 report on the 
pharmacist workforce documented the current 
and growing shortfall of pharmacists. 
Department of Health and 
Human Services, 2000 & 
2008 
Pharmacist gender 
makeup, Pharmacist 
supply, Patient 
Population Data 
To describe a Bureau of Health Professions 
model for estimating active pharmacists in the 
United States and its findings 
Gershon, Cultice, & Knapp, 
2000 
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Table 1. Summary of Research Domains on the Pharmacist Supply Found in the Literature 
(Continued)  
 
 
Understanding the environmental dynamics that help determine pharmacists supply and 
distribution throughout the United States may help communities, hospital administrators, and 
other pertinent personnel in determining the appropriate number of pharmacists to meet 
population demands.   
Key Variables  Point of Interest  Reference  
Demand for prescriptions or clinical 
services, patient population.  
To estimate the impact that the 
new Medicare drug benefit 
program will have on pharmacy 
workforce demand. 
Meissner, Harrison, Carter, & 
Borrego, 2006 
Number of community/outpatient 
prescriptions dispensed   
Number of active community and 
outpatient pharmacy licenses, 
Number of active pharmacy licenses, 
hospital setting , Per capita income , 
Age > 65 years                                                                                                                                                                                                         
Number of filled pharmacist 
positions in the state , Number of 
pharmacy technician and pharmacy 
aide positions, Pharmacist wages  
Examine the impact of supply and 
demand factors on filled positions 
for pharmacists and pharmacist 
extenders (pharmacist technicians 
and aides) and assess differences 
across states through analysis of 
state-level pharmacist
labor market data 
Walton, Cooksey, Knapp, 
Quist,& Miller, 2004 
Prescription Growth, Growth of 
Pharmacies, Pharmacy Vacancies 
Manpower issues for all pharmacy 
managers and the demand of 
prescription volume 
Knapp, 2001 
Number of Drugs Prescribed and 
Office Visits, Patient Population 
A report that describes ambulatory 
care visits made to physician 
offices in the U.S. 
Cherry, Woodwell, & 
Rechtsteiner, 2007 
Institutional/Legal component     
Key Variables  Point of Interest  Reference  
Trends of Hospital and Healthcare 
System pharmacy’s, Recruiting and 
Retaining Staff  
Assessment of Pharmacy’s 
changing demographic  
Deyton et al., 2007 
Pharmacy Practice Expansion, 
Improvements in Medicare and 
Medicaid 
Impact of Healthcare Reform on 
Pharmacy  Practices  
Matzke & Ross, 2010 
Work status, part-time work, 
secondary 
employment, full-time equivalents 
Examination of trends in work 
practices of pharmacists from 1990 
to 2000. 
Mott et al.,  2002 
Legislation, medication utilization, 
and mortality  
Pharmacists, Pharmaceuticals, and 
Policy Issues that are Shaping the 
Work Force in Pharmacy 
Manasse & Speedie, 2007 
                      
43 
          
In this chapter the role and importance of pharmacists in the U.S. healthcare system have 
been reviewed. There was an exploration of factors that affect supply and demand and there was 
a discussion of the dynamic nature of the relationship between the two.  Changes in the 
organization of healthcare services, including pharmacy services, changes in the demographics 
of the population and changes in the financing of healthcare will impact supply and demand 
where pharmacists are concerned. 
Previous research in this area has presented a nascent understanding of the confluence of 
myriad factors that may significantly impact the pharmacist supply, but there are gaps in our 
understanding of the context in which these factors operate and the interactions among them. An 
understanding of these factors will be useful to closing the gap that currently exists in our 
knowledge of the pharmacist supply and the interaction among the factors affecting it.   Within 
the context of this inquiry, an understanding of the pharmacist supply and the factors affecting it 
can only come about as a result of an empirically based, purposeful examination using a rigid 
theoretical framework.  It was proposed that the population ecology framework is suitable for the 
task at hand.  There will be more in depth discussion of the population ecology framework in the 
next chapter. 
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Chapter 3: Theoretical Framework 
 
The population ecology theoretical framework will be used to guide this inquiry of 
factors affecting the pharmacist supply in the United States.  The population ecology theory is an 
adaptation of Darwin’s theory of evolution and climactic change and consists of four main 
constructs:  population, natural selection, niche and carrying capacity.  In this chapter a there will 
be a description of the population ecology theoretical framework and statement of the hypotheses 
that will be tested in this inquiry. 
The Impact of Darwin’s Theory of Evolution on the Development of Population Ecology 
Darwin’s theory of evolution looks at growth and decline among species and accounts for 
growth and decline by considering the impact of environmental factors.  The species that can 
adapt to an environment continue to thrive, and those unable to do so disappear over time.  To 
illustrate the central premise of his theory Darwin thought that it might be helpful to consider a 
country undergoing some physical change, for instance, of climate.  
A portion of the country’s inhabitants would adapt to change and survive.  The 
inhabitants that do not are likely to become extinct (Darwin, 1859).  Darwin also noted that a 
numerical proportion of some of the inhabitants, independently of the climate change itself, 
would seriously affect the survival of many others.  Darwin’s theory of evolution by natural 
selection was based on the premise that species change and adapt to their environment with the 
fittest surviving and giving way to new species.  
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Darwin’s observations have been the focus of studies in biology and various other 
scientific disciplines (Adami, Ofria, & Collier, 2000; Gavrilets & Losos, 2009; Schluter, 2009).  
Darwin’s thoughts regarding variation in a population are focused on understanding the process 
of evolution (Bowler, 2009).  He believed that variation in a population was not the result of 
some predetermined developmental trend.  On the contrary, population variation was caused by 
something other than random variation.  It was later determined Darwin was actually talking 
about genetic mutations, which are not aimed in any one direction (Bowler, 2009).  Darwin 
rejected the notion that evolution occurred over time as a result of some predetermined 
developmental trend.  Rather, he stated, evolution is the result of a naturally occurring sequence 
of events in which environmental forces contribute to the adaptation of a species over others. He 
called this sequence “natural selection.”  
Over time it became the consensus of organization theorists that the environment could 
influence the survival of individual organizations and that there are environmental forces that 
produce and shape populations of organizational forms (Mckelvey & Aldrich, 1983).   Just as 
biological evolution of species is central to Darwin’s theory of natural selection, organization 
theorists have suggested that processes within organizational environments are essential to the 
emergence of organizational forms and to the defining attributes of populations of organizations.  
These processes are variation, selection and retention (Hansenfeld, 1992).  
Population Ecology Theory:  Constructs 
Population. 
  The population ecology theoretical framework enables researchers to understand changes 
in organizational forms based upon environmental factors and their impact on outcomes such as 
the financial and demographic disposition of organizational environments.  Among the typical 
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questions that organization theorists attempt to answer within the context of the population 
ecology perspective are “Why are there so many organizations?” and “What causes organizations 
to prosper or reduce?”   The differences among organizations’ characteristics, environmental 
characteristics, and the probabilities of entry and exit have been the dominant empirical concern 
of population ecologists (Alexander & Amburgey, 1987). 
The population ecology theory shifts the level of analysis from a single organization to a 
population of organizations.  In this inquiry the pharmacist supply will be referred to as an 
organization.  This approach has previously been utilized to understand factors affecting the physician 
supply in the U.S. (Jiang and Begun, 2002).  Treating the pharmacist supply as an organization 
allows the ability to explore the factors affecting it within the population ecology framework. 
Organization theorists who employ the population ecology framework to describe how 
organizational forms emerge have made certain assumptions.  Perhaps foremost among their 
assumptions is that populations of organizations can be defined in terms of Darwin’s natural 
selection thesis (Amburgey & Rao, 1996).   
    Along the same lines as Darwin’s concept of natural selection, organization theorists 
have pointed out that a longitudinal analysis is required to assess distributional relationships 
among organizational forms.  Such analyses enable researchers to account for the effect of time 
on the emergence of organizational forms.  The longer the period of time for which historical 
data are available, the more accurate the ecological picture (Alexander & Amburgey, 1987). 
By extension of their logic for using longitudinal studies as the correct methodological 
approach to studying organizational forms and their emergence, organization theorists reject 
studies that employ cross-sectional data, or that use shorter time periods.  Specifically, these 
latter two approaches are unable to adequately account for rare or uncommon occurrences, and 
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thus, may lead the researcher to misinterpretations and to reaching incorrect conclusions.  For 
these reasons, longitudinal studies are preferred among organization theorists.  In light of this 
rationale, this inquiry seeks to explore and delineate the impact of environment on the 
pharmacist supply in the U.S.  The fundamental premise here is that, as an organizational form, 
the pharmacist supply is actually the result of a process of natural selection in which the 
pharmacist supply is determined by environmental forces.  In this regard, it is a premise of this 
inquiry that the collective characteristics of pharmacists and trends within the profession of 
pharmacy fit within the population construct of the population ecology framework. 
             Natural Selection. 
Natural selection is the second construct in the population ecology theory.  It is 
comprised of three components or stages: variation, selection and retention.  Variation involves 
any kind of change or deviation in form, condition, appearance, or extent from a former or usual 
state or from an assumed standard; whether intentional or unintentional (McKelvey & Adrich, 
1983).  Variation in health manpower may involve formal recognition of new specialties or the 
emergence (or reemergence) of different forms for providing healthcare such as the use of 
physician assistants, nurse practitioners and pharmacy technicians (Rundall & McClain, 1982).  
Jiang and Begun (2002) declare that variation is a precondition for selection.  Theirs is a 
sociological perspective of population ecology.  Selection is the apparent predisposition of an 
organizational form for the environment in which it exists.  In other words, the selection of an 
organizational form for its environment refers to its suitability for its environment as a result of 
prior variation. 
Hannan and Freeman (1977) believe that very few organizations are able to change their 
structures quickly when faced with dramatic changes in. their environment.  Organizations that 
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are able to do so are selected over time and exhibit the fluidity that is required for them to adapt 
to a rapidly changing and sometimes complex environment.  Once selected for their 
environment, organizations demonstrate stability and the ability to survive.   
Hannan and Freeman further assert that organizational adaptation can best be understood 
in terms of being selected for multiple places (environments) as a result of natural selection 
versus being specifically and uniquely selected for a single environment.  The difference 
between these two organizations or organizational forms is their properties.  The properties of 
organizational forms are believed to be essential to an organization being selected for one or 
more environments.  Hannan and Freeman see selection as an adaptive process. Looking at 
variation in the pharmacy workforce over time, one can see the various settings in which 
pharmacists now have increased presence, such as managed care organizations, wholesale 
industries and long-term care.  This type of variation leads one to conclude that the pharmacist 
supply is suitable and likely to remain potent in the very volatile U.S. healthcare environment. 
In this inquiry it is proposed to view the pharmacist supply as an organization poised to 
take its place within the larger healthcare system.  The increasing specialization within the 
profession is an organizational form that predisposes it to survival in the volatile healthcare 
domain.  As the organization’s constituents (individual pharmacists) choose to become 
specialists, this collective action results in a new organizational form that is more suitable for the 
environment in which it operates.  It is contended in this inquiry that the rate at which the 
organization changes is equal to the rate at which specialization within the profession is 
occurring. 
In this vein, pharmacists selected for their environment will survive and thrive.  Although 
the decision making process that leads pharmacists to practice in one environment versus another 
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is beyond the scope of the present inquiry, it should be noted that the ultimate choice a 
pharmacist makes regarding practice venue may be a result of a number of factors including the 
healthcare workforce (number of other healthcare providers), socio-economics (insured 
population, employers based in vicinity), type of patients (elderly, young adults) and facilities 
(pharmacies, hospitals).  All of these are important for survival or retention possibilities in a 
particular environment.   
      Niche. 
The third construct in population ecology theory is niche. One of the important aspects of 
the environment with which a species must be concerned is other species. Each species needs a 
particular set of resources in order to survive and reproduce. This set of resources is their niche 
(Langston, 1987). When viewed as an organization, and in order to survive, pharmacists require 
a patient population, prescribers, a volume of prescriptions to be filled and an insured population.  
If one or more of these is missing, it is unlikely that the organization (pharmacists) will find its 
niche, and consequently would not be selected for that environment. 
The extent to which two species will compete with each other is determined by two 
factors: their degree of niche overlap and the amount of resources available in the local 
environment (Langston, 1987). Niche overlap occurs when two species in the local environment 
require the same resources for survival and reproduction.  When two or more species need the 
same amount or nearly the same amount of resources from their shared environment the 
competition between them will be intense.  If one species manages to obtain the amount of 
resources they need they are more likely to be selected for the environment and will be able to 
survive.  If neither of the species is able to achieve their niche, they may both disappear from the 
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environment, unless they both undergo transformations that result in them becoming a single 
organization and as such are able to get the resources needed for survival.     
In the present case it disputed that niche finding will not likely result in the disappearance 
of pharmacists.  Rather, in organizational terms, it will affect the total population of pharmacists 
(number) and yield an organization that is suited for survival in the tumultuous healthcare 
environment.  In the worst case scenario the size of the organization would diminish to the point 
that other health professions may perform functions that previously had been exclusively 
performed by pharmacists.  This inquiry seeks to explore the dynamics of environmental factors 
that may affect the pharmacist supply over time and seeks to fill gaps in our knowledge 
regarding the pharmacist supply within the population ecology theoretical framework. 
In this inquiry niche will be discussed within the context of the population ecology 
theory, but it will not be explored separately.   Although niche overlap may be a significant 
factor in the pharmacist supply in the U.S. (e.g. mail order pharmacists vs. retail pharmacists), 
the data used in this inquiry are not sufficient to test this potential competitive relationship. 
               Carrying Capacity. 
The fourth and final construct of the population ecology theory is carrying capacity.  
Carrying capacity is the population size that an area can support (Wholey & Sanchez, 1991). For 
example, the equilibrium number of organizations that can be supported in a specified area may 
depend on a community’s size, wealth, and other demographic factors (Wholey & Sanchez, 
1991).  Hence, as an environment changes over time so does its carrying capacity.    
The overall perspective of the population ecology theory is that the abundance or rarity of 
organizations and organizational forms may be discerned in terms of environmental surroundings 
(Namboodiri, 1994).  Namboodiri contends that environmental conditions affect the rate of 
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creation and extinction of organizations. The rate at which organizations change and the 
interactions that occurs within and among organizational populations constitutes the 
environmental surroundings. An analysis of populations possessing a unique character or 
attribute and of their environment is an extremely useful exercise for administrators and various 
decision makers because it facilitates strategic planning for the future.  
Several studies in various industries have utilized the population ecology theory.  
Freeman and Hannan (1983) used it to study restaurants, Carroll (1984) used it to study the 
newspaper industry and Jiang and Begun (2002) used it in a study of the physician population.   
Nielsen and Hannan (1977) and Carroll (1981) also utilized the population ecology perspective 
to study economic resources affecting the growth of education organizations.  The theory has 
been beneficial in research targeting the healthcare industry; particularly research looking at 
physician practice location and the environmental circumstances that help guide it. 
The use of the population ecology theoretical framework in this inquiry is expected to fill 
in some of the gaps in our knowledge concerning the pharmacist supply.  This inquiry will also 
provide a basis from which pharmacist leaders may be able to more effectively and optimally 
utilize environmental resources to ensure that sufficient numbers of pharmacists are available at 
all times to meet societal needs.  Based on findings from this inquiry and previous inquiries, 
population ecology researchers may be able to develop and test more detailed models that 
address the pharmacist supply.  The population ecology theory is considered one of the most 
abstract and broad perspectives on organizations. Although not necessarily rich in detail, it 
provides a critical basis for cumulative research (Bacharach, 1989).   
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Applying Population Ecology Theory to the Pharmacist Supply 
The majority of the studies on the pharmacist supply in the United States have used time 
periods encompassing ten years or less.  Two studies Mott et al. (2002) and Walton et al. (2004) 
applied a three year and ten year time frame, respectively, in their studies of the number of 
pharmacists.  The final determination of the appropriate length of time for a study depends on the 
research question, circumstances, and variables involved.  Variables that will be of importance 
for this inquiry include income, population composition and size of the insured population.  
Within the context of the population ecology theoretical framework, these variables describe the 
socio-demographic component of the environment.  In this instance, these variables, among 
others, describe the socio-demographic component of the environment in which pharmacists ply 
their trade.   Identifying and understanding the important variables and factors affecting the 
number of pharmacists in the U.S. may be extremely important in light of current and past 
discussions about reforming the U.S. healthcare system.  Fryer, Green, Dovey, Yawn, Phillips, 
and Lanier (2003) suggest that income, population composition, size of the insured population 
and having a consistent source of care are important and helpful for conceptualizing system 
redesign in order to address healthcare disparities. 
Population ecologists perceive the environment as a broad illustration of the resource 
pool from which organizations obtain their sustenance, thereby aiding in the organization 
selection process (Hurley & Kaluzny, 1987).  Accordingly, this perspective recognizes that much 
of the ongoing change within the health services arena may be a function of necessity to achieve 
a better fit between resources and the environment (Hurley & Kaluzny, 1987).  One example 
may be the growth of medical group practices and medical plans to better accommodate their 
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population base.  One area of research for many population ecologists is organizational 
mortality.   
Researchers in this area have asserted that failures of organizations are due to causes 
external to them (Carroll, 1985).  Along similar lines, variation in the pharmacist supply is 
believed to be a result of factors extrinsic to the profession of pharmacy. Using the population 
ecology framework, and consistent with the approach of population ecologists, the pharmacist 
supply may be seen in the same light as organizations.  Consequently, the pharmacist supply is a 
result of the operation of environmental forces as well as certain preferences and characteristics 
of individuals who choose pharmacy as a profession.  At various times the supply of pharmacists 
is inadequate and at other times it is adequate—in the former case not meeting the needs of the 
population and in the latter case meeting the needs of the population.  Another popular focus of 
research by organization theorists is organizational transformation.  Organizational 
transformation is a critical issue in health services delivery and can be examined using the 
ecological perspective.   
The process of change in the healthcare arena can perhaps be more accurately and clearly 
understood when researchers use the population ecology theoretical framework to provide 
insights into the process of change (Hurley & Kaluzny, 1987).  The study of organizational 
transformation usually includes three fundamental issues—rates of organizational founding, 
disbanding and change in a given population. Organizational founding is best explained in terms 
of two important concepts:  density dependence and population dynamics.   
An increase in organization volume (number of organizations in a particular geographical 
area) signals an increase in founding. At the same time, a larger number of organizations 
typically lead to more competition in the local environment and that results in disbanding.  
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Disbanding occurs when the environment cannot support the organization.   For example, in the 
context of this inquiry, if the needs and expectations of the patient and provider populations do 
not create a demand for pharmacists and the tasks that they perform, the number of pharmacists 
will diminish.    
The patient population here is synonymous with organizations that offer similar products.  
Insofar as the pharmacist supply is concerned, understanding founding (influx of pharmacists) 
and disbanding (decrease of licensed pharmacists available to provide services in the 
marketplace) are critical to recognizing and describing the cyclical patterns of rapid expansion 
and contraction that shape the pharmacist supply.  Hasenfeld (1992) suggests that this is true 
across the board in the human services field.   
The provider population also figures very prominently in this context, especially those 
providers whose usual breadth and scope of practice includes writing prescriptions for the 
medications that their patients require.  One important observation here is that interdependence 
among organizations may increase the rate of founding and disbanding among organizations 
operating in the same environment.  
 By way of example, it is suggested here that both patients and providers depend heavily on 
reimbursements from insurance companies and other third parties to the healthcare transaction for the 
services provided and received in the healthcare marketplace.  The availability or lack of availability 
of reimbursement will certainly affect the patients (causing limited access to care and their inability 
to obtain needed treatment) and their providers (causing them to restrict their practices or to cease to 
provide care to a segment of the population).  These scenarios may be tied to the coming and going 
of employers in the area (because they typically are the entities that make insurance coverage 
available to their employees and they determine the extent and duration of coverage when it is 
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provided).  Therefore, as mentioned previously, an exploration of the pharmacist supply using the 
population ecology framework must include variables such as the number of insured persons, the 
number of employers, and the number of healthcare providers with prescribing authority. 
Utilizing the population ecology framework to describe factors that impact the physician 
supply in America, Jiang and Begun (2002) noted that processes of change should be examined 
at the population level, rather than at the individual level. One implication of their work for 
explaining the supply of pharmacists is that the pharmacist supply is better understood by 
looking at macro trends among pharmacists and interactions with their environments as opposed 
to looking at the decisions, practices and environments of individual pharmacists.   
It has been stated that a population is an aggregate of individuals that have a common 
dependence on the material and social environment (Freeman & Hannan, 1989).  Examples 
of the material and social environment include facilities, prescriptions, physicians, and the 
patient population, where the pharmacist supply is concerned. These variables tend to fluctuate 
in an environment and are expected to have an impact on the number of practicing pharmacists 
(i.e., the pharmacist supply).  
Consistent with Darwin’s point of view, changes in the environment are expected to have 
similar effects on members (organizations) of a population. When this concept is applied to the 
health workforce, such as physicians who are generalists, or other health professionals such as 
nurses and pharmacists, these healthcare workers can be viewed collectively as a population.  
Hasenfeld (1992) states that there are two very important theoretical constructs that must be 
examined in research involving organizations and their environments:   1) openness of the orga-
nization toward its environment and 2) the degree to which the organization can control its own 
destiny. Organizations best positioned to take advantage of new environmental conditions will 
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survive and reproduce through social, cultural, and institutional transmissions of beliefs and 
values, (Alexander & Amburgey, 1987).   
Other observers have stated that the population ecology theoretical framework provides a 
useful perspective for examining the relationship between organizational transformation and 
organizational performance over time (Wischnevsky & Damanpour, 2006). The logic is that 
organizations that change at their core confront problems that are prevalent in new organizations.  
Hannan and Freeman (1984) believe that organizations are unable to change at the same pace as 
the environment due to structural inertia. Structural inertia is an organization’s limited ability to 
adapt to its environment (Hannan & Freeman, 1977).   In Hannan’s and Freeman’s view the 
faster and easier organizations adapt to their environments the more quickly they will achieve 
stability; thus ensuring their long-term survival.  A summary of the studies that have been 
utilized in the development and study of the population ecology theory are provided in Table 2.  
The following section the hypotheses that will be tested in this inquiry are presented.  
These hypotheses have been developed to provide the empirical foundation upon which this 
inquiry into the pharmacist supply in America is based and they are consistent with the 
population ecology theoretical framework that has been discussed in this chapter.  
Hypotheses 
 Hypotheses H1 – H7 address the environmental dimension of munificence.  Hypotheses 
H8 H12 address the environmental dimension of concentration and the final hypothesis (H13)  
addresses density-dependence.  The data that will be used to test these hypotheses are described  
in the next chapter.                
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Table 2. Studies on the Creation and the Development of the Population Ecology 
 
Key Points of Interest Title  Reference  
Species, environment, resources Determining the survivability of 
species in relation to their 
environment 
Darwin, 1859 
Determination of changes in the U.S. hospital industry 
through the application of population ecology theory. The 
process of ecological selection rather than the transformation 
of individual organizations. 
The Dynamics of Change in the 
American Hospital Industry: 
Transformation or Selection? 
Alexander & Amburgey, 1987 
Political Economy, Marxist Theory, Population Ecology 
Theory 
Theoretical Approaches to Human 
Services Organization. 
Hansenfeld, 1992 
Key issues facing ecological research Organizational Ecology: Past, 
Present, and Future Directions 
Amburgey & Rao, 1996 
Review of the population perspective with an outline for 
developing a classification of organizational forms. 
Suggestions on how to improve the application of 
organizational research. 
Populations, Natural Selection, and 
Applied Organizational Science 
McKelvey & Aldrich, 1983 
A conceptual framework on physician distribution and 
forecasting regional physician supply. The study addresses 
an environmental selection model in which populations of 
physicians are viewed as the unit of analysis. 
Environmental Selection and 
Physician Supply 
Rundall & McClain, 1982 
 
This study explores the physician supply based on 
population ecology theory, the framework attempts to 
explain the growth of a particular physician population by 
four mechanisms 
Dynamics of change in local 
physician supply: an ecological 
perspective 
Jiang & Begun, 2002 
A population ecology perspective is assessed for its utility on 
organization to environment relations instead of the 
conventional adaptation perspective. There is a discussion on 
models that have attempted to discuss the organizational 
environment.   
The Population Ecology of 
Organizations 
Hannan & Freeman, 1977 
An overview of human ecology is presented, with an 
ecological perspective on demography of households. 
The Human Ecological Approach to 
the Study of Population Dynamics 
Namboodiri, 1994 
A model is developed to study environmental variability on 
populations of organizations is studied, specifically specialist 
and generalist organizations. This model predicts that death 
and growth rates of generalists and specialists in relation to 
environmental variation 
Niche Width and the Dynamics of 
Organizational Populations 
Freeman & Hannan, 1983 
 Educational organizations are assessed utilizing population 
ecology.  It was found that the educational organizations and 
characteristics were dependent on the national environment 
abundance of resources.  
The Expansion of National 
Educational Systems: Tests of a 
Population Ecology Model 
Nielsen & Hannan,1977 
 
A study of national systems of education and how they 
expand organizationally at varying speeds in different 
countries and time periods. The results suggest that 
organizational expansion in large, geographically 
decentralized systems follows a process dependent upon the 
limits of the environmental resources. 
 
Dynamics of Organizational 
Expansion in National Systems of 
Education 
 
Carroll, 1981 
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Munificence. 
This scenario correlates with carrying capacity. Environmental resources important to 
the pharmacist supply include total resident population, number of physicians, number of 
pharmacies and hospitals and the financial viability of communities (e.g., median household 
income of residents).  One would expect that as the resident population increases so does the 
patient population.   
H1 There is a linear, positive relationship between a change in the size of the population   
and a change in the pharmacist supply over time. 
While the size of the population may be important in determining pharmacist supply, the 
size of certain segments of the population may have a disproportionate effect on the need for 
pharmacists.  Older residents utilize a disproportionate share of pharmacist manpower because 
they are more likely than their younger population counterparts to have chronic conditions that 
require pharmaceutical interventions (Kaiser Family Foundation, 2011).  Older residents utilize a 
disproportionately higher number of prescribed medications than younger residents. 
Hence, more pharmacists may be required in a community with a large proportion of older 
residents than in a similar community with the same proportion of young residents.  The elderly 
consistently account for a majority of the prescriptions filled in many communities across the 
U.S.   
H2  There is a positive, linear relationship between a change in the size of the elderly  
        population and a change in the pharmacist supply over time. 
Beginning in 2001 schools of pharmacy in the United States was required to have a 
curriculum leading to the Pharm.D. degree as the entry level degree for the profession.  In 
addition, the profession experienced increased specialization among its practitioners.  From a 
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population ecology point of view, the survival of the profession would be dependent on the 
extent to which the environment in which pharmacists practice can accommodate more highly 
trained entry-level pharmacists and greater specialization among them.  In particular, the 
profession must work to ensure that pharmacists are given the opportunity to use their skills on 
the job (Cox & Fitzpatrick, 1999).  
 There appears to be a disparity of opportunity to do so between community-based and 
institutional settings.  Hospital-based pharmacists are more likely to have an opportunity to 
utilize their skills to the fullest extent possible compared to their community-based counterparts.                                                                                         
In hospital and other institutional settings pharmacists are often members of medical teams 
providing a wide array of duties such as drug therapy and other clinical services for 
institutionalized patients. 
H3   There is a positive, linear relationship between the number of hospitals with     
pharmacies and the pharmacist supply over time. 
Pharmacists practice in a variety of environments including managed care organizations, 
academia, and industry.  However, the majority of pharmacists work in pharmacies located either 
in a community (retail) setting or a hospital.  Regardless of the setting, pharmacists perform a 
number of tasks essential to desirable, high quality patient care outcomes.  Among these tasks 
are accuracy of order fulfillment, review of prescriptions for drug interactions and errors in drug 
selection and dosage, assistance with the selection of medications consistent with the ability of 
patients to pay for them, problem solving related to payment/reimbursement for filled 
prescriptions and answering patients' and other healthcare providers' general questions.  Despite 
these facts, all too often, there is too little contact between pharmacists and patients. 
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The need for pharmacists may be greater in certain community/retail settings than in 
hospital or institutional settings.  A number of previous studies have provided empirical evidence 
regarding the consequences of an insufficient number of pharmacists in the face of increasing 
demand (Mott, Doucette, Gaither, Pedersen, Kreling, & Schommer, 2006; & Knapp, et al. 2005).  
Some pharmacies have shortened their business hours, decreasing their accessibility to patients, 
while others (especially in rural communities) have closed because a replacement could not be 
found for a retiring pharmacist (Manasse & Speedie, 2007).  
H4   There is a positive, linear relationship between the number of pharmacies and the  
pharmacist supply over time. 
Another important factor pertaining to munificence where the pharmacist supply is concerned is 
the volume of prescriptions filled.  The writing of a prescription is one of the most common, and 
important, therapeutic interactions between physicians and their patients. About three billion 
prescriptions were dispensed in 2001 by more than 136,000 full-time equivalent (FTE) 
pharmacists.   
According to Pal (2002) those three billion prescriptions amounted to approximately 
30,000 prescriptions /pharmacist/year. Based upon current trends and annual growth rates it is 
estimated that approximately 7.2 billion prescriptions will be written to be filled in 2020; or 
about 90,000 prescriptions/pharmacist/year (Pal, 2002). This projection appears to be reasonable 
and tenable in light of the fact that approximately 4 billion prescriptions were dispensed in 2010 
(Kaiser Family Foundation, 2011).  Pal estimates that an additional 80,000 to 100,000 FTE 
pharmacists will be needed by 2020 to meet such a great prescription demand.   
H5  There is a positive, linear relationship between the number of prescriptions filled and  
        the pharmacist supply over time. 
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According to one national survey, physicians wrote over 4 billion prescriptions in 2007.  
Physicians are responsible for the majority of the prescriptions written in the U.S.(Medical 
Expenditure Panel Survey, 2008). To keep this in perspective, there were approximately 1.5 
billion physician office visits in 2008, with approximately 20% of those visits resulting in 
patients leaving with at least one prescription (Medical Expenditure Panel Survey, 2010). Studies 
have revealed that there has been a consistent increase in both the physician and pharmacist 
workforce populations in recent years (Shih, 1999; DHHS, 2006; DHHS, 2008).  Empirical 
findings reported by these studies seem to support the notion that the pharmacist supply increases 
to match the demand for more prescriptions to be filled by an increasing number of physicians. 
H6  There is a positive, linear relationship between the size of the physician supply and  
        the pharmacist supply over time. 
The affluence in an environment gives rise to the ability to afford healthcare. 
Communities that are relatively wealthy are better able to afford healthcare compared to 
communities that are not doing as well financially. A healthcare quality survey was conducted by 
Weinwick, Byron, and Bierman (2005) to collect detailed information about experiences with 
healthcare from a nationally representative sample of 6,722 adults ages 18 and older living in the 
continental United States. Approximately 16.9% of those included in the survey said they had 
postponed care, not filled prescriptions, used alternative care, or engaged in other noncompliant 
behavior as a result the exorbitant cost of healthcare and their inability to afford it. This statistic 
lends itself to the notion that people with higher levels of income tend to purchase more 
healthcare, all other factors being equal (Sing, Miller, & Banthin, 2008). 
H7  There is a positive, linear relationship between the wealth of a community and the   
       pharmacist supply over time. 
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             Concentration.  
Concentration describes the level to which resources are distributed.  In the healthcare 
arena the organizations and entities that impact the distribution of resources include pharmacies, 
hospitals, physicians, and employers.  In the case of hospitals, the distributions of these facilities 
affect pharmacists’ options regarding where they are going to work.  Hospitals that are involved 
in mergers may be participating in consolidation across markets that have no customer overlap 
(Ho & Hamilton, 2000).  Increasing mergers of hospitals in an area may lead to improvements in 
services such as pharmaceutical services (Brooks & Jones, 1997).  Hospitals in more competitive 
markets have a greater probability of mergers and acquisitions, but not closures; which increases 
market power (Ho & Hamilton, 2000).   
Based upon a study by Dasatani & Siganga (2003) the greatest effects that mergers and 
strategic alliances were expected to have on pharmacists’ duties and responsibilities is an 
increase in clinical duties, administrative duties, and an increase in patient-monitoring duties. 
Pharmacy directors also indicated that there would be increases in inpatient and outpatient drug 
distribution duties (Dasatani & Siganga, 2003). 
Hospitals with a strong market share have the ability to promote the provision of tertiary 
care services, this leads to an increase in occupied beds in a facility.  This in turn increases the 
demand for pharmacists who are integral in drug therapy for patients.  The importance of clinical 
pharmacists to hospitals cannot be understated; their roles have increased with emphasis on 
collaborative care and patient interaction (Kaboli, Hoth  McClimon, & Schnipper, 2006).  The 
ASHP conducted a national survey, which ended in 2000 on pharmacy practices in hospitals.   
The number of pharmacists involved in monitoring increased to 84% of hospitals in the 
2008 survey with larger bedded hospitals employing a greater number of pharmacists (Pederson, 
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Schneider, & Scheckelhoff, 2009).  This number increased to over 93% of the hospitals surveyed 
with 200 beds or more reported having their clinical pharmacists actively involved in monitoring 
patients (Pedersen, Schneider, & Scheckelhoff, 2012).  The hypothesis proposed applies to 
hospital beds and its impact on the pharmacist supply.   
H8  There is a positive, linear relationship between hospital beds per 100,000 population    
        and the pharmacist supply over time.                                                                              
Some regions of the country may have higher volumes of pharmacies based upon the demand of 
their population.  States with large elderly populations may have more pharmacies and may have 
a larger volume of prescriptions filled annually than states with smaller elderly populations.   
Chain pharmacies employ nearly 118,000 full-time equivalent (FTE) pharmacists 
(NACDS, 2011).  More community pharmacies in a state may provide more potential work 
opportunities for pharmacists and more desirable benefits such as flexible schedules, upward 
mobility and l higher salaries.  Marketplace factors have a greater impact on the number of 
community pharmacies than geography (Christensen & Farris, 2006).  There are approximately 
55,400 community pharmacies in the U.S., More than 50% are members of chains and the 
remainders are independently owned.  Chain pharmacies fall into the following categories: 
traditional chains (e.g. CVS), mass merchandisers (e.g. Walmart), and supermarket pharmacies 
(e.g. Safeway) (Christensen & Farris, 2006).  Chain pharmacies operate approximately 39,000 
pharmacies and fill nearly 2.6 billion prescriptions annually, which are more than 72% of annual 
prescriptions in the United States (NACDS, 2011).  The majority of currently employed 
pharmacists work for community pharmacies. 
H9   There is a positive linear relationship between the number of pharmacies per 100,000  
        people and the pharmacist supply over time. 
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The numbers of physicians practicing in states across the U.S. vary as a result of many 
factors.  These factors include practice environments and preferences for their personal lives.  
Insofar as practice environments are concerned, factors affecting a physician’s decision to 
establish a practice in a certain location include specialty, academic and healthcare resources and 
patient population. Outside of the office physicians desire good neighborhoods for their families, 
good schools and a wide selection of leisure activities.  According to one study utilizing 
economic theory, physicians locate both in previously underserved smaller communities, as well 
as in locations where their colleagues are already practicing in an attempt to balance their patient 
loads (Rosenthal, Zaslavsky, and Newhouse, 2005).  Physicians are primarily responsible for 
almost all of the prescriptions that are written in the United States.   
According to a study by Cherry et al. (2007) physicians wrote two billion prescriptions 
during office visits in 2005.  Physicians also write prescriptions in hospitals, long-term care 
facilities and governmental agencies.  When physicians are part of a larger physician network 
they tend to be more concentrated geographically.  The vicinity in which physicians practice 
lends itself to the potential for a certain volume of prescriptions being generated, thereby leading 
to a specified need of pharmacists to meet the rising demands.    
H10  There is a positive linear relationship between the number of office based physicians  
          per 100,000 population and the pharmacist supply over time. 
Employers are a principal source of healthcare benefits for the general population.  
Recent estimates from the United States Chamber of Commerce suggest that United States 
companies spend approximately $0.11 of every payroll dollar on healthcare benefits (Abraham, 
Feldman, Carlin, Christianson, & Davis, 2005).  Employers play a key role as purchasers and 
administrators of health insurance for the working-age population in the United States. In 2003, 
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approximately 174 million Americans (60.4% of the U.S. population) obtained their health 
insurance through an employer (Denavas-Walt, Proctor, & Mills, 2004).   
Nearly 60% of people with employer-sponsored health insurance coverage obtain it 
through a very large employer (500 or more employees). Slightly more than one in four persons 
with employer-sponsored health insurance coverage obtained it through a small employer (fewer 
than 100 employees) (State Health Access Data Assistance Center [SHADAC], 2011).  With this 
in mind it can be surmised that employers wield a considerable amount of buying power in the 
healthcare arena, and consequently, may substantially impact the pharmacist supply.   
H11a    There is a positive linear relationship between the number of employers and 
     the pharmacist supply over time. 
H11b1  There is a positive linear relationship between employer size (19 or less employees)  
  and the pharmacist supply over time. 
H11b2  There is a positive linear relationship between employer size (20 or more   
             employees) and the pharmacist supply over time. 
 In the past decade, prescription drug utilization and spending in the United States has 
increased dramatically (Reed, 2005).  One study of Medicare beneficiaries reported that drug 
coverage was associated with a 9.6% increase in the probability of any prescription use (Huh, 
Rice, and Ettner, 2008).  One review of studies examining the implementation of Medicare Part 
D found that there has been a 6% to 13% increase in reported drug use since its implementation 
(Geib, 2007).  Ostensibly, increased utilization of medication benefits leads to an increased 
prescription workload for pharmacists, which may exceed the capacity of the pharmacist supply 
(Geib, 2007).   In addition to the increased number of Medicare beneficiaries obtaining 
prescription access through Medicare Part D; by 2014 approximately 32 million Americans who 
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are currently uninsured will gain access to healthcare benefits including coverage for prescription 
drugs through some form of insurance (Vivian, 2010).  
 Provisions of the Affordable Care Act of 2010 are expected to play a very significant 
role in the increase of the number of insured Americans by 2014. The most prominent outcome 
of a larger percentage of persons having coverage for prescription drugs is likely to be an 
increased volume of prescriptions being written, which will increase demand for more 
pharmacists and pharmacy personnel (Vivian, 2010).      
H12 There is a positive linear relationship between the number of insured and  
the pharmacist supply over time. 
      Density Dependence. 
Complete data on interactions between organizations in a community are generally not 
available. Ecologists have therefore relied on the indirect evidence provided by the estimated 
effects of population density (the number of organizations in a population) on vital rates 
(founding and mortality) (Staber, 1992).   Population ecologists study competition and symbiotic 
relationships and their outcomes in an attempt to discover and describe density dependence.     
According to Hannan & Freeman (1977) the rate at which units are added to populations 
of organizations depends on how much of the fixed capacity has already been exhausted. The 
greater the unexhausted capacity in an environment, the faster should be the rate of growth of 
populations of organizations. There are two distinctive ecological considerations: the capacity of 
the environment to support forms of organization and the rate at which the populations grow (or 
decline) when the environmental support changes.  This lends itself to the understanding that 
competition grows with density at an increasing rate. The pharmacist supply is believed to also 
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be susceptible to environmental competition. If there is an oversaturation of pharmacists at any 
given point this may impede the future growth of the pharmacist supply.   
Organizational forms presumably fail to flourish in certain environmental circumstances 
because other forms successfully compete with them for essential resources. As long as the 
resources which sustain organizations are finite and populations have unlimited capacity to 
expand, competition must ensue (Hannan & Freeman, 1977).  With this notion of potential finite 
resources, it is imperative to assess the pharmacist supply while accounting for density.  Staber 
(1992) asserts that a current population’s growth rate must be taken into account in order to 
clearly understand how density dependence may alter this population’s growth rate as density 
changes; otherwise the population projections may be deceptive.  The Population Ecological 
Framework and hypotheses for this inquiry are listed in Figure 2 and Table 3, respectively. 
H13 Is there a change in the total number of pharmacist’s overtime. 
     
          
 
 
 
Figure 2.  Pharmacist Supply and the Ecological Spectrum of the Hypotheses 
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Table 3.  Hypotheses 
 
 
H1 
There is a positive linear relationship between a change in the size of the   and a 
change in the pharmacist supply over time. 
H2 
There is a positive, linear relationship between a change in the size of the elderly 
population and a change in the pharmacist supply over time. 
H3 
There is a positive, linear relationship between the number of hospitals with 
pharmacies and the pharmacist supply over time. 
H4 
There is a positive, linear relationship between the number of pharmacies and the 
pharmacist supply over time. 
H5 
There is a positive, linear relationship between the number of prescriptions filled 
and the pharmacist supply over time.  
H6 
There is a positive, linear relationship between the size of the physician 
population and the pharmacist supply over time. 
H7 
There is a positive, linear relationship between the median household income and 
the pharmacist supply over time. 
H8 
There is a positive, linear relationship between hospital beds per 100,000 
population and the pharmacist supply over time. 
H9 
There is a positive linear relationship between the number of pharmacies per 
100,000 people and the pharmacist supply over time. 
H10 
There is a positive linear relationship between the number of office based 
physicians per 100,000 population and the pharmacist supply over time. 
H11a 
There is a positive linear relationship between the number of employers and the 
pharmacist supply over time. 
H11b1 
There is a positive linear relationship between employer size (19 or less 
employees) and the pharmacist supply over time. 
H11b2 
There is a positive linear relationship between employer size (20 or more 
employees)   and the pharmacist supply over time. 
H12 
There is a positive linear relationship between the number of insured and 
pharmacist supply over time. 
H13  Is there a change in the pharmacist supply overtime.  
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Chapter 4: Methodology 
 
This inquiry examines the impact of environmental factors on the pharmacist work force 
in the United States.  A review of the relevant, extant literature was presented in chapter two.  
The theoretical framework for this inquiry was presented in chapter three.  In this chapter an 
overview of the study design, the data and the procedures and techniques for analyzing the data 
are presented.     
Study Design 
A non-experimental cohort design will be used to examine the effects of changing 
environmental conditions on the pharmacist supply.  This study design is appropriate for 
studying a subset of a population over time (Polit & Beck, 2004).  The time frame for this 
inquiry covers the 16 years between 1994 and 2009.  During this period there was a significant 
and noteworthy shift in the accreditation process for U.S. schools of pharmacy.  All schools of 
pharmacy were required to make the transition from the B.S. degree as the entry level 
professional degree to the Pharm.D. degree as the entry level degree for the profession.  This 
change and the widespread implementation of the standardized curriculum leading to the 
Pharm.D. degree is beyond the scope of this inquiry.  
 However, the mandatory transition from the B.S. to the Pharm.D. degree is an important 
environmental factor that is believed to have significant, discernible impact on the pharmacist 
supply during the time frame for this inquiry and should be examined in a separate inquiry.   
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Determining an appropriate length of time to examine the pharmacist supply is a 
challenge.  Findings from a majority of previous studies addressing the issue of the pharmacist 
supply  were based on a time frame of fewer than 10 years  (Gershon, Cultice, & Knapp, 2000; 
Walton, Cooksey, Knapp, Quist,& Miller, 2004). This inquiry will be utilizing a timeframe from 
1994 – 2009, with some variables being tested on a slightly shorter timeframe based on data not 
being available for the entire timeframe.  A table depicting all variables and timeframe available 
is presented later in this chapter.       
Lotka-Volterra Model 
A good proportion of the previous research on the population ecology of organizations 
has relied on models of multiple populations.  Such models capture population growth and 
decline.  Most frequently, these models are multivariate extensions of the logistic model 
commonly referred to as the Lotka Volterra (LV) model (Carroll, 1985).  The LV model, 
developed by American physical chemist Alfred Lotka and Italian mathematician Vito Volterra, 
attempts to describe the dynamics of biological systems in which two species interact.   
The use of LV equations was initially advocated by Hannan & Freeman (1977) for use in 
studies involving populations of organizations.  Since their use by Hannan and Freeman, these 
models have been used in additional studies involving various professions and professional 
organizations (Carroll, 1981; Wholey & Brittain, 1986). 
 The LV equation has become the basis of modern-day population ecology, although some 
consider it to be of limited practical utility for complex organizations.  Today, LV equations are 
regarded for their instructive value, rather than their applied utility (Dorschner, Fox, Keener, & 
Eikenbary, 1987).  The LV equation will provide the methodological and conceptual framework 
for this inquiry.  The change in size of the pharmacist supply between 1994 and 2009 will be 
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examined using the LV equation.  The LV equation will be particularly useful for exploring the 
two population ecology dimensions as they relate to the pharmacist supply:  munificence and 
concentration. The adaptation of the LV equation for this inquiry is represented by the following 
equation.  
                            
  
Ni= number of organizations in population i, Ki = environmental carrying capacity for 
population i, ri= growth response parameter for population i (i.e. the speed with which the 
population grows in the absence of competition), ij= the interdependence coefficient, which is 
the effect of population j on i (Jiang and Begun, 2002).  This specification describes the growth 
rate of an organization or population.  The growth is influenced by population size relative to 
the environmental carrying capacity for the population (Baum & Singh, 1994). 
Model Specification 
Munificence (M) and Concentration (C) are two environmental factors that help 
determine the pharmacist carrying capacity. The munificence dimension will be measured using 
the following variables: patient population, hospital facilities, pharmacy facilities, prescription 
volume, physician population, and community wealth.  The concentration dimension will be 
measured using hospital beds per 100,000 population, pharmacies per 100,000 population, office 
based physicians per 100,000 population, employer volume, employer size, and number of 
insured.   Munificence and concentration vary with time and cannot be observed directly.  
However, these dimensions are useful for determining and specifying resource availability. The 
following model and formulas will be utilized to explore the pharmacist supply over time. 
J
j i
i i ij i
i
i i
i
K N NdN
r N
Kdt
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  Pjk = ß0 + ß1j* yearj+ ß2+ k + jk  Where j= 1994-2009  
 
Pjk = ß0 + ß1j*yearj+ ß2 Pop+ k + jk   Where Pop = Total population  
 
Pjk = ß0 + ß1j*yearj+ ß2 Pop 65+ + k + jk      Where Pop 65+= Total number over 65 in the 
population  
 
Pjk = ß0 + ß1j*yearj+ ß2 Hosp+ k + jk         Where Hosp  = Total number of hospitals  
 
Pjk = ß0 + ß1j*yearj+ ß2 PharmF+ k + jk   Where PharmF  = Total number of pharmacies  
 
Pjk = ß0 + ß1j*yearj+ ß2 Rx+ k + jk       Where Rx = Total number of prescriptions filled  
 
Pjk = ß0 + ß1j*yearj+ ß2 Dr + k + jk       Where Dr = Total number of physicians 
 
Pjk = ß0 + ß1j*yearj+ ß2 MHI + k + jk    Where MHI = Median Household Income 
 
Pjk = ß0 + ß1j*yearj+ ß2 HospC+ k + jk  Where HospC  = Number of hospitals per 100,000 
population  
 
Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+ k + jk   Where PharmFC  = Number of pharmacies per 
100,000 population  
 
Pjk = ß0 + ß1j*yearj+ ß2 OBDR + k + jk    Where OBDR = Number of office based physicians 
per 100,000 population  
 
Pjk = ß0 + ß1j*yearj+ ß2 EmpV + k + jk   Where EmpV  = Total number of employers  
 
Pjk = ß0 + ß1j*yearj+ ß2 EmpS1+ k + jk     Where EmpS1 = Total number of employers by size  
(0-19 employees)  
 
Pjk = ß0 + ß1j*yearj+ ß2 EmpS2+ k + jk     Where EmpS2 = Total number of employers by size 
(20+ employees)  
 
Pjk = ß0 + ß1j*yearj+ ß2 Ins+ k + jk     Where Ins = Total Number of Insured  
 
Pjk represents the pharmacist supply as it interacts with the environment. The parameter 
ß0i is the intercept term; it is a baseline estimate according to the model.  The parameter ß1j 
represents the relationship between year and the pharmacist supply. ß2j is the relationship 
between the pharmacist supply and the current variable.  k represents random effects in the 
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model.  E represents the error term within the model. This is a mixed effects model and it takes 
into account both fixed and random effects.   
  Data 
For the purposes of this inquiry, the pharmacist supply will be the unit of analysis.  The 
pharmacist supply is defined as the total number of licensed pharmacists at a point in time.  Data 
for this inquiry come from a number of sources and are supplied on a state by state basis.  In 
order to effectively assess the environment’s impact on the pharmacist supply, data will be 
drawn from several sources.  The first source is the National Association of Boards of 
Pharmacy (NABP).  Founded in 1904 the NABP is a professional organization that supports the 
state boards of pharmacy in protecting public health.   
The NABP’s member boards of pharmacy are grouped into eight districts that include all 
50 United States, the District of Columbia, Guam, Puerto Rico, the Virgin Islands, eight 
Canadian provinces, and New Zealand. The Association is governed by its Executive 
Committee, whose officers and members are elected at an annual conference. The data that are 
compiled by the NABP are produced by the Survey of Pharmacy Law Census.  The survey 
describes and summarizes how the state boards of pharmacy are organized, how they function, 
and their requirements for licensure.  
  There are limited options for obtaining pharmacist and pharmacy data. The NABP is 
perhaps the most suitable source for such data.  The NABP receives its data from each state’s 
board of pharmacy. When pharmacists and pharmacies apply for licensure to their state’s board 
of pharmacy, certain information is collected and added to a database.  The NABP collects the 
databases from each state and assembles a master database of pharmacist and pharmacy data that 
may then be used in research such as this inquiry.   
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One limitation of using NABP data is that practice location is determined from 
professional mailing addresses.  However, the state of residence may not necessarily indicate the 
state in which a pharmacist practices.  A licensed pharmacist may work in a state that borders 
his/her state of residence.  At this juncture, the NABP provides the most comprehensive data 
available on the pharmacist supply and pharmacy demographics. 
The Area Resource Files (ARFs) are the second source of data for this inquiry.  
Quality Resource Systems, Inc. (QRS) maintains the ARF System under contract from the 
Health Resources and Services Administration of the U.S. Dept of Health and Human Services 
and has maintained and expanded the database for the past fifteen years.  
The database contains data from many sources including the American Hospital 
Association, the American Medical Association, the Centers for Medicare and Medicaid 
Services, the National Center for Health Statistics, and the Census.   The database is an annually-
updated file with over 6,000 variables of interest that pertain to health facilities, health 
professions, measures of resource scarcity and socioeconomic and environmental characteristics.   
ARF data used in this inquiry include number of hospital facilities and number of 
licensed physicians. The AMA data on physician workforce in the ARF contains data on all 
doctors in the United States who have completed or are completing requirements to practice 
medicine. This number includes graduates of foreign medical schools who reside in the United 
States as well as doctors of osteopathy who have met the educational and credentialing 
requirements necessary for licensure.  The one main limitation, as with the NABP data, is that a 
physician’s state of residence may not necessarily indicate the state in which he or she practices 
medicine.   The AHA is the national organization that represents and serves all types of hospitals 
and is comprised of nearly 5,000 member hospitals. The AHA database contains               
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hospital-specific data obtained annually through a survey of hospitals in the United States.  
Hospital specific ARF data include an analysis of trends and data on personnel, resource 
utilization, budgets, and bed size. 
The third data source for this inquiry is the National Association of Chain Drug Stores, 
which represents traditional drug stores, supermarkets, and mass merchants with pharmacies 
from regional chains with four stores and national companies.  The chains operate 39,000 
pharmacies, and employ approximately 118,000 full-time pharmacists, and fill nearly 2.6 billion 
prescriptions annually, which are more than 72% of annual prescriptions in the United States 
(NACDS, 2011).  
The prescription data utilized by NACDS is compiled by Wolters Kluwer Health, which 
is an organization that has been around for over 170 years and provides important information to 
global and national pharmacy professionals and the pharmaceutical industry.  Wolters Kluwer 
Health obtains electronic drug data and clinical information from more than 20,000 pharmacies, 
2,000 hospitals, and numerous health insurers and physicians' offices. Prescription fill data used 
in this inquiry will come from the NACDS database.   
The fourth data source for this inquiry is provided by the U.S Department of Commerce 
which promotes job creation, economic growth, and sustainable development and improved 
standards of living for all Americans by working in partnership with businesses, universities, 
communities and our nation’s workers.  The U.S Department of Commerce collects information 
on employers throughout the United States based upon County Business Patterns. The 
department compiles data from an annual report that contains data on budgetary projections, 
market potential and sales quotas over time.  Businesses utilize the data for analyzing market 
potential, measuring the effectiveness of sales and advertising programs, setting sales quotas, and 
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developing budgets. The data on the number and size of employers per state will be obtained 
from the U.S Department of Commerce and utilized in this study.   
The fifth and final data source that will be utilized is provided by the U.S. Census 
Bureau.  The Census Bureau is an agency within the U.S. Dept of Commerce and is the premier 
source of quality data about the nation's population and economy.  The Census Bureau collects a 
variety of data about the U.S. population and various subpopulations.  The census also collects 
and analyzes data pertaining to median household income and insurance status.  
Sampling 
Unless otherwise noted, the data used in this inquiry are derived from the entire 
population or sub-population of interest.  No sampling will be used in this inquiry.  However, it 
should be noted that data obtained from some of the sources mentioned above may be obtained 
from samples as indicated by the data owner.  Analyses will be performed using the data 
provided by the sources above.  
Study Variables 
The following variables will be used in this inquiry; in some instances a few of these 
variables have been utilized in previous studies that have used the population ecology theoretical 
framework to examine environmental factors impacting the supply of health professionals.  A 
description of the variables can be found in Table 4. 
      Dependent Variable.  
The dependent variable for this inquiry is the pharmacist supply in the United States.  For 
the purposes of this inquiry the pharmacist supply will be the total number of pharmacists in the 
United States in a given year.  The total number of pharmacists for each state is based on data 
reported by the NABP.  To prevent duplication and over counting, only those pharmacists with 
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addresses within their reported state of residence are counted in the state totals. The majority of 
the studies that have looked at pharmacist supply have used national data from the U.S. Census 
Bureau. However,  the data from the Pharmacy Census produced by the NABP is the most 
accurate data to measure the number of pharmacists by state because the NABP data are derived 
from the actual data submitted by each state pharmacy board; compared to the estimates from the 
U.S. Census Bureau Survey.    
      Independent Variables. 
 Total population. is a variable obtained from the Census and will be all encompassing of the  
       population from babies to the elderly by state.   
 Elderly population. is a subset of the total population and is provided by the Census and will 
be based upon the population that are 65 years and older and will be compiled by state. 
 Hospitals. is based upon facilities who are members of the AHA. The data utilized for this 
study will be compiled on a state by state basis for all AHA hospitals and is located within 
the ARF.   
 Pharmacies. Data will cover all pharmacy settings from retail pharmacies to institutional 
pharmacies. This data is supplied by the NABP and provides the total number of pharmacies 
for each state based upon all the licensures requested.  
 Prescriptions filled.  The volume of prescriptions data are provided by the NACDS in 
collaboration with Wolters Kluwer Health Source which is the primary source for filling 
prescriptions throughout the United States.  The data is compiled on a state by state basis 
 Physicians. The data for this variable is provided by the AMA and is subject to licensed 
practitioners on a state by state basis, and is contained within the ARF.      
     
79 
 
 Median Household Income.  The Median Household Income for each state will be measured 
upon the median house hold income provided by the Census Bureau.  
 Hospital Beds Per 100,000 population. The data is measured on the number of hospital beds 
per 100,000 population. The data utilized for this study will be retrieved from the AHA and 
the Census Bureau located within the ARF. 
 Pharmacies per 100,000 population. The data is measured on the number of community 
pharmacies per 100,000 population. The data utilized for this study will be retrieved from the 
NACDS and the Census Bureau. 
 Office Based Physicians Per 100,000 population. The data is measured on the number of 
licensed practitioners practicing in an office setting per 100,000 population.  The data is 
provided by the AMA contained within the ARF and the Census Bureau.      
 Employer Size. The data is provided by the United States Commerce.  The data represents 
the total number of employers that employ a certain number of people it is categorize by a 
specified employee range. 
 Employer Volume The data is provided by the United States Commerce.  The data represents 
the total number of employers by state. 
 Insured Population.  The data is based upon the total number of insured (public & private) by 
state and is provided by the Census Bureau. 
Analytic Methods 
     Univariate Analysis. 
Descriptive statistics will be computed for each variable.   The simple means of each 
variable and the standard errors will be provided. 
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      Multivariate Analysis.  
A Repeated Measures Regression Analysis will be used to test the hypotheses presented 
in this study. Repeated Measures Regression Analysis employs a mixed effects regression model 
and is able to account for the impact of covariates on the dependent variable (Brown and 
Prescott, 2006).  In the present case, year is a covariate of the pharmacist supply.   The presence 
of missing data does not pose the major problems for analysis that can occur with traditional 
regression analysis (Brown & Prescott, 2006).  Another benefit of repeated measures regression 
is its ability to reveal trends over time as opposed to single point estimates of changes in the 
dependent variable.  The variable descriptions are listed in Table 4.  
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Table 4. Variable Definitions 
  
  
Variables 
Variables 
Abbreviation Levels Dates Description Source  
# of Pharmacists Pharm Continuous 
1994-
2009 
Total # of  Pharmacists 
with in state addresses  NABP 
Employer Size 
EmpS1, 
EmpS2 Continuous 
1988-
2008 
Total # of Employers by 
Employee Size:  0-19,20 
or more                                   Census 
Employer Volume EmpV Continuous 
1988-
2008 
Total # of U.S. 
Employers by State                                   Census
# of Pharmacies PharmF Continuous 
1994-
2009 
Total # of Pharmacies by 
State NABP 
Total # of U.S.  of 
Hospitals  Hosp Continuous 
1995-
2007 
Total # of U.S. Hospitals 
by State ARF 
# of Prescriptions Rx Continuous 
1996-
2009 
Total # of Prescriptions 
Filled By State in Chain 
Drug Stores                      
Wolters 
Kluwer 
Health Source  
Total # of U.S. 
population Insured 
by State Ins Continuous 
1994-
2009 
Total # of U.S. 
population  Insured by 
State Census 
# of U.S. people 
over 65 years old by 
State  Pop 65+ Continuous 
1994-
2009 
Total U.S. Population 
Over 65 years of age by 
State                     Census 
Total U.S. 
Population by State  Pop Continuous 
1994-
2009 
Total U.S. Population by 
State                     Census 
# of Physicians Dr Continuous 
1994-
2008 
Total # of  Physicians 
with in State addresses  ARF 
Median Household 
Income MHI Continuous  
1994-
2009 
Median Household 
Income by State Census 
Hospital Beds Per 
100,000 population  HospC Continuous  
1995-
2007 
Number of Hospitals Per 
100,000 population 
ARF & 
Census 
Pharmacies Per 
100,000 population   PharmFC Continuous  
1994-
2008 
Number of Pharmacies 
Per 100,000 population 
NACDS & 
Census 
Office Based 
Physicians Per 
100,000 population   OBDR Continuous  
1995-
2008 
Number of Physicians 
Per 100,000 population 
ARF & 
Census 
 
All Figures are summed across all states unless noted otherwise. 
     
82 
 
Chapter 5: Results 
 
This chapter will present the results of the analysis on the environmental factors affecting 
the pharmacist supply in the U.S.  A descriptive summary of the data is provided in the first 
section of the chapter.  Table 5 provides the change in pharmacist supply from year to year; in 
appendices D-F the changes in the independent variables from year to year are displayed.  Table 
6 displays the descriptive statistics of all the variables being utilized in this study including the 
timeframe of the data available.   The second section of the chapter presents the results of each 
hypothesis in the context of its construct association.  In addition, there is a summary of each 
construct in relation to the results of all the variables.  The last section of the chapter provides a 
summary of the findings based upon the results of the hypothesis testing utilizing the repeated 
measures regression analysis.   
Descriptive Statistics 
Changes in the Pharmacist Supply Between 1994 and 2009. 
Between 1994 and 2009 the number of licensed pharmacists in the U.S. grew from 
181,134 to 264, 527; an average 2.5% increase per year during this 16 year period (NACDS, 
2011).  The dependent variable for this inquiry is the total number of licensed pharmacists with 
instate addresses., this provides more of an accurate count considering a pharmacist may have 
several state licenses for practicing pharmacy. 
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As Table 5 indicates, the supply was the greatest in 2008 and least in 1994. During the 16 
year period of this inquiry, on average, there were 224,301 licensed pharmacists with instate 
addresses in the U.S., i.e. approximately 79 per 100,000 population.  Table 6 illustrates the 
descriptive statistics of the independent and dependent variables.   
Table 5.  Percentage Change in Pharmacist Supply Per Year, 1994-2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Year # of Pharmacists 
 
% of Change 
 
1994 181134  
1995 185818 3 
1996 198053 6 
1997 201084 2 
1998 201590 0 
1999 206002 2 
2000 197678 -4 
2001 216248 9 
2002 218609 1 
2003 236009 7 
2004 246392 4 
2005 247560 0 
2006 254566 3 
2007 264490 4 
2008 269066 2 
2009 264527 -2 
     
            
Table 6.  Descriptive Statistics for Study Variables 
 
 
 
                
These descriptive statistics represent the mean for the totals of the years specified above.
Variables Mean Median Minimum Maximum Standard Error Timeframe 
Dependent Variable        
Pharm 224,301.6 217,428.5 181,134.0 269,066.0 7513.38 1994-2009 
Independent Variables        
Munificence        
Pop 284,153,822.8 286,582,792.5 260,348,536.0 307,006,550.0 3950694.7 1995-2008 
Pop 65+ 36,159,035.4 35,947,903.5 33,208,822.0 39,570,590.0 419026.9 1994-2009 
Hosp 6,429.7 6,346.0 6,285.0 6,641.0 52.1 1995-2007 
PharmF 77,667.6 74,918.0 68,130.0 87,246.0 1650.8 1994-2009 
Rx 2,991,969,779.9 3,061,141,763.0 2,211,372,768.0 3,658,892,270.0 122064017.2 1996-2009 
DR 757,028.9 765,474.0 623,403.0 848,933.0 18484.1 1994-2008 
MHI 50,153.9 50,616.1 46,399.1 52,138.1 429.8 1994-2009 
Concentration        
HospC 377.1 367.8 356.1 446.8 9.4 1995-2007 
PharmFC 30.1 29.6 27.8 33.2 0.4 1994-2008 
OBDR 178.2 180.6 157.0 187.8 2.8 1995-2008 
EmpV 7,129,851.2 7,095,302.0 6,509,065.0 7,705,018.0 97276.1 1988-2008 
EmpS1(Employers 
with 19 or less 
employees) 4,610,787.7 4,376,391.0 4,115,583.0 5,466,985.0 131812.4 1988-2008 
EmpS2 (Employers 
with 
20 or more employees) 2,519,063.5 2,588,372.0 2,090,551.0 2,882,961.0 64963.1 1988-2008 
Ins 239,895,687.5 242,307,500.0 222,418,000.0 255,141,000.0 2898134.2 1994-2009 
8
4
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Variable Overview 
Population (Pop)  The U.S. population grew by approximately 2-3 million people per 
year during the period 1994 through 2009.   In the last several years of the timeframe, 
the population grew by 3 million people per year.  On average, over 284 million people lived in  
the U.S. between 1994 and 2009.  In 2009 the U.S. population reached 307 million people.   
Elderly Population (Pop65+) Persons 65 years old and older comprise one of the fastest 
growing segments of the U.S. population.  During the 16 year period for this inquiry, this 
segment of the U.S. population grew by six million (16%).  This segment of the population  
accounts for a disproportionately higher share of prescription drug use and is expected to  
continue to grow at a faster rate than the rest of the population as a result of the continual  
development of new medications to treat chronic conditions      
Hospitals (Hosp) The number of hospitals with pharmacies in the U.S. remained fairly  
stable during the period of time covered by this inquiry.  The number of these U.S. hospitals 
increased by approximately 360 between 1995 and 2007. In 2005, there were 6,641 hospitals  
with pharmacies in the U.S. The mean number of such hospitals during the period of time  
covered by this inquiry was 6,429. The number of hospitals decreased from the mid 1990s to the  
mid 2000s then the number of hospitals started climbing. 
Pharmacies (Pharm) There was an average of 77,667 pharmacies in the U.S. between 1994 and 
2009.  During the early part of this period the number of pharmacies fluctuated and there was a 
downward trend in the number of pharmacies.  In the years following 2001, there was a 
remarkable upward trend in the number of pharmacies and by 2009 there were 84,813 
pharmacies, an increase of 16% between 2001 (when the number of pharmacies was the lowest 
for the period) and 2009.   
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Prescription Filled (Rx)  The number of prescriptions filled has consistently increased every year 
from 1996 through 2009.  There were over 2.2 billion prescriptions filled in 1996 with this 
number increasing to over 3.6 billion by 2009.  The mean number of prescriptions filled for the 
timeframe for this inquiry was 2.9 billion.  It is likely that the volume of prescriptions written 
and dispensed will continue to rise as a result of many factors. Perhaps the most noteworthy of 
these factors is the rapid growth of the 65 and over segment of the population and a rapid and 
significant increase in the proportion of the population that is insured.    
Physicians (Dr)   Between 1994 and 2008 the number of physicians grew by 27%. The mean 
number of physicians during this period was 757,028.  There was a consistent upward trend in 
the number of physicians during the period of time for this inquiry.  The number of physicians 
reached a peak of 848,933 in 2008.  The size of the physician population is marked by such 
demographic trends as the influx of international medical graduates and fluctuations in the 
number of allopathic and osteopathic medical schools.  
Median Household Income (MHI)   The median household income fluctuated between 1994 and 
2009 reaching a high of $52,138 in 2008 and a low of $46,399 in 1994.  The mean median 
household income for this 16--year time period was $50,153.  There was a remarkable decline in 
the median household income during the last two years of the 16 year period covered by this 
inquiry.   
Number of hospitals beds per 100,000 population (HospC)  The number of hospital beds per 
100,000 population decreased consistently over the 13 year time period beginning in 1995 and 
ending in 2007.  During this period, there was a mean of 377 hospital beds per 100,000 
population.  The maximum number of hospitals beds per 100,000 population during this 13 year 
period peaked at 447 in 1995.   
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The number of hospital beds per 100,000 population is expected to be marked by a perceptible 
decrease in coming years due to a growing trend of shifting inpatient care to outpatient care. 
Number of pharmacies per 100,000 population (PharmC)  The number of pharmacies per 
100,000 population remained stable over the period  1995 to 2008, with a mean of 30 pharmacies 
per 100,000 population.  The number of pharmacies per 100,000 population reached a peak of 33 
in 2006 and a low of 28 in 1995.       
Office Based Physicians per 100,000 population (OBDR) The number of office based physicians 
per 100,000 population grew every year between 1995 and 2008.  During this period there was a 
mean of 178 office based physicians per 100,000 population, with a minimum of 157 and a 
maximum of 180.      
Employer Volume (EmpV)  During the period of time covered by this inquiry there was a mean 
of 7.1 million employers in the U.S. The number of employers reached a maximum of 7.7 in 
2007.  There was a downturn in the U.S. economy during the latter part of the decade ending in 
2009.  Consistent with a decline in the economy there was a decrease in the number of employers 
during the last two years of the period of time covered by this inquiry.  
Employer Size (EmpS1, EmpS2)  For the purposes of this inquiry, employers size consists of 
two categories:  employers having 19 or fewer employees (EmpS1) and those with 20 or more 
(EmpS2). There was a mean of 4.6 million employers with 19 or fewer employees during the 
period for this inquiry.  The corresponding mean for employers with 20 or more employees was 
2.5. Employers with 20 or more employees reached a maximum of 2.8 million in 2004.  The 
maximum number of employers with 19 or fewer employees was 5.4 in 2007.                      
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Insured Population (Ins) The number of U.S. citizens with health insurance grew consistently 
during the 16 year period for this inquiry.  In fact, the number of insured increased in each year 
of the period with a total increase of 13% between 1994 and 2009.  On average, there were 240 
million Americans with health insurance for the period 1994 to 2009. The insured population 
grew from 222 million in 1994 to 253 million by 2009.   The insured population accounted for 
82% of the entire U.S. population in 2009.    
Model Specification Interpretation 
The model for this inquiry was presented in chapter 3. Within the context of the 
population ecology theoretical framework are munificence (M) and concentration (C) which are 
the overarching constructs posited to have an appreciable impact on the pharmacist supply.  The 
indicators of these two dimensions are the independent variables that were discussed in chapter 3 
and summarized in the above section.    While munificence and concentration vary with time and 
cannot be observed directly, they are useful for identifying and characterizing environmental 
factors and interactions among them that affect the pharmacist supply.    The pharmacist supply 
is represented by the following model.  
Pjk = ß0 + ß1j* yearj+ ß2j + k + jk 
Pjk represents the pharmacist supply as it interacts with the environment. ß0 is the 
intercept for the model and it is an estimate of the baseline of the pharmacist supply.  The 
parameter ß1j represents the relationship between year and the pharmacist supply. ß2j represents 
the relationship between the pharmacist supply and the independent variable being measured.   
The pharmacist supply in this inquiry, as previously stated it is the sum of the total number of 
pharmacists in each state and the District of Columbia with instate addresses.  It is believed that 
there may be forces at work in each state that could affect the pharmacist supply when the data 
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from the states are combined. It is believed that there is not sufficient data to account for these 
forces in the states.  k represents random effects in the model that may be the result of these 
forces.   E represents the error term within the model. 
A mixed effects statistical model was used in this inquiry of the pharmacist supply.  The  
inclusion of a random effects term in the model makes it more robust and more methodologically 
sound.  It is believed that more of the variation in the pharmacist supply can be accounted for 
using a statistical model with both fixed and random effects than with a fixed effects model 
alone.  Moreover, the inclusion of a random effects term is consistent with the LV model 
discussed previously in the literature and in this inquiry.  
 It follows logically that if year is the covariate in the repeated measures regression that is 
the principal statistical tool used in this inquiry, a random effects term is needed to account for 
the fact that the total number of pharmacists from year to year are not orthogonal.  As a result, 
without the random effects term, our model may yield tenuous results that may confound our 
findings in this inquiry.  
 It is assumed that the random effects follow a distribution across years and they inform 
the model that the observations for the pharmacist supply are correlated.  Consequently, a mixed 
effects statistical model allows the ability to draw more tenable conclusions using repeated 
measures regression to explain the variation in the total number of pharmacists from year to year 
during the period covered by this inquiry. 
Assumption Testing 
Pharmacist supply was found to have a non-normal distribution over the 16 year 
timeframe.  A basic requirement of linear regression is that the dependent variable is normally 
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distributed.  In order to overcome this problem, a transformation of the dependent variable was 
completed using its natural logarithm.   
This is a common and frequently used statistical manipulation to achieve a normally distributed 
dependent variable for the purposes of linear regression (Tabachnick & Fidell, 2001). 
Hypothesis Testing 
      Munificence.  
M refers to the level of resource supply within the environment. In this inquiry hypotheses H1-
H7 are tested to determine whether or not M is a significant environmental factor impacting the 
pharmacist supply.  
H1 There is a positive, linear relationship between a change in the size of the  
       population and a change in the pharmacist supply over time. 
 Equation1: Pjk = ß0 + ß1j*yearj+ ß2 Pop+ k + jk    
 
It is hypothesized that the size of the population is positively, linearly associated with the 
pharmacist supply over time.  This hypothesis was tested using repeated measures regression.  
Population was found to have a significant, statistically discernible impact on the number of 
licensed pharmacists with instate addresses during the 16--year period covered by this inquiry 
(p=.04).  The results of the repeated measures regression analysis are summarized in Tables 7 
and 8. 
Table 7. Summary of the Fixed Effect of Population on Pharmacist Supply, 1994-2009 
 
 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den DF F Value Pr > F 
Year 15 663 68.76 <.0001 
Pop 1 709 4.15 0.042 
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Table 8.  Parameter Estimates for Population, 1994-2009 
 
 
  Year Estimate Standard 
Error 
DF t Value Pr > |t| 
Intercept  8.1026 0.1497 49.8 54.14 <.0001 
Year 1994 -0.3293 0.01481 670 -22.24 <.0001 
Year 1995 -0.3069 0.01473 669 -20.83 <.0001 
Year 1996 -0.2611 0.01458 668 -17.91 <.0001 
Year 1997 -0.2505 0.0145 668 -17.27 <.0001 
Year 1998 -0.2542 0.01443 667 -17.62 <.0001 
Year 1999 -0.2163 0.01436 667 -15.07 <.0001 
Year 2000 -0.1856 0.01423 665 -13.04 <.0001 
Year 2001 -0.167 0.01401 664 -11.92 <.0001 
Year 2002 -0.1474 0.01395 664 -10.57 <.0001 
Year 2003 -0.1349 0.01383 663 -9.75 <.0001 
Year 2004 -0.13 0.01371 663 -9.48 <.0001 
Year 2005 -0.1201 0.01368 663 -8.78 <.0001 
Year 2006 -0.099 0.01372 662 -7.22 <.0001 
Year 2007 -0.0597 0.0137 662 -4.35 <.0001 
Year 2008 -0.0265 0.01383 662 -1.91 0.0561 
Year 2009 0 . . . . 
Pop   1.06E-08 0 0 . . 
   
The test results for H1 lead to acceptance and to conclude that the size of the resident 
population is a significant environmental factor impacting the pharmacist supply.  This finding is 
consistent with other findings in the literature.  Walton et al. (2004) corroborates these results.  
In their inquiry it was found that population was a strong retro prospective predictor of 
pharmacists. Year was found to be a significant covariate.  Thus, the size of the population in one 
year is a significant predictor of the pharmacist supply in a subsequent year.   
H2  There is a positive, linear relationship between a change in the size of the elderly 
population and a change in the pharmacist supply over time. 
Equation2: Pjk = ß0 + ß1j*yearj+ ß2 Pop 65+ + k + jk       
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Persons 65 years of age and older use a disproportionate share of prescription 
medications because they are more likely to have one or more chronic conditions that are 
controlled and treated with prescription medications.  In H2 it is hypothesized that the size of the 
elderly population would have a positive, significant impact on the pharmacist supply over time.  
The 65+ segment of the population was not found to have a statistically significant impact on the 
pharmacist supply over time (p=.06). The results of the repeated measures regression analysis for 
H2 are presented and summarized in Table 9.   
Table 9.  Summary of the Fixed Effect of the 65+ Population on Pharmacist Supply 1994-2009 
 
 
 
 
 
 
The test results for H2 lead to rejection and to conclude that the size of the elderly 
population is not a significant environmental factor impacting the pharmacist supply.  The census 
projections indicate that the elderly will make up at least 20% of the U.S. population by the year 
2030, and the prediction is that the prescription drug use will continue to climb (Manasse & 
Speedie, 2007).   
In addition to this growth in the elderly population are all indicators of a rapid and 
persistent rise in demand for pharmacists (Gershon, Cultice, & Knapp, 2000).  While these two 
studies display the elderly population having a strong impact on the pharmacist supply, the 
empirical evidence in this study oppose this premise. The parameter estimates for the 65+ 
population based upon the repeated measures regression analysis for H2 are presented in Table 
10. 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 15 664 95.56 <.0001 
Pop65+ 1 679 3.4 0.0657 
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Table 10.  Parameter Estimates for the 65+ Population 1994-2009 
 
H3  There is a positive, linear relationship between the number of hospitals with pharmacies and 
       the pharmacist supply over time. 
 
Equation 3: Pjk = ß0 + ß1j*yearj+ ß2 Hosp+ k + jk  
 
Hospitals are a primary location in which pharmacists utilize their unique skill set.  In this  
setting, pharmacists often work on teams alongside physicians and nurses to provide optimal  
therapies leading to desirable patient outcomes.  In light of this fact, it seems plausible that the  
pharmacist supply would be positively impacted by growth in the number of hospitals with  
pharmacies as more pharmacists would be required to staff these hospitals.  The results of a  
repeated measures regression analysis to test H3 revealed that there is a positive, linear  
association between the number of hospitals with pharmacies and the pharmacist supply  
Solution for Fixed Effects 
Effect Year Estimate Standard 
Error 
DF Pr > |t| 
Intercept   8.1372 0.1511 48.9 <.0001 
Year 1994 -0.3343 0.01421 665 <.0001 
Year 1995 -0.3116 0.01418 665 <.0001 
Year 1996 -0.267 0.01396 665 <.0001 
Year 1997 -0.2563 0.01393 664 <.0001 
Year 1998 -0.2593 0.01394 664 <.0001 
Year 1999 -0.2211 0.01393 664 <.0001 
Year 2000 -0.1876 0.01408 665 <.0001 
Year 2001 -0.1686 0.01389 665 <.0001 
Year 2002 -0.1485 0.01388 665 <.0001 
Year 2003 -0.1357 0.01378 665 <.0001 
Year 2004 -0.1305 0.01368 664 <.0001 
Year 2005 -0.1204 0.01366 664 <.0001 
Year 2006 -0.099 0.0137 664 <.0001 
Year 2007 -0.0597 0.01369 664 <.0001 
Year 2008 -0.0267 0.01381 664 0.0541 
Year 2009 0 . . . 
Pop65+   3.88E-08 0 0 . 
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(p=.006), controlling for year.  The results of the analysis are presented in Tables 11 and 12.  
Table 11. Summary of the Fixed Effect of Hospitals with Pharmacies on Pharmacist Supply 
1995-2007. 
 
 
 
          
 
 
 
 
 
Table 12. Parameter Estimates for Hospitals with Pharmacies 1995-2007 Results. 
 
Solution for Fixed Effects 
Effect Year Estimate Standard 
Error 
DF Pr > |t| 
Intercept   8.0901 0.1472 48.8 <.0001 
Year 1995 -0.2541 0.01243 360 <.0001 
Year 2000 -0.1294 0.01244 360 <.0001 
Year 2001 -0.1102 0.01229 360 <.0001 
Year 2002 -0.09 0.01229 360 <.0001 
Year 2003 -0.0755 0.01222 360 <.0001 
Year 2004 -0.0706 0.01212 360 <.0001 
Year 2005 -0.0628 0.01209 360 <.0001 
Year 2006 -0.0402 0.01215 360 0.001 
Year 2007 0 . . . 
Hosp   0.00043 0.00016 368 0.0064 
 
The test results for H3 lead to acceptance and to conclude that the number of hospitals 
with pharmacies is a significant environmental factor impacting the pharmacist supply.  The 
DHHS (2000) supported the premise that hospitals need for pharmacists are due to an ever 
expanding role to care for a growth in the number of complex diseases and conditions treatable 
by medication.  The sharp increase in the utilization of prescription drugs, among additional 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
  Year 8 360 64.69 <.0001 
Hosp 1 368 7.51 0.0064 
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factors, has been a driving force in the need for pharmacists in the hospital setting (Wisconsin 
Hospital Association, 2006). 
The findings in this inquiry are consistent with these assessments made by DHHS and the 
Wisconsin Hospital Association.  Year was found to be a significant covariate.  Thus, the number 
of hospitals in one year is a significant predictor of the pharmacist supply in a subsequent year.   
H4  There is a positive, linear relationship between the number of pharmacies and the 
pharmacist supply over time. 
Equation 4: Pjk = ß0 + ß1j*yearj+ ß2 PharmF+ k + jk    
Although the number of hospitals with pharmacies employing pharmacists increased 
between 1995 and 2007, the primary venue in which pharmacists practice continues to be retail 
pharmacies, super market pharmacies, and chain drugstores. Ostensibly, it would appear that the 
number of community-based pharmacies might have a significant impact on the pharmacist 
supply over time.  Hypothesis 4 was tested with this in mind.  It was hypothesized that the 
number of pharmacies is positively, linearly associated with the pharmacist supply over time.  
An analysis to test this hypothesis revealed that, for the period 1995-2007 the number of 
pharmacies does not have a statistically discernible impact (p=.13) on the pharmacist supply 
from year to year.  The results of the analysis are presented in Table 13.  
Table 13. Summary of the Fixed Effect of Number of Pharmacies on Pharmacist Supply,  
                1995-2007 
 
 
 
 
 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 14 619 89.83 <.0001 
# of Pharmacies 1 621 2.23 0.1362 
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The test results for H4 lead to the rejection and to conclude that the number of 
pharmacies is not a significant environmental factor impacting the pharmacist supply.  The need 
for pharmacists has been a constant area of concern as pharmacies have cut their hours of service 
and in some instances retired pharmacists reentering the work force (Manasse & Speedie 2007).   
The need for pharmacists may be greater in certain community/retail settings than in hospital or 
institutional settings (Mott et al., 2006).  The results in this inquiry are in direct contrast with the 
literature.  The parameter estimates for the number of pharmacies based upon the repeated 
measures regression analysis for H4 are presented in Table 14. It bears watching how the number 
of pharmacies changes over time as an increasing number of pharmacists enter the healthcare 
arena. 
Table 14. Parameter Estimates for Number of Pharmacies, 1995-2007 
 
 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF Pr > |t| 
Intercept   8.1566 0.1525 48.5 <.0001 
Year 1995 -0.3139 0.01359 619 <.0001 
Year 1996 -0.2681 0.01359 619 <.0001 
Year 1997 -0.2572 0.01346 619 <.0001 
Year 1998 -0.2605 0.01345 619 <.0001 
Year 1999 -0.2219 0.01347 619 <.0001 
Year 2000 -0.1897 0.01353 619 <.0001 
Year 2001 -0.1701 0.01344 619 <.0001 
Year 2002 -0.1492 0.01342 619 <.0001 
Year 2003 -0.1375 0.01327 619 <.0001 
Year 2004 -0.1324 0.01318 619 <.0001 
Year 2005 -0.1228 0.01317 619 <.0001 
Year 2006 -0.1009 0.01323 619 <.0001 
Year 2007 -0.061 0.01323 619 <.0001 
Year 2008            -0.02728 0.01337 619 0.0418 
Year 2009 0 . . . 
# of pharmacies              6.72E-06 4.51E-06 621 0.1362 
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H5  There is a positive, linear relationship between the number of prescriptions filled and 
the pharmacist supply over time 
Equation 5:  Pjk = ß0 + ß1j*yearj+ ß2 Rx+ k + jk  
 
Hypothesis 5 addresses the number of prescriptions filled over time and its impact on the 
pharmacist supply.  The number of prescriptions filled is another indicator of M.   
It is hypothesized that there is a positive, linear relationship between the number of 
prescriptions filled and the pharmacist supply over time.  This hypothesis was tested using 
Equation 5 above.  Results from a repeated measures regression reveal that the number of 
prescriptions filled does not have a statistically discernible impact (p=.12) on the pharmacist 
supply over time.  Based on this finding H5 was rejected. Results of the test of H5 are presented 
in Table 15. 
Table 15.  Summary of Fixed Effects of Prescriptions Filled on Pharmacist Supply, 1996-2009 
 
 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 13 579 50.87 <.0001 
Rx 1 589 2.34 0.1263 
 
The test results for H5 lead to rejection and to conclude that the number of prescriptions 
is not a significant environmental factor impacting the pharmacist supply.  This outcome is rather 
surprising considering the current volume of prescriptions being filled. Based upon current 
trends and annual growth rates, it is estimated that approximately 7.2 billion prescriptions will be 
written to be filled in 2020, with an estimated 80,000 to 100,000 additional FTE pharmacists 
needed to meet such a great prescription demand (Pal, 2002). According to the Kaiser Family 
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Foundation (2011), this projection appears to be probable in light of the fact that approximately 4 
billion prescriptions were dispensed in 2010.  
 At this juncture, the prescription volume appears not to be a good predictor of the 
pharmacist supply, possibly due to the current pharmacist supply’s ability to handle the 
workload.   Nevertheless, this trend seems to be in jeopardy based upon projections of 
prescriptions to be filled and may cause a serious ramification for the future.  The parameter 
estimate results for the number of prescriptions filled H5 are presented in Table 16. 
Table 16. Parameter Estimate for Number of Prescriptions filled, 1996-2009 
 
   
H6  There is a positive, linear relationship between the size of the physician population and   
        the pharmacist supply over time. 
Equation 6: Pjk = ß0 + ß1j*yearj+ ß2 Dr + k + jk 
 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF Pr > |t| 
Intercept   8.1976 0.1574 49.1 <.0001 
Year 1996 -0.2817 0.01508 581 <.0001 
Year 1997 -0.2699 0.01487 581 <.0001 
Year 1998 -0.2719 0.01451 581 <.0001 
Year 1999 -0.2316 0.01398 580 <.0001 
Year 2000 -0.198 0.01374 579 <.0001 
Year 2001 -0.1779 0.0134 579 <.0001 
Year 2002 -0.1569 0.01329 579 <.0001 
Year 2003 -0.1432 0.01318 579 <.0001 
Year 2004 -0.1374 0.01307 579 <.0001 
Year 2005 -0.1263 0.01298 579 <.0001 
Year 2006 -0.1036 0.01291 579 <.0001 
Year 2007 -0.06223 0.0128 578 <.0001 
Year 2008 -0.02818 0.01291 578 0.0295 
Year 2009 0 . . . 
Rx   -4.00E-10 0 0 . 
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Physicians are key players in the U.S. healthcare system.  They diagnose and treat 
diseases.  Among the treatment options used by physicians are pharmaceutical interventions that 
require prescriptions.  It seems logical that the size of the physician population might be related 
to the pharmacist supply. 
In previous studies it has been shown that there is a consistent increase in both the 
physician and pharmacist workforce populations in recent years (Shih, 1999; DHHS, 2006; 
DHHS, 2008). In light of previous studies, it is hypothesized that there is a positive, linear 
relationship between the number of physicians and the pharmacist supply.   
Hypothesis H6 was tested using a repeated measures regression analysis. Results indicated that, 
controlling for year, there is no statistically significant relationship (p=.48) between the 
physician population and the pharmacist supply for the 16 year period covered by this inquiry.  A 
summary of the tests of H6 is found in Table 17. 
Table 17.  Summary of the Fixed Effects of Number of Physicians on Pharmacist Supply,  
                 1994- 2008 
 
 
 
 
 
 
 
 
 
 
The relationship between physicians and pharmacists seems to be one of possible 
commensalism.  Commensalism refers to a relationship where one subject or organism benefits 
but the other is neutral (there is no harm or benefit). This will continue to be a relationship of 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Year 14 623 51.46 <.0001 
DR 1 656 0.49 0.4832 
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interest as the number of physicians continues to increase. The yearly results of the repeated 
measures regression analysis for H6 are presented in Table 18.  
Table 18.  Parameter Estimates for Number of Physicians, 1994-2008      
 
                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
H7   There is a positive, linear relationship between the median household income and 
        the pharmacist supply over time. 
Equation 7:  Pjk = ß0 + ß1j*yearj+ ß2 MHI + k + jk     
 
In H7 it was hypothesized that there is a positive, linear relationship between median 
household income and pharmacist supply over time.   
Solution for Fixed Effects 
  Effect Year Estimate Standard Error DF Pr > |t| 
 
             Intercept  8.161 0.1582 49.7 <.0001 
Year 1994 -0.3173 0.01578 631 <.0001 
Year 1995 -0.2936 0.01532 629 <.0001 
Year 1996 -0.2469 0.01499 628 <.0001 
Year 1997 -0.2352 0.0147 626 <.0001 
Year 1998 -0.2379 0.01445 625 <.0001 
Year 1999 -0.1991 0.01431 624 <.0001 
Year 2000 -0.1664 0.01425 624 <.0001 
Year 2001 -0.1471 0.014 623 <.0001 
Year 2002 -0.1264 0.01389 623 <.0001 
Year 2003 -0.1125 0.01371 622 <.0001 
Year 2004 -0.1069 0.0136 622 <.0001 
Year 2005 -0.09621 0.01357 622 <.0001 
Year 2006 -0.07419 0.01361 622 <.0001 
Year 2007 -0.03395 0.01359 621 0.0128 
Year 2008 0 . . . 
DR  -1.16E-06 1.65E-06 656 0.4832 
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Median household income is the final indicator of M used in this inquiry.  Hypothesis H7 was 
tested utilizing a repeated measures regression and found that median household income did not 
have a statistically discernible impact (p=.89) on pharmacist supply for the time period covered 
by this inquiry. These results are presented in Table 19.   
Table 19.  Summary of Fixed Effects of Median Household Income on Pharmacist Supply, 
                 1994-2009 
 
 
 
 
 
 
 
Hypothesis 7 was rejected when it was tested to determine if the median household 
income supports the premise that income level affected pharmacist supply.  The yearly results of 
the repeated measures regression analysis for H7 are presented in Table 20 this is illustrated by 
the parameter estimates.  Previous research provided empirical evidence that a community’s 
wealth does impact their ability to afford healthcare.   
To support this premise there are findings that have determined that people with higher 
levels of income tend to purchase more healthcare, all other factors being equal (Sing, Miller, & 
Banthin, 2008).  This study provides some indication that income can affect one’s ability to 
attain healthcare which affects the supply needed to meet a perceived demand for certain services 
and supplies.   
So, while median household income was not a predictor of the pharmacist supply, 
however it seems there is the ability for it to have an indirect impact on the pharmacist supply. 
Type 3 Tests of Fixed Effects 
Effect 
Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 15 665 90.88 <.0001 
MHI 1 668 0.02 0.8976 
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The median household income was found not to be statistically significant; however it may be 
possible that health insurance safeguards compensate for income for some families. 
Table 20.  Parameter Estimates for Median Household Income, 1994-2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacist Supply Munificence Summary 
 
The goal of utilizing munificence in this inquiry was to measure the environmental 
resources on the pharmacist supply.  This will help to facilitate strategic decisions on the 
pharmacist supply.  The greater the level of munificence, the more opportunities the environment 
provides which tremendously increases organization’s ability to survive and flourish.   
It has been noted through multiple studies that there is a plethora of factors that has the 
potential to influence the pharmacist supply.   The Walton et al. (2004) study determined that 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF Pr > |t| 
Intercept  8.175 0.1622 60.2 <.0001 
Year 1994 -0.3399 0.01442 665 <.0001 
Year 1995 -0.3168 0.01422 665 <.0001 
Year 1996 -0.2705 0.01402 665 <.0001 
Year 1997 -0.2592 0.01391 665 <.0001 
Year 1998 -0.2622 0.01389 665 <.0001 
Year 1999 -0.2237 0.01401 665 <.0001 
Year 2000 -0.191 0.01412 665 <.0001 
Year 2001 -0.1719 0.01386 665 <.0001 
Year 2002 -0.1517 0.01379 665 <.0001 
Year 2003 -0.1386 0.01371 665 <.0001 
Year 2004 -0.1331 0.01363 665 <.0001 
Year 2005 -0.1226 0.01363 665 <.0001 
Year 2006 -0.1007 0.01376 665 <.0001 
Year 2007 -0.06076 0.01387 665 <.0001 
Year 2008 -0.0271 0.01383 665 0.0505 
Year 2009 0 . . . 
 MHI  -1.34E-07 0 0 . 
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population and the number of community pharmacy prescriptions were very accurate predictors 
of the number of pharmacists.   
There have been studies such as Reissman (2004) that look at the elderly and insured 
population with certain instances in the study alluding to its impact on the pharmacist supply.  In 
the majority of the studies reviewed the pharmacists are directly tested against environmental 
factors such as facilities, prescriptions filled, or the population.  While this is important, it is 
imperative to expand the scope of research and examine the pharmacist supply against 
environmental factors such as the number of physicians and median household Income.   
The ability for physicians to influence the pharmacist supply is not relegated to just 
prescriptions written, there are other aspects such as consulting calls, and placement of both on 
multidisciplinary teams.   The ability to afford one’s healthcare is also vital to this research in 
that it has not been addressed whether income levels are predictors of the pharmacist supply.  
The evidence in this inquiry will help to determine if the number of prescriptions affects the 
pharmacist supply.  This inquiry will not only address previous environmental factors but 
additional ones as well which will provide empirical evidence for future investigational studies. 
Concentration  
Concentration describes the level to which resources are evenly distributed.  It will be measured  
by H8-H12.  
H8  There is a positive, linear relationship between hospital beds per 100,000 population  
        and the pharmacist supply over time. 
Equation 8:  Pjk = ß0 + ß1j*yearj+ ß2 HospC+ k + jk 
 
Hospitals provide treatment and care at varying levels, with the level of specialization 
having an association with the number of occupied beds and length of stay.  The provision of 
                              
104 
 
tertiary care leads to an increase in occupied beds in a facility.  This, in turn, can amplify the 
demand for pharmacists who are integral in drug therapy for patients.  
In H8 it was hypothesized that the number of hospital beds per 100,000 population would 
have a positive, significant impact on the pharmacist supply over time.  The analysis conducted 
determined that the number of hospital beds per 100,000 population did not have a statistically 
tangible impact on the pharmacist supply for the period of time in this study (p=.09).  Tables 21 
and 22 presented below display the results for H8. 
Table 21. Summary of Fixed Effects of Hospital Beds Per 100,000 Population on Pharmacist    
                Supply, 1995-2007 
 
 
 
 
 
 
 
 
Table 22. Parameter Estimates for Hospital Beds Per 100,000 Population, 1995-2007 
 
 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 8 362 21.19 <.0001 
Beds 1 377 2.86 0.0919 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF t Value Pr > |t| 
Intercept   8.0145 0.171 74.8 46.87 <.0001 
Year 1995 -0.2893 0.02322 372 -12.46 <.0001 
Year 2000 -0.1429 0.01401 364 -10.2 <.0001 
Year 2001 -0.1236 0.01376 364 -8.98 <.0001 
Year 2002 -0.1001 0.01301 362 -7.69 <.0001 
Year 2003 -0.08353 0.01256 361 -6.65 <.0001 
Year 2004 -0.07624 0.01226 360 -6.22 <.0001 
Year 2005 -0.06405 0.01214 360 -5.27 <.0001 
Year 2006 -0.04063 0.01217 360 -3.34 0.0009 
Year 2007 0 . . . . 
Beds   0.000385 0.000228 377 1.69 0.0919 
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The test results for H8 lead to rejection and to conclude that the number of hospital beds 
per 100,000 population is not a significant environmental factor impacting the pharmacist 
supply.  Hospitals with tertiary care services are subject to longer occupied beds days compared 
to facilities with less specialized services.   
This, in turn, increases the demand for pharmacists whose role has increased with 
emphasis on collaborative care and patient interaction (Kaboli, Hoth McClimon, & Schnipper, 
2006).  The number of pharmacists involved in monitoring patients increased to 84% of hospitals 
in the 2008 survey compared to 75%  in 2000 with larger bedded hospitals employing a greater 
number of pharmacists (Pederson, Schneider & Sheckelhoff, 2009).  While these two studies 
exhibit hospital beds having a strong impact on the pharmacist supply, the empirical evidence in 
this study oppose this premise.                                                                                                                      
H9  There is a positive linear relationship between the number of pharmacies per 100,000  
        people and the pharmacist supply over time. 
Equation 9: Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+ k + jk    
As noted earlier there are approximately 55,400 community pharmacies in the U.S., More than 
50 percent are members of chains and the remainders are independently owned.  Chain 
pharmacies fall into the following categories: traditional chains (e.g., CVS), mass merchandisers 
(e.g., Walmart), and supermarket pharmacies (e.g., Safeway) (Christensen & Farris, 2006).  
Hypothesis 9 in the concentration dimension measures the number of pharmacies per 100,000. 
population and the pharmacist supply over time.  It is hypothesized that the number of 
pharmacies per 100,000 population is positively linearly associated with the pharmacist supply 
over time.  The analysis conducted determined that the number of pharmacies per 100,000 
population did not have a statistically significant impact on the pharmacist supply for the period 
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of time in this study (p=73).  Due to the statistical results, H9 was rejected as a predictor of 
pharmacist supply.  Chain pharmacies operate approximately 39,000 pharmacies and fill nearly 
2.6 billion prescriptions annually, which account for more than 72% of annual prescriptions 
filled in the United States (NACDS, 2011).  Tables 23 and 24 illustrate the results for H9. 
Table 23.  Summary of Fixed Effects of Pharmacies Per 100,000 Population on Pharmacist      
                 Supply, 1994-2008. 
 
Table 24. Parameter Estimates for Pharmacies Per 100,000 Population, 1994-2008 
 
 
The majority of currently employed pharmacists work for community pharmacies. While 
these statistics from the literature point to the magnitude of prescriptions dispensed by chain 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Year 14 619           95.58 <.0001 
Pharmacies per 100,000 population 1 619 0.11 0.7387 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF t Value Pr > |t| 
Intercept   8.1675 0.1535 48.4 53.21 <.0001 
Year 1995 -0.3163 0.01351 619 -23.42 <.0001 
Year 1996 -0.2708 0.0135 619 -20.07 <.0001 
Year 1997 -0.2589 0.01342 619 -19.29 <.0001 
Year 1998 -0.2621 0.01342 619 -19.53 <.0001 
Year 1999 -0.2238 0.01342 619 -16.67 <.0001 
Year 2000 -0.1913 0.01351 619 -14.16 <.0001 
Year 2001 -0.1725 0.0136 619 -12.68 <.0001 
Year 2002 -0.1506 0.01341 619 -11.23 <.0001 
Year 2003 -0.1385 0.01327 619 -10.44 <.0001 
Year 2004 -0.133 0.01319 619 -10.09 <.0001 
Year 2005 -0.1227 0.01319 619 -9.3 <.0001 
Year 2006 -0.1009 0.01325 619 -7.62 <.0001 
Year 2007 -0.0611 0.01325 619 -4.61 <.0001 
Year 2008 -0.0276 0.01338 619 -2.06 0.0399 
Year 2009 0 . . . . 
Pharmacies per 
100,000 population 
  2.1E-05 6.3E-05 619 0.33 0.7387 
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pharmacies, it does not account for the over-the-counter consumers asking questions and needing 
behind the counter nonprescription medication. While there are studies in the literature that lend 
support to pharmacies as a predictor, the empirical evidence in this study opposes this assertion. 
H10 There is a positive linear relationship between the number of office based    
 physicians per 100,000 population and the pharmacist supply over time. 
Equation 10:  Pjk = ß0 + ß1j*yearj+ ß2 PharmFC+ k + jk  
 
Physicians are primarily responsible for almost all of the prescriptions that are written in 
the United States.  Hypothesis 10 is focused on office-based physicians per 100,000 population, 
a variable within the concentration dimension of the population ecology theory.  The volume of 
scripts being written can impact the workload of pharmacists.  In an outpatient or office-based 
setting, physicians write a significant amount of prescriptions, thereby leading to a specified 
need for pharmacists to meet the demands.  It is hypothesized that the number of office-based 
physicians per 100,000 population has a positive linear association with the pharmacist supply 
over time.  The results of the analysis determined that when adjusting for year the number of 
office based physicians per 100,000 population does not have an effect on the pharmacist supply 
(p=.51).  The results are displayed in Tables 25 and 26. 
Table 25.  Summary of Fixed Effects of Office Based Physicians Per 100,000 Population on    
                 Pharmacist Supply, 1995-2008  
 
 
 
 
 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Year 9 405 33.36 <.0001 
OBDR per  
100,000 population 
1 419 0.42 0.5184 
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Table 26. Parameter Estimates for Office Based Physicians Per 100,000 Population, 1995-2008 
 
 
Solution for Fixed Effects 
Effect Year Estimate Standard 
Error 
DF t Value Pr > |t| 
Intercept   8.2666 0.1989 132 41.57 <.0001 
Year 1995 -0.301 0.02134 414 -14.11 <.0001 
Year 2000 -0.171 0.01449 408 -11.8 <.0001 
Year 2001 -0.1487 0.01256 405 -11.83 <.0001 
Year 2002 -0.1286 0.01262 405 -10.19 <.0001 
Year 2003 -0.1118 0.01227 404 -9.11 <.0001 
Year 2004 -0.1058 0.01226 404 -8.63 <.0001 
Year 2005 -0.0929 0.01314 406 -7.07 <.0001 
Year 2006 -0.0716 0.01261 405 -5.67 <.0001 
Year 2007 -0.032 0.01251 405 -2.56 0.011 
Year 2008 0 . . . . 
OBDR per  
100,000 population 
  -0.0005 0.00074 419 -0.65 0.5184 
 
 
The empirical evidence provided by the analysis lead to the rejection of H10.  According 
to a study by Cherry et al. (2007), physicians wrote 2 billion prescriptions during office visits in 
2005.  To keep this in perspective, there were approximately 1.5 billion physician office visits in 
2008, with approximately 20% of those visits resulting in patients leaving with at least one 
prescription (Medical Expenditure Panel Survey, 2010).    
These two studies provide support to the argument that office based physicians can be a 
strong predictor on the pharmacist supply through the volume of prescriptions physicians 
generate.   Although the empirical evidence in this inquiry was rejected, there may to be a 
potential commensalism relationship between office-based physicians and the pharmacist supply 
or an indirect influence.     
H11a   There is a positive linear relationship between the number of employers and the  
 pharmacist supply over time. 
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H11b1  There is a positive linear relationship between employer size (19 or less employees)  
  and the pharmacist supply over time. 
H11b2  There is a positive linear relationship between employer size (20 or more employees)    
             and the pharmacist supply over time. 
Equation 11a:    Pjk = ß0 + ß1j*yearj+ ß2 EmpV + k + jk    
Equation 11b1:  Pjk = ß0 + ß1j*yearj+ ß2 EmpS1+ k + jk ,  
Equation 11b2:  Pjk = ß0 + ß1j*yearj+ ß2 EmpS2+ k + jk ,      
 
Employers play a key role as purchasers and administrators of health insurance for the 
working-age population in the United States, with the majority of Americans obtaining their health 
insurance through an employer. The following two hypotheses address the employers and influence 
on the pharmacist supply.  Hypotheses 11a, 11b1 and 11b2 in the concentration dimension is 
characterized by the total number of employers and the size of the employer (19 employees or 
less, 20 or more employees) respectively.  Specifically, it is hypothesized in 11a that the number 
of employers is positively linearly associated with the pharmacist supply over time.   
In H11a the total number of employers was not found to be significant predictor of the 
pharmacist supply (p=.85), therefore H11a was rejected.  The results of the statistical analysis on 
H11a are illustrated in Tables 27 and 28.   
Table 27. Summary of the Fixed Effect of Total Number of Employers on Pharmacist Supply,    
                1994-2008  
  
 
 
 
 
 
 
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Year 14 621 61.83 <.0001 
EmpV 1 668 0.03 0.8534 
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Table 28. Parameter Estimates for Total Number of Employers, 1994-2008 
 
 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF Pr > |t| 
Intercept   8.1343 0.1572 49.9 <.0001 
Year 1994 -0.311 0.0148 628 <.0001 
Year 1995 -0.2882 0.01465 627 <.0001 
Year 1996 -0.242 0.01441 625 <.0001 
Year 1997 -0.231 0.01422 624 <.0001 
Year 1998 -0.2342 0.01417 623 <.0001 
Year 1999 -0.1959 0.01411 623 <.0001 
Year 2000 -0.1636 0.01411 622 <.0001 
Year 2001 -0.1446 0.01393 622 <.0001 
Year 2002 -0.1244 0.01386 621 <.0001 
Year 2003 -0.111 0.01375 621 <.0001 
Year 2004 -0.1057 0.0136 620 <.0001 
Year 2005 -0.09531 0.01356 620 <.0001 
Year 2006 -0.07364 0.01361 620 <.0001 
Year 2007 -0.03389 0.01362 620 0.0131 
Year 2008 0 . . . 
EmpV   4.41E-08 0 0 . 
 
While the total number of employers was not significant, the measurement of employers 
with varying employee sizes yielded mixed results.   
In H11b1 and H11b2 it is hypothesized that the size of the employers is positively 
linearly associated with the pharmacist supply over time.   Employers with 19 or less employees 
were found not to be significant (p=.35), and employers with 20 or more employees were found 
to be significant predictor when adjusting for year (p=.02). Tables 29-32 display the results of 
employer size. 
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Table 29. Summary of the Fixed Effect of Employers with 19 or Less Employees on Pharmacist                                 
                Supply 1994-2008  
 
Type 3 Tests of Fixed Effects 
Effect Num DF Den DF F Value Pr > F 
Year 14 623 69.09 <.0001 
EmpS  (19 or less employees) 1 640 0.84 0.3586 
 
 
Table 30. Parameter Estimates for Employers with 19 or Less Employees, 1994-2008 
 
 
Solution for Fixed Effects 
Effect Year Estimate Standard 
Error 
DF Pr > |t| 
Intercept   8.16 0.157 49 <.0001 
Year 1994 -0.3163 0.01463 624 <.0001 
Year 1995 -0.2931 0.01456 624 <.0001 
Year 1996 -0.2466 0.01441 624 <.0001 
Year 1997 -0.2353 0.01436 624 <.0001 
Year 1998 -0.2385 0.01433 624 <.0001 
Year 1999 -0.2 0.01431 624 <.0001 
Year 2000 -0.1675 0.01435 623 <.0001 
Year 2001 -0.1484 0.01417 623 <.0001 
Year 2002 -0.1282 0.01419 623 <.0001 
Year 2003 -0.1147 0.01409 623 <.0001 
Year 2004 -0.109 0.01394 623 <.0001 
Year 2005 -0.0953 0.01352 622 <.0001 
Year 2006 -0.0734 0.01359 622 <.0001 
Year 2007 -0.03342 0.01359 622 0.0142 
Year 2008 0 . . . 
EmpS1 (19 or less employees)   -1.75E-07 0 0 . 
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Table 31.  Summary of the Fixed Effect of Employers with 20 or More Employees on  
                 Pharmacist Supply 1994-2008 
 
 
 
Table 32.  Parameter Estimates for Employers with 20 or More Employees, 1994-2008 
 
 
Solution for Fixed Effects 
Effect Year Estimate Standard 
Error 
DF Pr > |t| 
Intercept   8.0993 0.1492 48.6 <.0001 
Year 1994 -0.3148 0.01392 622 <.0001 
Year 1995 -0.2925 0.01395 622 <.0001 
Year 1996 -0.2472 0.01392 622 <.0001 
Year 1997 -0.238 0.01407 623 <.0001 
Year 1998 -0.2416 0.0141 623 <.0001 
Year 1999 -0.204 0.01418 623 <.0001 
Year 2000 -0.1724 0.01435 623 <.0001 
Year 2001 -0.1534 0.01418 624 <.0001 
Year 2002 -0.1351 0.01444 624 <.0001 
Year 2003 -0.1221 0.01442 625 <.0001 
Year 2004 -0.118 0.01454 625 <.0001 
Year 2005 -0.09254 0.01359 622 <.0001 
Year 2006 -0.07216 0.01361 622 <.0001 
Year 2007 -0.03358 0.01359 622 0.0137 
Year 2008 0 . . . 
EmpS2 (20 or more employees)   9.25E-07 0 0 . 
 
The test results lead to the rejection of H11a, and 11b1, while accepting H11b2 and 
concluding that the number of employers is not a significant environmental factor impacting the 
pharmacist supply.  However, the size of the employers can be a significant predictor in this 
regard.  Findings in the literature have determined that large employers have significantly more 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F Value Pr > F 
Year 14 623 87.37 <.0001 
EmpS2 (20 or more employees) 1 645 5.15 0.0236 
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employees who obtain healthcare coverage through their employer compared to smaller 
employers (SHADAC, 2011).  Previous research provides credence to the empirical evidence 
found in H11b1 and H11b2, which helps one to deduce that employers wield a considerable 
amount of purchasing power in the healthcare arena, and consequently, may substantially impact 
the pharmacist demand and supply. The increase in the number of large employers affects the 
supply, by having the potential to offer more types of drug coverage which has the propensity to 
increase medication demand, while the increase in the number of small employers does not 
provide the same influence. 
H12  There is a positive linear relationship between the number of insured and  
          pharmacist supply over time. 
 
Equation 12:  Pjk = ß0 + ß1j*yearj+ ß2 Ins+ k + jk      
The number of insured is significant in determining one’s ability to obtain prescriptions  
which facilitates a pharmacist’s workload and pharmacist demand.  Hypothesis 12 focuses on the 
insured population and is the last variable in the concentration dimension being measured as part  
of the population ecology theory.  In H12 it is hypothesized that the number of insured would 
have a positive, significant impact on the pharmacist supply over time.  The number of insured 
was found to have a significant, statistically discernible impact on the number of licensed 
pharmacists with instate addresses during the 16--year period covered by this inquiry (p=.17). 
Table 33 provides the summary of repeated measures analysis on the number of insured.    
The parameter estimate results of the number of insured is presented in Table 34. The empirical 
evidence provided in this inquisition leads to acceptance of H12.  
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Table 33.  Summary of the Fixed Effect of Number of Insured on Pharmacist Supply, 1994-2009  
 
 
 
 
 
 
 
 
 
 
 
Table 34.  Parameter Estimates for Number of Insured, 1994-2009 
 
 
 
 
 
 
Type 3 Tests of Fixed Effects 
Effect Num 
DF 
Den 
DF 
F 
Value 
Pr > F 
Year 15 663 72.21 <.0001 
Insured 1 711 5.66 0.0176 
Solution for Fixed Effects 
Effect Year Estimate Standard Error DF Pr > |t| 
Intercept  8.0876 0.1483 49.9 <.0001 
Year 1994 -0.3294 0.01457 668 <.0001 
Year 1995 -0.307 0.01451 667 <.0001 
Year 1996 -0.2612 0.01438 667 <.0001 
Year 1997 -0.2502 0.01436 667 <.0001 
Year 1998 -0.2539 0.01431 666 <.0001 
Year 1999 -0.2184 0.01406 664 <.0001 
Year 2000 -0.1867 0.01408 663 <.0001 
Year 2001 -0.1677 0.0139 663 <.0001 
Year 2002 -0.1479 0.01388 663 <.0001 
Year 2003 -0.1353 0.01378 662 <.0001 
Year 2004 -0.1307 0.01366 662 <.0001 
Year 2005 -0.1209 0.01364 662 <.0001 
Year 2006 -0.0995 0.0137 662 <.0001 
Year 2007 -0.0608 0.01368 662 <.0001 
Year 2008 -0.0276 0.01383 662 0.046 
Year 2009 0 . . . 
Insured  1.6E-05 6.62E-06 711 0.0176 
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The results of the analysis corroborates with previous research findings that the insured 
population has an impact on the pharmacist supply.  One example of insurance coverage impact 
on the pharmacist supply is the implementation of Medicare Part D which helps make 14 to 30 
million prescriptions available monthly at a cost savings to persons who may not have been able 
previously to afford their prescription drugs (Kostick, 2006).  
 In addition, the healthcare reform act would offer health insurance to an estimated 32 
million previously uninsured people which would drive up the demand (Wechsler, 2010).  These 
two studies in the literature add credence to the empirical evidence found in this investigation.  
 Pharmacist Supply Concentration Summary 
Concentration describes the level to which resources are distributed.   As with the goals 
specified in the munificence summary the primary interests in concentration revolve around 
applicability to the pharmacist supply.   Organizations and entities that impact the distribution of 
resources include pharmacies, hospitals, physicians, and employers.  The number of hospitals 
beds per 100,000 Population is of interest as it has been noted in several studies that more 
hospitals are making a concerted effort to increase the number of pharmacists they have to be 
part of their healthcare teams for monitoring patients (Pederson et al., 2009).   
Measurement of chain pharmacies per 100,000 population had the potential to add 
considerable insight into the pharmacist supply.  It was noted by NACDS (2011) that the chain 
pharmacies which are a part of their organization, operate approximately 39,000 pharmacies, and 
fill nearly 2.6 billion prescriptions annually, and account for more than 72% of annual 
prescriptions in the United States.  The majority of currently employed pharmacists work for 
community pharmacies. While these statistics from the literature point to the magnitude of 
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prescriptions dispensed by chain pharmacies, it does not account for the over-the-counter 
consumers asking questions and needing behind the counter nonprescription medication.   
Measurement of the pharmacies per 100,000 population helps to directly examine the part 
of the pharmacy consumer and pharmacist workload not captured by the sheer number of 
prescriptions filled.    Analysis of the office based physicians provides a more detailed 
interpretation of physicians on the pharmacist supply.   
This is an important measurement since according to a study by Cherry et al. (2007), 
physicians wrote two billion prescriptions during office visits in 2005.  The two hypotheses that 
were statistically significant in the concentration dimension were the size of employers (20 or 
more employees) and the number of insured.    Nearly 60% of people with employer-sponsored 
health insurance coverage obtain it through large employers compared to slightly more than one 
in four persons with smaller employers (SHADAC, 2011).  The evidence provided by this study 
corroborates the results in our inquiry.   In addition another study was conducted on Medicare 
beneficiaries reported that drug coverage was associated with a 9.6% Increase in the probability 
of any prescription use (Huh, Rice, & Ettner, 2008).   
The most prominent outcome of a larger percentage of persons having coverage for 
prescription drugs is likely to lead to an increased volume of prescriptions being written, which 
will increase demand for more pharmacists and pharmacy personnel (Vivian, 2010).  These 
several studies demonstrate that employer size and the numbers of insured have an impact on the 
pharmacist supply which supports the empirical evidence in this study.  The results from this 
inquiry will factor in the determination of the need to recruit pharmacists based upon the number 
of insured in your service area in conjunction with the type and size of employers that are in the 
service area. 
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             Density.  
Density explains the interactions between organizations in a community.  It will be measured by  
H13. 
H13    Is there a change in the pharmacist supply overtime.   
 
The last hypothesis measured density in the pharmacist supply.  Testing H13 was to 
determine if there is change in pharmacist population overtime. Some states had big spurts in 
growth from one year to the next year.  In order to attain the correct results, the bonferroni 
correction, was utilized in order to account for the 14 differences that were tested.  Based upon 
the bonferroni correction the significance level was calculated as .0035.   
Overall, the pharmacist supply continued to rise at a consistent pace throughout the years, 
with their seeming to be no impact on its growth from the previous year supply levels.  It is 
important to point out that while the pharmacist supply continued to grow steadily over the 
timeframe researched, there were only two years that were statistically significant 1995-1996 
(p=.0008) and 2006-2007 (p=.0029). The results of the analysis are presented in Tables 35-38.   
Table 35.  Year Significance Test Results 
 
 
 
 
 
 
 
 
 
 
 
Type 3 Tests of Fixed Effects 
     Effect Num  
DF 
Den 
DF 
F Value Pr > F 
     Year     15      666 104.1 1995 –1996,  
.0008 
2006 – 2007, 
.0029 
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Table 36.  Year Parameter Estimate Results 
 
 
 
 
Table 37.  Yearly Change in Parameter Estimates  
 
 
Differences of Least Squares Means 
Effect Year Year Estimate Standard Error DF Pr > |t| Alpha Lower Upper 
Year 1994 1995 -0.023 0.01379 666 0.0964 0.05 -0.05 0.00412 
Year 1995 1996 -0.0462 0.01372 666 0.0008 0.05 -0.0732 -0.0193 
Year 1996 1997 -0.0111 0.01363 666 0.4141 0.05 -0.0379 0.01563 
Year 1997 1998 0.00322 0.01363 666 0.8133 0.05 -0.0236 0.02999 
Year 1998 1999 -0.0384 0.01363 666 0.005 0.05 -0.0652 -0.0116 
Year 1999 2000 -0.0327 0.01372 666 0.0176 0.05 -0.0596 -0.0057 
Year 2000 2001 -0.0192 0.01365 666 0.1606 0.05 -0.046 0.00763 
Year 2001 2002 -0.0203 0.01348 666 0.1329 0.05 -0.0468 0.00619 
Year 2002 2003 -0.0131 0.01342 666 0.3284 0.05 -0.0395 0.01322 
Year 2003 2004 -0.0055 0.01328 666 0.6772 0.05 -0.0316 0.02055 
Year 2004 2005 -0.0105 0.0132 666 0.427 0.05 -0.0364 0.01543 
Year 2005 2006 -0.0218 0.01328 666 0.1015 0.05 -0.0478 0.0043 
Year 2006 2007 -0.0398 0.01334 666 0.0029 0.05 -0.066 -0.0137 
Year 2007 2008 -0.0339 0.0135 666 0.0123 0.05 -0.0604 -0.0074 
Year 2008 2009 -0.0272 0.01381 666 0.0494 0.05 -0.0543 -7E-05 
Least Squares Means 
Effect Year Estimate Standard 
Error 
DF Pr > |t| Alpha Lower Upper 
Year 1994 7.8289 0.1535 48.4 <.0001 0.05 7.5203 8.1375 
Year 1995 7.8518 0.1535 48.4 <.0001 0.05 7.5432 8.1604 
Year 1996 7.8981 0.1535 48.4 <.0001 0.05 7.5895 8.2066 
Year 1997 7.9092 0.1535 48.4 <.0001 0.05 7.6006 8.2178 
Year 1998 7.906 0.1535 48.4 <.0001 0.05 7.5974 8.2146 
Year 1999 7.9444 0.1535 48.4 <.0001 0.05 7.6358 8.253 
Year 2000 7.977 0.1535 48.4 <.0001 0.05 7.6684 8.2856 
Year 2001 7.9962 0.1535 48.4 <.0001 0.05 7.6876 8.3048 
Year 2002 8.0165 0.1535 48.4 <.0001 0.05 7.7079 8.3251 
Year 2003 8.0296 0.1535 48.4 <.0001 0.05 7.721 8.3382 
Year 2004 8.0351 0.1535 48.4 <.0001 0.05 7.7266 8.3437 
Year 2005 8.0456 0.1535 48.4 <.0001 0.05 7.7371 8.3542 
Year 2006 8.0674 0.1535 48.4 <.0001 0.05 7.7588 8.376 
Year 2007 8.1072 0.1535 48.4 <.0001 0.05 7.7987 8.4158 
Year 2008 8.1411 0.1535 48.4 <.0001 0.05 7.8326 8.4497 
Year 2009 8.1683 0.1535 48.4 <.0001 0.05 7.8597 8.4769 
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Table 38. Natural Log of Pharmacist Supply Growth Estimate Over Time 
 
 
 
 
 
Summary of Findings 
 The pharmacist supply was measured over time to attain an understanding of the 
environment’s impact on it.  Of the 13 hypotheses posited in this inquiry, five were accepted as a 
result of the empirical testing.   The size of the population and the number of hospitals were the 
two variables found to be statistically significant when measuring munificence.  Previous 
research has corroborated the empirical evidence found in this study that the population is a focal 
point when determining predictors of pharmacists supply (Knapp, Shah, & Barnett, 2010; 
Manolakis, & Skelton, 2010).  The second hypothesis in munificence that was statistically 
significant was the number of hospitals.  
 It seems that the consensus among hospitals to address concerns related to rising multi-
drug therapy regimens and medication safety is to employ additional pharmacists (Pederson, 
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Schneider, & Scheckelhoff, 2009). This trend in one setting in which pharmacists work is 
characterized by its positive, linear association with the total number of pharmacists. 
Employers with 20 or more employees and the number of insured were the variables  
found to be statistically significant when measuring concentration.  Employers with 20 or more  
employees were found to be statistically significant.  This result is further supported by previous 
empirical evidence that larger employers are more likely to offer health/medication coverage  
than smaller employers. 
This leads to a potential causal relationship where larger employers equate to more 
coverage which translates to more prescription utilization and pharmacists.  Empirical evidence 
from this inquiry provided the basis for accepting the hypothesis regarding the relationship 
between the number of insured and the total number of pharmacists.  This finding is 
consistent with empirical findings in the extant literature on the pharmacist supply reported 
by previous investigators. Insurance coverage impact on the pharmacist supply is exemplified in 
two studies which showed that Medicare Part D helped make 14 to 30 million prescriptions 
available monthly at a cost savings to persons who may not have been able previously to afford 
their prescription drugs and it increased the probability of any prescription use by 9.6% (Kostick, 
2006; Huh, Rice, & Ettner, 2008).  In addition, other studies have reported an increase in 
prescription drug utilization and pharmacist workload when accounting for insurance coverage 
(Huh, Rice, and Ettner, 2008; & Geib, 2007).   
The last hypothesis pertained to pharmacist growth over time.  The pharmacist supply 
exemplified a change in supply over the timeframe analyzed with two segments of the timeframe 
being significant based upon the threshold established by the bonferonni correction. The results 
of the hypotheses are summarized in Table 39.   
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Table 39. Summary of Hypotheses Tested 
 
Hypotheses Variable Status F Value Pr > F 
  Munificence        
H1 Pop Accepted 4.13 0.0426 
H2 Pop65+ Rejected 3.4 0.0657 
H3 Hosp Accepted 7.51 0.0064 
H4 PharmF Rejected 2.23 0.1362 
H5 Rx Rejected 2.34 0.1263 
H6 Phys Rejected 0.49 0.4832 
H7 MHI Rejected 0.02 0.8976 
  Concentration       
H8 HospC per 100,000 population Rejected 2.86 0.0919 
H9 PharmFC per 100,000 population Rejected 0.11 0.7387 
H10 OBDR per 100,000 population Rejected 0.42 0.5184 
H11a EmpV Rejected 0.03 0.8534 
H11b1 EmpS1 (19 or less employees) Rejected 0.84 0.3586 
H11b2 EmpS2 (20 or more employees)  Accepted 5.15 0.0236 
H12 Ins Accepted 5.66 0.0176 
  Density       
H13 Year Accepted 104.1 
1995 –1996,  .0008 
2006 – 2007, .0029 
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Chapter 6: Discussion 
  
 
The purpose of this study was to assess the feasibility of using the population ecology 
theoretical framework to examine the impact of environmental factors on the pharmacist 
supply.   
Munificence Results 
The first environmental dimension, munificence, is addressed in hypotheses H1-H6.  
Hypothesis 1 addressed the impact of population size on the pharmacist supply. A test of H1 
revealed that there is a positive, linear relationship between size of the residential population and 
the pharmacist supply; as a result H1 was accepted. This finding is consistent with other findings 
in the literature.  The primary source for a pharmacist supply to sustain itself is a viable patient 
population. It is logical and reasonable to expect that as the size of the residential population 
increases there is likely to be a corresponding increase in the patient population.  A larger patient 
population may lead to a greater demand for prescriptions to be dispensed and, thus, an increased 
demand for the services of pharmacists. 
H2 focused on a subset of the population.  This hypothesis addressed the impact of the 
elderly on the pharmacist’s supply.  The results were not statistically significant and, therefore, 
divergent from the expectations that the elderly (65+ years old) population could impact 
pharmacist supply.  This was a surprising result considering the volume of prescriptions utilized 
by the elderly population, which has been referenced in previous studies (Kaiser Family 
Foundation, 2011; Stagnitti, 2007).   
                              
123 
 
It is important to note that although this result was not significant, this population 
continues to grow and may be of interest as healthcare insurance policies are adjusted over the 
next several years.  This surprising finding may be attributed to several environmental factors 
such as the impact of Medicare Part D and the fact that the baby boomer generation is just 
starting to comprise a substantial proportion of the elderly population.  Future research focusing 
on environmental factors affecting the pharmacist supply should include a closer examination of 
these factors.  
H3 addressed the impact of hospital facilities with pharmacies and was accepted. The 
increased utilization of hospital-based pharmacists on treatment teams appears to be a significant 
environmental factor that may impact the pharmacist supply.  This finding points to the fact that 
pharmacists have a wider range of responsibilities in the hospital setting and they are expected to 
apply their extensive pharmaceutical expertise to ensure optimal drug therapy outcomes and to 
minimize medication errors in the hospital setting.  
The impact of clinical pharmacists in hospitals has been documented in the literature and 
findings from this inquiry are consistent with previous empirical findings regarding the role of 
clinical pharmacists in hospital settings.  In direct contrast to hospital settings, the number of 
retail pharmacies was not found to be a significant environmental factor affecting the pharmacist 
supply.  H4 was rejected.  This result was unexpected and surprising.  The reason for this finding 
is not immediately clear.  It will be imperative to include this variable in future research on 
environmental factors affecting the pharmacist supply.  One possible explanation may be that 
retail pharmacies are utilizing alternative manpower solutions to meet growing demands for 
pharmacist services.  
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Retail pharmacies appear to be searching for and implementing innovative and creative solutions 
that involve an increased reliance on pharmacy technicians and advanced technology 
(automation, robotics, electronic transmission of prescriptions) to handle the growing volume of 
prescriptions to be filled.  Such strategies may satisfy the demands of growing prescription 
volume while at the same time having a neutral or negligible economic impact on the bottom line 
of retail pharmacies.  Although the implementation of advanced technology may initially be 
expensive, retail pharmacies may be able to realize greater profit margins in the long-term 
because pharmacy technicians are substantially less expensive than pharmacists. Future research 
will need to examine these strategic choices in greater detail so that there will be a clearer, 
empirically based understanding of their impact on the pharmacist supply.  Downsides of these 
strategic decisions include an increased propensity for medication errors and reduced 
opportunities for pharmacist-patient interactions.    
The volume of prescriptions being filled was not found to be a significant environmental 
factor impacting the pharmacist supply.  Consequently, H5 was rejected.  Previous findings in 
the extant literature on the pharmacist supply suggested that there indeed is a statistically 
significant, linear relationship between the number of prescriptions filled and the pharmacist 
supply.  In light of the results from this inquiry, more empirical studies will be needed to clarify 
the impact of this variable on the pharmacist supply.  One possible explanation for this finding is 
that, although the volume of prescriptions to be filled is growing, it has not reached the threshold 
at which its impact can be discerned in light of other environmental factors affecting the 
pharmacist supply.  More empirical evidence is needed in order to reach more conclusive 
findings regarding prescription volume and the pharmacist supply.   
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It appears that there may be a significant interaction between prescription volume and the 
number of prescriptions that can be reasonably filled by a single pharmacist during a shift.  
Future studies should explore this possibility by including an interaction term in statistical 
models purporting to explain the impact of environmental factors on the pharmacist supply.  
H6 explored the relationship between the physician supply and the pharmacist supply. 
The test of H6 revealed no statistically significant relationship between the total number of 
physicians and the pharmacist supply.  Consequently, H6 was rejected.  In light of the fact that 
physicians write the overwhelming majority of prescriptions to be filled in the U.S., it seemed 
logical that this environmental factor could have a statistically discernible impact on the 
pharmacist supply.   It seems plausible that as the physician population increases there will be an 
increase in the number of prescriptions written and, in turn, an increased demand for pharmacists 
to keep pace with the growing volume of prescriptions to be filled.  Although this association 
was not confirmed in this inquiry, future research should continue to explore this relationship.   
 The number of physicians, total number of pharmacists and the volume of prescriptions 
being written are all expected to continue to increase in coming decades.  One possible 
explanation for the finding in this inquiry may be that, while physicians do write a large number 
of prescriptions, a large portion of these prescriptions may never be filled.  Thus, there may not 
be a sufficient enough increase in prescription volume to increase the demand for pharmacists.  
Paramount among the reasons a patient may choose not to have one or more of their 
prescriptions filled is a lack of insurance or a means of paying to have a prescription filled.   
Improved methodological approaches for exploring the relationship between the 
physician supply and the pharmacist supply may shed more light on this relationship and enable 
the ability to reach more tenable conclusions and consensus regarding the impact of the 
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physician supply on the pharmacist supply.  Such methodological approaches may include better 
predictive models and a means of controlling for possible intervening variables that could 
confound the presumptive relationship between the physician supply and the pharmacist supply 
in a population ecology framework.    
 Wealth of the community was the final environmental factor that was believed to have 
an impact on the pharmacist supply.  It is hypothesized that there would be a positive, linear 
relationship between wealth of the community and the pharmacist supply.  A test of H7 caused 
the rejection of this hypothesis.  It was not a statistically significant relationship between wealth 
of the community (indicated by median household income) and the pharmacist supply in this 
inquiry.  This finding contradicts our premise that increasing community wealth will lead to an 
increased demand for pharmacists.  It was our contention that wealthier communities could better 
afford prescription medications and are more likely to get their prescriptions filled compared to 
less wealthy communities.  Future research into the environmental factors impacting the 
pharmacist supply may need to test for an interaction effect involving number of prescriptions, 
insurance status and wealth.  Additionally, future models may need to also control for 
community health status.  It is well-known in the health services literature that health status and 
income (one indicator of wealth) are inversely related. 
Concentration Results 
Concentration describes the level to which resources are evenly distributed.  H8 was the 
first hypothesis tested in the concentration dimension and it explored the relationship between 
hospital beds per 100,000 population and the pharmacist supply.  This variable was not found to 
be statistically significant and lead to the rejection of H8.  This finding is surprising in light of 
the fact that the number of hospitals was found to be a significant environmental factor 
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impacting the pharmacist supply.  Future research may need to explore the relationship between 
hospital size and the pharmacist supply to shed more light on how this dimension affects the 
pharmacist supply.  One possible explanation for this finding may be that the number of hospital 
beds per 100,000 may not be as pertinent a point in measuring pharmacist supply as are factors 
within a hospital, such as the type of services they provide and their patient mix.  These hospital 
attributes may prove to be more important antecedents to the pharmacist supply than the size of 
the hospital.        
  The number of pharmacies per 100,000 population was the next indicator of 
concentration that was examined in this inquiry and it was the focus of H9.  As was the case for 
H8, a test of H9 did not yield statistically significant results and it was rejected.  It seemed 
logical that as the ratio of pharmacy facilities to the population increase there would be more 
pharmacist positions to fill and, thus, the pharmacist supply would increase.  The primary source 
for a pharmacist to sustain himself or herself is a viable patient population and the setting in 
which those services will be rendered.  Community-based pharmacies would appear to meet that 
need for practicing pharmacists.  Although not significant in this inquiry, this variable should be 
explored in future studies seeking to understand how environmental factors impact the 
pharmacist supply.  It may be helpful in such studies to control for type of pharmacy facility 
(e.g., grocery stores, wholesale warehouses and mail-order). 
   The third indicator of concentration that was explored in this inquiry was the number of 
office-based physicians per 100,000 population.  It is hypothesized that there is a positive, linear 
relationship between the number of office-based physicians per 100,000 population and the 
pharmacist supply.  This relationship was the focus of H10.  Based on the results from testing 
H10, it was rejected it and concluded that the number of office-based physician per 100,000 
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population is not a significant environmental factor affecting the pharmacist supply.  Although 
the number of office-based physicians per 100,000 population continues to increase, it does not 
impact the growth of the pharmacists supply.  This may be due to the supply of pharmacists 
being able to handle the increased volume of prescriptions at this juncture; possibly augmented 
by medication dispensing technology and pharmacy technicians (Adams, Martin, & Stolpe, 
2011).   The specific types of physicians along with their patient mix may provide a better 
barometer of how the number of office-based physicians per 100,000 population may impact the 
pharmacist supply and should be explored in more detail in future studies.    
Hypotheses 11a and 11b address employer concentration levels.  Employers are the 
primary source of health insurance coverage. H11a focused on employer volume (number of 
employers) and was rejected.  The number of employers does not have a significant impact on 
the pharmacist supply.  Although the numbers of employers was not found to be significant, 
employer size does appear to have a significant environmental impact on the pharmacist supply.   
H11b1 and H11b2 focused on employer size, with H11b1 being rejected, and H11b2 
being accepted based upon test results.  Large employers (20 or more employees) were found to 
have a statistically significant effect on the pharmacist supply.  Two separate repeated measures 
regression equations were solved to reach this conclusion.  Results were not statistically 
significant for the equation that included employers with 19 or fewer employees.  Large 
employers have at least two advantages over their smaller counterparts: (1) they are more able to 
offer health coverage and (2) they can offer better medication insurance coverage.  Small 
employers who may have predominantly lower-wage workers are much less likely to offer health 
insurance since the greater cost of underwriting and administering coverage for each enrollee in a 
small workforce adds to the cost of the premium.   
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H12 addressed insurance coverage and was accepted based on test results.  Insurance 
coverage was found to be a statistically significant environmental factor affecting the pharmacist 
supply.  The impact of increased insurance coverage for prescription drugs has resulted in a 
significant increase in prescription volume. Health insurance is usually the primary source for 
paying for prescriptions.  The ability to pay for prescriptions through insurance coverage plays a 
vital role in the volume of prescriptions to be filled, which in turn plays a role in the need for 
pharmacists.  This result places emphasis on the importance of insurance as individuals decline 
filling prescriptions due to lack of insurance.  Increased access to prescription drugs through 
insurance coverage appears to impact the pharmacist supply.  
Density Results 
Hypotheses H1-H12 explored the impact of munificence and concentration the 
pharmacist supply.  H13 was the final hypothesis tested in this inquiry.  A test of H13 sought to 
answer the question of whether there was a statistically significant change in the pharmacist 
supply over the 16-year time period of this inquiry.  This question addresses the dimension of 
density in the population ecology theoretical framework. 
In this inquiry the pharmacist supply was treated as an organization within the context of 
the population ecology theoretical framework.  It is important to note that, while the environment 
plays a role in determining the ebb and flow of organizations, in this instance the pharmacist 
supply, it is important to determine what type of impact changes in the organization has on the 
organization over time.  For instance, does the organization have different factions, and if so, 
what types of interactions exist among these factions (e.g. symbiosis, commensalism, 
competition).  In the case of the pharmacists supply, it seems that if there are any factions they 
may likely be work milieu and degree of specialization.   Competition at some level is plausible 
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given the primary functions all pharmacists are capable of performing.  However, this is most 
likely to occur when there is a scarcity of resources. 
An examination of the possible factions mentioned above with regard to the pharmacist 
supply is beyond the scope of this inquiry.  The test of H13 was performed to answer the 
question of whether there was a statistically significant change in the pharmacist supply between 
the first year of the time period for this inquiry (1994) and the last year (2009).  If that is the 
case, there will be some indication of the extent to which the past pharmacist supply impacts 
future supply. 
Hypothesis 13 was accepted and it was concluded that the past pharmacist supply does 
impact the future supply.  Future studies will need to consider the roles of the factions mentioned 
above in this relationship.  Overall, the pharmacist supply continued to rise at a consistent pace 
across the years in the period of time covered by this inquiry.  Aside from the statistically 
significant change in the pharmacist supply between 1994 and 2009, there was a significant 
change for two other years within the time period for this inquiry when the bonferonni correction 
was applied: 1995-1996 and 2006-2007. 
Possible reasons for the continuous growth of the pharmacist supply between 1994 and 
2009 include: (1) expansion of the scope of practice, (2) expanded practice settings, (3) an 
increase in the number of pharmacy schools and increased class sizes within schools and (4) a 
higher influx of international pharmacy graduates who meet licensure requirements and become 
licensed to practice in the U.S.  
Summary of Hypothesis Testing 
H1-H7 addressed the munificence dimension of the population ecology framework.  H8-
H12 addressed the concentration dimension.  H1 and H3 were accepted and it was concluded that 
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the size of the population and the number of hospitals are significant munificence factors 
affecting the pharmacist supply.     
H11b2, H12 and H13 were accepted.  Employers with 20 or more employees and having 
insurance were found to be significant concentration factors affecting the pharmacist supply 
between 1994 and 2009.  Previous pharmacist supply was found to significantly affect future 
supply.  
Implications 
Theoretical Implications.  
The theoretical framework utilized in this inquiry has been used by organization theorists 
to determine how environmental factors impact organizations in the restaurant, newspaper and 
health care industries in the past.  The population ecology theory has both benefits and 
limitations when it is applied to the study of the pharmacist supply.  Among the benefits, the 
population ecology theory enables the ability to explore the impact of environmental factors on 
the pharmacist supply overall as well as specific subsets of it (e.g., mail order pharmacists, retail 
pharmacists).  The inclusion of carrying capacity helps to ensure that the role of the environment 
on the pharmacist supply can be explored in terms of dimensions such as munificence (e.g., the 
residential population) and concentration (e.g., pharmacies per 100,000 population).   
The use of the population ecology framework in this inquiry provides an opportunity to 
expand the use of this theory to shed more empirical light on the impact of environmental factors 
on the healthcare workforce.  The exploration of the density construct within the healthcare 
industry is particularly promising.  In density, all organizational members are assumed to be 
equivalent in terms of measuring competition for resources.  This, however can have the ability 
to lead to some misinterpretation due to the fact not all members of an organization are equally 
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competitive.  A second area in which the population ecology theory may not be beneficial in the 
measurement of the pharmacist supply is where a pharmacist may have two competing roles such 
as a retail pharmacist at day and a mail order pharmacist at night serving the same population.  
For instance how can the size of populations or resource space be determined if they work as 
retail pharmacists during the day and mail order pharmacists at night servicing the same 
geographical population?  
Future studies should include an analysis of specialties within the profession of pharmacy 
and additional healthcare providers that may impact the pharmacist supply.   
Methodological Implications. 
Treating the pharmacist supply as an organization and examining it within the population 
ecology theoretical framework appears to have been a suitable methodological approach for 
examining environmental factors affecting the pharmacist supply.  The profession of pharmacy is 
broad enough in scope so that it is amenable to being examined from the perspective of the 
various dimensions of the population ecology theory.   
Growing specialization within the profession has expanded the practice settings for 
pharmacists and they can be found in a number of settings in which they are able to perform 
basic and advanced functions.  Although the population ecology framework has been used in 
previous studies of various industries, its use in the healthcare industry has been limited.  This 
framework was particularly amenable to employing repeated measures as a means of testing 
empirically based hypotheses to shed light on how various environmental dimensions affect the 
pharmacist supply over time (e.g., munificence, concentration and density).  
 Understanding how the pharmacist supply is impacted individually and collectively by 
environmental factors will yield fertile ground for more sophisticated statistical and 
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methodological approaches to examine this topic in the future.  The use of a 16-year time frame 
for this inquiry was a noteworthy departure from previous studies that have used as few as two 
years.  Longer time periods allow the ability to obtain a more accurate picture of the impact of 
environmental factors on the pharmacist supply.    
Health Policy Implications. 
The pharmacist workforce continues to grow and diversify into a myriad of disciplines as 
demands for pharmaceutical services has entered specialty areas such as geriatrics, oncology, and 
radioactive pharmaceuticals.   
Numerous studies have reported that an increase in prescription drug utilization and 
pharmacist workload occurs when the proportion of the resident population with insurance 
coverage increases.  The passage of the Affordable Care Act and its gradual implementation over 
the next several years is expected to have a very significant and discernible impact on this well 
established relationship.  It is estimated that 32 million previously uninsured people will become 
insured as a result of the Affordable Care Act.  No doubt this fact will significantly change the 
pharmacist workforce landscape.  It is likely that with the growth in insurance coverage, the 
pharmacist supply will grow as well and pharmacists will be presented with additional practice 
opportunities in more practice settings.  Another environmental factor that could potentially 
impact the pharmacist supply in coming years is the increase in the elderly segment of the 
residential population.  Although this was not found to be a significant environmental factor in 
this inquiry, it should be explored in future studies of the pharmacist supply as it has been found 
to be significant in past studies.  If it is a significant environmental factor, it will no doubt have a 
profound impact on the pharmacist supply with important health care policy implications. 
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 The practice of defensive medicine is a third environmental factor that may warrant 
exploration in futures studies of the pharmacist supply in the context of the population ecology 
theory.  Defensive medicine refers to situations in which physicians prescribe medications to 
ensure that they have covered every possibility; even in circumstances wherein prescription 
medications may not be indicated.  
 The implementation of Medicare Part D is projected to result in an increase of 14 to 30 
million prescriptions to be filled monthly (Kostick, 2006). While the healthcare reform act will 
not just provide healthcare services to the elderly, one must be cognizant of the potential increase 
in the prescription volume and the demands that are accompany this influx of potentially new 
patients.    
Managerial/Administrative Implications.  
Growth in the pharmacist supply as a result of the reasons mentioned above has 
implications for healthcare executives, managers and personnel administrators.  These 
individuals will face various challenges as they strive to manage a larger, increasingly more 
complex pharmacist workforce.  They will need to keep abreast of changes in their environment 
as they attempt to meet the needs of their professional workforce and dynamic patient/customer 
population.  An understanding of the demographic changes in their complex work environments 
will enable executives and managers to respond more rapidly and appropriately to their practice 
environments.  A thorough knowledge of their work and practice environments will enable them 
improve patient care and healthcare efficiency.   
 Pharmacy managers may need to develop more innovative strategies and pursue new 
means of finding and hiring pharmacists to meet the needs of their practices (e.g., professional 
recruitment agencies).  Pharmacy schools have increased their class sizes in an attempt to meet 
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the needs for pharmacist’s services in a growing resident population.   Hospitals managers will 
possibly need to award bonuses and other incentives to attract new hires, which may include 
payment for relocation expenses and tuition assistance. It is imperative for pharmacy schools to 
align their programs to meet the demands of hospitals as they try to curtail medication errors and 
decrease mortality and morbidity rates. 
The number of large employers and the number of insured both impact the pharmacist 
supply.  Large employers are more apt to provide insurance coverage, hence the potential to 
increase prescriptions.  Incentives directed toward retention and recruitment would be the staple 
for managers where they may have to utilize salary increases, stay-on bonuses, and tuition 
assistance for pharmacists. An additional bargaining tool may be the current or future influx of 
large employers which will increase the hiring organization’s argument that they will have not 
only a sufficient workload, but possibly the ability to give presentations at these facilities on 
various medication topics. The questions that help determine and form their strategic goals/plans 
are: how many pharmacists are needed at my hospital and will it improve the quality of care in 
the community? Is the number of pharmacists in my community sufficient to address the number 
of insured and physicians in the geographical area?  Evaluating one’s environmental needs will 
help to ensure that a practical plan is developed.  This should help to guarantee that an 
appropriate number of pharmacists are available to meet the current and changing demands of 
their surrounding environment.  
Limitations  
The data used in this inquiry came from a number of sources.  While the data were 
sufficient to conduct the tests described in this inquiry, it should be noted that the two limitations 
of the data.  The first limitation relates to the prescription fill data obtained from NACDS.   
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NACDS data come only from retail pharmacies that are members of the association.  Future 
studies should attempt to use as many sources as possible in order to get the most accurate, 
comprehensive, unduplicated prescription fill data available.   
Although the NACDS prescription fill data were sufficient for this inquiry, it should also 
be noted that the conclusions are based on using these data may not be as generalizable as might 
have been preferred. NACDS members represent a subset of prescription fill data sources in the 
U.S.  There is no single retail database of prescription fill data in the U. S.  Should such a 
database become available in the future, it will be very useful for inquiries such as this one.  The 
best source of data on prescriptions filled in institutional settings comes from medication orders 
in hospitals.  As is the case with retail prescription fills data, there is no single source of 
prescription fill data for institutions.  One problem with medication orders data is that a single 
medication order may represent one to twenty separate prescriptions (DHHS, 2000).  The 
availability of more representative prescription fill data will greatly enhance studies of the 
pharmacist supply in the future.  
The second limitation of the data used in this inquiry was that there was no inclusion of 
pharmacy technicians.  Pharmacy technicians can perform a variety of tasks under the 
supervision of a pharmacist.  It is reasonable to assume that if a single pharmacist can supervise a 
number of pharmacy technicians at a time, there may be less of a need for pharmacists and this 
will impact the pharmacist supply.   
Future studies of environmental factors impacting the pharmacist supply should include 
data on pharmacy technicians.  These health care workers have extensive training and provide 
extensive support in the practice environment (Manasse & Speedie, 2007).  There does not seem 
to be an accurate source for tracking the technician workforce.  The inclusion of more 
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representative prescription fill data and data on pharmacy technicians should greatly enhance 
future studies of the pharmacist supply and factors that impact it.  
Future Research 
The primary goal of this inquiry was to determine the feasibility of using the population 
ecology theory to explore the impact of environmental factors on the pharmacist supply in the 
U.S.  Thirteen hypotheses were generated from a review of the literature and tested in this 
inquiry.  H1-H7 examined factors from the munificence construct of the population ecology 
theory.  As a result of testing these hypotheses H1 and H3 were accepted and it was concluded 
that the size of the residential population and the number of hospital facilities are significant 
munificence factors impacting the pharmacist supply. 
H8-H12 examined the concentration construct of the theory.  Tests of these hypotheses 
resulted in acceptance of H11b2 and H12.  It was concluded that employers with 20 or more 
employees and having health insurance significantly impact the pharmacist supply.  With regard 
to density, H13 was accepted and it was concluded that past pharmacist supply significantly 
impacts future pharmacist supply.While the findings from this inquiry are believed to be 
contributions to the literature on environmental factors affecting the pharmacist supply, future 
research should also take into account several additional variables.  The first of these is physician 
specialty (e.g. orthopedics, surgery, psychiatry etc.).  The physician population was not found to 
be a significant factor affecting the pharmacist supply in this inquiry. The inclusion of physician 
specialty in future research may shed more light on the impact of this variable.  Second, if the 
data are available, it would be informative to have more data on pharmacist practice settings and 
include such data in predictive models (e.g. retail pharmacists, mail-order pharmacists). 
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Third, instead of using a dichotomous variable for insurance coverage, it might be 
insightful to use type of coverage (e.g. HMO, PPO, etc). Fourth, if the data are available, it 
would be advantageous to include information on pharmacy technicians in future studies.  
Pharmacy technicians comprise an integral component of manpower in hospital and retail 
pharmacy settings. The inclusion of pharmacy technician data in future studies is very important 
because increasing number of states are introducing and enacting laws to expand the scope of 
practice of pharmacy technicians.  One example of this emerging trend is a tech-check-tech 
(TCT) system, where a technician’s accuracy is reviewed by another technician as opposed to a 
pharmacist (Adams et al., 2011; Reed, Thomley, Ludwig, & Rough 2011). This trend may have a 
very significant impact on the pharmacist supply in the future and should be explored 
empirically. 
Technology used in various pharmacy settings continues to evolve.  Future research must 
examine the impact of evolving technology in order to more fully understand how it impacts the 
pharmacist supply.  One example of this technology is the use of dispensing machines. Central-
fill pharmacies may be a viable option to handle an increasing demand for pharmacist services in 
coming decades.  This increase in demand for pharmacist services has been precipitated by a 
growing volume of prescriptions to be filled, especially in retail settings in the community.   
Future research into the environmental factors affecting the pharmacist supply  
must include a close examination of the trend toward central fill pharmacies and the technologies 
that they employ (e.g. increase use of dispensing machines) in order to fully understand how it 
may impact the pharmacist supply.  A mixed methods approach, involving both qualitative and 
quantitative modalities, should be used in conjunction with the repeated measures regression 
used in this inquiry to explore this variable.  
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Within the context of the population ecology theoretical framework, central fill  
pharmacies appear to be related to the density and concentration constructs.  It will be  
particularly interesting to examine this trend toward central fill pharmacies after 2009,  
the last year in the period for this inquiry.  
Finally, this inquiry examined the impact of environmental factors on the pharmacist 
supply from a national perspective.  It may be useful in future inquiries to examine these factors 
by looking at regions or other sub national levels (e.g., metropolitan statistical areas, census 
tracks, rural areas, etc.).  By doing so it maybe plausible to provide a more detailed description 
of environmental factors and their impact on pharmacist supply in the local practice 
environment. 
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Appendix A  
 
 
 
    Pharmacy Supply Model Results 1991-2020: Total Active Pharmacists 
 
Year 
Active as of 
Jan 1 Graduates IPGs 
Workforce Losses Due to Estimated 
Death and Retirement Net Gain 
Total Active 
Dec 31 
1991 NA NA NA NA NA NA 
1992 171611 7113 314 5664 1763 173374 
1993 173374 7380 314 5491 2203 175577 
1994 175577 7504 314 5347 2471 178048 
1995 178048 7837 314 5240 2911 180959 
1996 180959 8003 314 5168 3149 184108 
1997 184108 7772 314 5127 2959 187067 
1998 187067 7400 314 5084 2630 189697 
1999 189697 7829 314 5047 3096 192793 
2000 192793 7945 314 5040 3219 196012 
2001 196011 7494 314 5101 2707 198718 
2002 198718 7485 314 5157 2642 201360 
2003 201359 7717 314 5195 2836 204195 
2004 204194 7965 314 5230 3049 207243 
2005 207243 8054 314 5289 3079 210322 
2006 210321 8054 314 5400 2968 213289 
2007 213289 8054 314 5486 2882 216171 
2008 216171 8133 314 5578 2869 219040 
2009 219041 8133 314 5657 2790 221831 
2010 221832 8133 314 5756 2691 224523 
2011 224524 8213 314 5842 2685 227209 
2012 227209 8213 314 5929 2598 229807 
2013 229807 8213 314 6004 2523 232330 
2014 232330 8293 314 6058 2549 234879 
2015 234879 8293 314 6128 2479 237358 
2016 237358 8293 314 6203 2404 239762 
2017 239762 8373 314 6266 2421 242183 
2018 242182 8373 314 6325 2362 244544 
2019 244543 8373 314 6385 2302 246845 
2020 246844 8452 314 6524 2242 249086 
 
    Data Gershon et al., (2000) Study. 
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Appendix B   
  
 
 
NACDS Surveys, 1998 to 2006: Unfilled Positions 
 
 
Employment Survey 
Time Series 
Vacancies Full-Time of 
Chain RPh 
Vacancies Part-Time of 
Chain RPh Total Vacancies 
February 1998 2,163 505 2,668 
August 1998 2,862 648 3,510 
February 1999 3,453 1,024 4,477 
August 1999 4,679 1,263 5,942 
February 2000 5,971 949 6,920 
August 2000 5,546 879 6,425 
February 2001 5,723 841 6,564 
August 2001 6,666 1,078 7,743 
January 2002 5,619 883 6,503 
July 2002 4,703 772 5,475 
January 2003 4,886 613 5,499 
July 2003 3,818 845 4,663 
January 2004 3,538 470 4,008 
July 2004 3,414 610 4,024 
January 2005 4,542 1,420 5,962 
July 2005 4,971 1,000 5,971 
January 2006 3,941 3,558 7,499 
July 2006 4,044 389 4,443 
                              
         
Appendix C 
 
 
 
  Mean U.S. ADI Values from September 1999 through September 2003 
 
State 
Mean 
ADI State 
Mean 
ADI State 
Mean 
ADI State 
Mean 
ADI 
Alabama 4.06 Illinois 4.05 Montana 3.63 Rhode Island 3.13 
Alaska 4.05 Indiana 4.12 Nebraska 3.56 
South 
Carolina 4.02 
Arizona 4.04 Iowa 3.94 Nevada 3.77 South Dakota 3.42 
Arkansas 3.65 Kansas 3.84 New Hampshire 3.79 Tennessee 4.24 
California 4.73 Kentucky 4.42 New Jersey 3.57 Texas 4.39 
Colorado 3.89 Louisiana 3.75 New Mexico 3.93 Utah 3.86 
Connecticut 4.03 Maine 4.09 New York 4.05 Vermont 3.58 
Delaware 3.45 Maryland 4.35 North Carolina 4.05 Virginia 4.32 
District of 
Columbia 4.2 Massachusetts 3.82 North Dakota 3.45 Washington 3.98 
Florida 4.15 Michigan 4.31 Ohio 4.15 West Virginia 4.22 
Georgia 4.05 Minnesota 4.54 Oklahoma 3.8 Wisconsin 4.6 
Hawaii 3.1 Mississippi 4 Oregon 3.87 Wyoming 3.73 
Idaho 3.61 Missouri 3.92 Pennsylvania 3.94 
   
   Data provided by Knapp et al. (2005)   
   ADI = Aggregate Demand Index. Ratings are defined as follows: 5 = high demand for pharmacists, difficult to fill positions, 4 = moderate      
   demand, some difficulty filling positions, 3 = demand in balance with supply, 2 = demand is less than the pharmacist supply available and             
   1 = demand is much less than the pharmacist supply available.
1
6
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Appendix D 
 
 
 
             Percentage Change in Number of Hospitals, Insured Population, Population 65+, Pharmacy Facilities, and Number of  
             Physicians Per Year, 1994-2009  
  
 
    
 
 
 
 
 
 
 
                     
                   1 
Calculated in 1,000s, 
2
 Calculated in 1,000,000s      
Year Hosp1  % Change  Ins2 % Change  Pop 65+2 % Change  PharmF1 % Change  DR1 % Change  
1994 0 NA 222.4 NA 33.20 NA  0 NA 623.4 NA 
1995 6.4 NA 223.7 1% 33.55 1% 68.13 NA 653.7 5% 
1996 0 NA 225.0 1% 35.53 6% 70.77 4% 672.6 3% 
1997 0 NA 225.6 0% 35.98 1% 72.87 3% 695.9 3% 
1998 0 NA 227.4 1% 35.77 -1% 73.31 1% 720.2 3% 
1999 0 NA 237.1 4% 36.04 1% 72.03 -2% 735.9 2% 
2000 6.3 -2% 240.3 1% 34.99 -3% 73.75 2% 752.2 2% 
2001 6.2 -1% 241.4 0% 35.28 1% 72.93 -1% 765.4 2% 
2002 6.2 0% 243.1 1% 35.59 1% 74.91 3% 783.4 2% 
2003 6.2 0% 244.0 0% 35.91 1% 78.47 5% 802.6 2% 
2004 6.3 1% 246.8 1% 36.29 1% 80.85 3% 808.9 1% 
2005 6.6 4% 249.0 1% 36.78 1% 87.24 7% 818.8 1% 
2006 6.6 0% 249.8 0% 37.25 1% 85.26 -2% 828.0 1% 
2007 6.6 0% 253.4 1% 37.88 2% 85.67 0% 844.8 2% 
2008 0 NA 255.1 1% 38.86 3% 83.94 -2% 848.9 0% 
2009 0 NA 253.6 -1% 39.57 2% 84.81 1% 0 NA 
1
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Appendix E 
 
 
 
                    Percentage Change in Pop, Pharmacies Per 100,000, Employers by Size Per Year 
 
 
 
 
 
 
 
 
 
 
 
                            1 
Calculated in 1,000s, 
2
   Calculated in 1,000,000s 
Year Pop2 
% 
Change 
in Pop 
Per 
Year  Rx2 
% 
Change 
in Rx  
Per 
Year  
Pharmacies 
Per 
100,000 
population 
(PharmFC) 
% Change in 
Pharmacies Per 
100,000 
population Per 
Year (PharmFC)  
Employers 
with 19 or 
Less 
employees 
(EmpS)1 
% Change in 
Employers with 
19 or less 
employees Per 
Year  (EmpS) 
Employers 
with 20 or 
More 
employees 
(EmpS)2 
% Change in 
Employers 
with 20 or 
more 
employees Per 
Year (EmpS) 
1994 260.34 NA 0 NA 0 NA 4.11 NA 2.39 NA 
1995 262.76 1% 0 NA 27.81 NA 4.18 2% 2.42 1% 
1996 265.28 1% 2211 NA 28.40 2% 4.25 2% 2.48 2% 
1997 267.60 1% 2290 3% 28.98 2% 4.30 1% 2.59 4% 
1998 270.24 1% 2437 6% 28.90 0% 4.33 1% 2.60 1% 
1999 272.65 1% 2682 9% 29.62 2% 4.24 -2% 2.58 -1% 
2000 281.42 3% 2838 6% 29.52 0% 4.36 3% 2.70 4% 
2001 284.79 1% 2974 5% 29.64 0% 4.38 1% 2.70 0% 
2002 288.36 1% 3038 2% 29.11 -2% 4.37 0% 2.82 4% 
2003 290.80 1% 3083 1% 29.97 3% 4.43 1% 2.82 0% 
2004 293.65 1% 3116 1% 30.80 3% 4.50 2% 2.88 2% 
2005 296.41 1% 3192 2% 31.08 1% 5.40 17% 2.09 -38% 
2006 299.39 1% 3309 4% 33.21 6% 5.42 0% 2.17 4% 
2007 301.62 1% 3496 5% 32.37 -3% 5.46 1% 2.23 3% 
2008 304.05 1% 3556 2% 32.30 0% 5.34 -2% 2.25 1% 
2009 307 1% 3658 3% 0 NA 0 NA 0 NA 
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Appendix F 
 
 
 
    Percentage Change in Employer Volume, Hospital Beds Per 100,000, Office based Physicians 100,000,  
    and Median Household Income Per Year 
 
Year 
Total 
Employers 
(EmpV)2 
% Change in 
Employers Per 
Year (EmpV) 
Hosp beds Per 
100,000 
population 
(HospC) 
% Change in 
Hosp Beds Per 
100,000 
population Per 
Year (HospC)  
OBDR 
Per 
100,000 
population 
% Change 
in OBDR 
Per 100,000 
population 
Per Year  
Median 
household 
income 
(MHI) 
% Change in 
Median 
household 
income Per 
Year  (MHI) 
1994 6.50 NA 0 NA 0 NA $46,399   
1995 6.61 2% 446.8 NA 156.9 NA $47,255 2% 
1996 6.73 2% 0 NA 0 NA $47,810 1% 
1997 6.89 2% 0 NA 0 NA $48,774 2% 
1998 6.94 1% 0 NA 0 NA $50,661 4% 
1999 6.83 -2% 0 NA 0 NA $51,815 2% 
2000 7.07 3% 384.2 -16% 170.3 8% $52,017 0% 
2001 7.09 0% 382.4 0% 177.3 4% $51,248 -2% 
2002 7.20 1% 374.0 -2% 176.7 0% $50,511 -1% 
2003 7.25 1% 367.7 -2% 180.8 2% $50,648 0% 
2004 7.38 2% 363.4 -1% 182.5 1% $50,529 0% 
2005 7.49 1% 360.6 -1% 187.7 3% $50,771 0% 
2006 7.60 1% 357.9 -1% 184.7 -2% $51,439 1% 
2007 7.70 1% 356.0 -1% 183.9 0% $52,138 1% 
2008 7.60 -1% 0 NA 180.3 -2% $50,583 -3% 
2009 0 NA 0 NA 0 NA $49,857 -1% 
 
                                  1
   Calculated in 1,000s,
 2
   Calculated in 1,000,000s
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